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Abstract 
i 
ABSTRACT 
This study has involved the analysis of volatile fingerprints using a hybrid electronic 
nose (e-nose) to discriminate between and diagnose the microorganisms which cause 
ventilator–associated pneumonia (VAP), one of the most important infections in the 
hospital environment. This infection occurs in hospitalised patients with 48-72 hrs of 
mechanical ventilation. VAP diagnostics still remains a problem due to the lack of a 
precise diagnostic tool. The current tests are mostly based on quantitative cultures of 
samples from the lower lung airways with clinical findings, which do not often result in 
accurate diagnoses of the disease.  
The objectives of this study were to examine the use of a hybrid e-nose system to 
investigate the discrimination of five different VAP microorganisms (Enterobacter 
cloacae, Klebsiella pneumoniae, Staphylococcus strain, Candida albicans and 
Aspergillus fumigatus) using volatile fingerprints. Firstly, the medium to use was 
optimised, then the level of sensitivity of detection and the ability of discrimination in 
mixed cultures based on volatile fingerprints were examined; also, examination of the 
potential for discrimination when anti-fungal compounds are applied, and the use of 
complex and saline-based media to build in vitro models to distinguish between the 
VAP microorganisms was done to facilitate the diagnoses of a data set of clinical 
samples. 
Initially, three different commercial media were tested: Nutrient broth (NB), Tryptone 
soy broth (TSB) and Brain heart infusion broth (BHIB). The analysis of volatiles with 
the e-nose using two microorganisms (C.albicans and K.pneumoniae) showed better 
discrimination after 24 hrs incubation with NB. This medium was used for the analysis 
of sensitivity of detection, mixed cultures and discrimination between the five VAP 
causing microorganisms. 
The sensitivity threshold of detection using volatile fingerprints was found to be with 
10
2 
cells ml
-1
 for the bacteria after 24 hrs growth; 48 hrs for C.albicans; and 72 hrs for 
A.fumigatus.  The potential discrimination of mixtures of two microorganisms, 
C.albicans + E.cloacae and Staphylococcus species + E.cloacae showed that in most 
cases one of the species (E.cloacae) was predominant. This suggests that the use of 
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volatile fingerprints for discriminating mixtures may depend on relative concentrations 
and growth rates and competitiveness of individual species.  
The ability to discriminate between the five VAP microorganisms was compared in NB, 
and in saline solution which is used to obtain patient samples. This showed that it was 
possible to obtain discrimination between the five species within 24 hrs with an initial 
concentration of 10
4
 cells/spores ml
-1
. Similar results were obtained with NB and saline 
solution. This suggests that it is possible to use the saline solutions from patients for 
analyses using the e-nose approach. 
Complimentary studies were carried out to analyse the head space of VAP causing 
microorganisms by using GC-MS and SIFT-MS. Volatile profiles were investigated 
from all five VAP microorganisms on NA at 37°C for 24 hrs in nalophan bags. Key 
component for the microbial discrimination were: 1,4-pentadiene present only in 
A.fumigatus and E.cloacae; 4,4-dimethyl-1-pentene, 2-methyl-3-isopropylpyrazine and 
methyl mercaptan in A.fumigatus; mercaptoacetone in C.albicans and 2-methyl-1-
propanol in K.pneumoniae and E.cloacae cultures. The ketone, 2-pentanone was found 
in all the species except in the Staphylococcus strain. 3-methyl-butanal was not seen in 
A.fumigatus and 3-methyl-1-butanol was remarkably found in E.cloacae but not in 
blank medium and A.fumigatus. 
The efficacy of anti-fungal agents against C.albicans and A.fumigatus was evaluated to 
determine the potential of using volatile fingerprints to differentiate between ED50 and 
ED90 concentrations of benomyl, tebuconazole and fluconazole. Discrimination was 
obtained between ED50, ED90 and controls after 48 hrs for A.fumigatus with benomyl 
and tebuconazole at 37°C on solid medium; and after 48hrs slight discrimination was 
found for C.albicans in NB at 25°C. For the latter, no distinction between treatments 
was found at 37°C in saline solution.  Interestingly C.albicans was resistant to 
fluconazole in saline solution at 37°C but not in NB at 25°C; A.fumigatus was resistant 
to fluconazole. There were only a few differences between volatile biomarkers in 
treatments. Some compounds were found to be more abundant in the presence of anti-
fungal treatments. In ED50 concentrations of benomyl, SIFT-MS showed that 
A.fumigatus produced more isoprene and methanol whereas more methyl pentadiene 
and ethanol were found when tebuconazole was present.  GC-MS studies showed the 
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presence of some alcohols (3-methyl-butanol, 2-methyl-1-propanol) in A.fumigatus 
cultures and more presence of 2-methyl-1,3-pentadiene in tebuconazole ED50 
treatments. With C.albicans, regardless of fungicide treatment, no significant 
differences were found between treatments. 
The data obtained in vitro was used to develop a model to try and discriminate between 
patient samples. This data set was obtained in a previous study.   The clinical samples 
were divided into 4 groups: Gram-negative bacteria, Gram-positive, fungi and no 
growth. Two types of multivariate analyses were investigated, discriminant analysis 
(DA) and partial least square for DA (PLS-DA). The accuracy of prediction of clinical 
samples was 63.6% for both techniques in saline solution and 52.3% with PLS-DA and 
53.4% with DA in NB.  
The present study has demonstrated the ability of the e-nose to discriminate between 
five different VAP microbial species in vitro. The attempt of prediction of clinical 
samples was not successfully achieved but shows some promise.  The provision of more 
clinical samples would be required to evaluate whether the in vitro models can be 
successfully used for determining which drug should be used for more effective 
treatment of VAP.  
  
 
Acknowledgements 
iv 
ACKNOWLEDGEMENTS 
I would like to thank my supervisor, Prof. Naresh Magan for his advice and kindness 
and my second supervisor, Dr. Catherine Kendall for her comments and suggestions and 
Dr. Natasha Sahgal for replying to my questions so quickly.  
I also express my gratitude to Prof. Hugh Barr from the Gloucestershire Hospitals NHS 
Foundation Trust and Cranfield Health for funding this project. 
Next, I am very grateful to all the students in the lab, Esther Baxter and especially to Dr. 
Àngel Medina Vayá for his help in statistics knowledge. 
I give my thanks to all the personnel, staff and students for their help in 
chromatographic analyses made in Cranfield Health: Dr. Claire Turner, Dr. Chris 
Walton, Dawn Fowler and Mitesh Patel from “Volatiles Research Group” and Veronica 
Brown from Environmental Toxicology. 
Also thanks to Dr. Michael Cauchi for his help in PLS-DA analyses. 
I would like to mention and recognise a very special gratitude to my family for its 
delicious deliveries from home. 
 
 
 
 
 
 
 
 
 
 
 
Table of contents 
v 
TABLE OF CONTENTS 
ABSTRACT  ................................................................................................................. i 
ACKNOWLEDGEMENTS ............................................................................................ iv 
TABLE OF CONTENTS ................................................................................................. v 
LIST OF FIGURES ....................................................................................................... viii 
LIST OF TABLES ........................................................................................................ xiii 
LIST OF ABBREVIATIONS ........................................................................................ xv 
LIST OF EQUATIONS ................................................................................................. xix 
CHAPTER 1: LITERATURE REVIEW ....................................................................... 1 
1.1 INTRODUCTION ............................................................................................. 1 
1.2 VENTILATOR-ASSOCIATED PNEUMONIA ............................................... 2 
1.3 VOLATILE FINGERPRINTS-I: ELECTRONIC NOSES ............................... 9 
1.3.1 WHAT IS AN ELECTRONIC NOSE? ...................................................... 9 
1.3.2 TYPES OF ODOUR SENSORS .............................................................. 12 
1.3.3 APPLICATIONS ...................................................................................... 15 
1.4 VOLATILE FINGERPRINTS-II: MICROBIAL DETECTION AND 
DISCRIMINATION STUDIES ................................................................................. 18 
1.5 VOLATILE FINGERPRINTS-III: GC-MS AND SIFT-MS TECHNIQUES 24 
1.6 AIMS AND OBJECTIVES ............................................................................. 25 
CHAPTER 2: MATERIALS AND METHODS ......................................................... 28 
2.1 BACTERIAL AND FUNGAL CULTURES .................................................. 28 
2.2 ANALYSES OF VOLATILES OF VAP MICROORGANISMS IN 
DIFFERENT MEDIA................................................................................................. 29 
2.3 SENSITIVITY OF DETECTION OF VAP MICROORGANISMS ............... 29 
2.4 DISCRIMINATION USING VOLATILES IN MIXED CULTURES ........... 30 
2.5 DISCRIMINATION BETWEEN SPECIES IN NUTRIENT BROTH AND 
SALINE SOLUTION ................................................................................................. 31 
2.6 USE OF VOLATILE PRODUCTION PATTERNS TO DISCRIMINATE 
BETWEEN DIFFERENT ANTI-FUNGAL TREATMENTS AGAINST 
A.FUMIGATUS AND C.ALBICANS .......................................................................... 32 
2.6.1 EFFECT OF ED50/ED90 ANTI-FUNGALS ON GROWTH .................... 32 
Table of contents 
vi 
2.6.2 EFFECT OF ED50/ED90 OF ANTI-FUNGALS ON VOLATILE 
PRODUCTION PATTERNS AND DISCRIMINATION BETWEEN 
TREATMENTS ...................................................................................................... 34 
2.7 GC-MS AND SIFT-MS EXPERIMENTS ...................................................... 35 
2.8 ELECTRONIC NOSE SYSTEM USED ......................................................... 38 
2.8.1 OPERATING PRINCIPLE OF THE E-NOSE SYSTEM ....................... 39 
2.8.2 SAMPLE PREPARATION FOR E-NOSE ANALYSES ........................ 41 
2.8.3 E-NOSE DATA ANALYSIS ................................................................... 42 
2.8.4 OPTIMISING SENSOR COMBINATIONS ........................................... 47 
2.8.5 CONTROL OF SENSOR RESPONSES .................................................. 50 
CHAPTER 3: RESULTS ............................................................................................. 52 
3.1 ANALYSIS OF VOLATILES OF VAP MICROORGANISMS IN 
DIFFERENT MEDIA................................................................................................. 52 
3.2 SENSITIVITY OF DETECTION OF VAP MICROORGANISMS ............... 54 
3.3 DISCRIMINATION USING VOLATILES IN MIXED CULTURES ........... 58 
3.4 USE OF VOLATILE PRODUCTION PATTERNS TO DISCRIMINATE 
BETWEEN DIFFERENT ANTI-FUNGAL TREATMENTS AGAINST 
A.FUMIGATUS AND C.ALBICANS .......................................................................... 61 
3.5 IDENTIFICATION OF VOLATILES USING GC-MS AND SIFT-MS 
SYSTEMS .................................................................................................................. 68 
3.5.1 ANALYSIS OF VOLATILES OF 5 MICROORGANISMS GROWN ON 
NUTRIENT AGAR ................................................................................................ 68 
3.5.2 IDENTIFICATION OF VOLATILES PRODUCED DURING 
EXPOSURE TO ANTI-FUNGALS ....................................................................... 70 
3.6 COMPARISON OF DISCRIMINATION BETWEEN 5 
MICROORGANISMS USING NUTRIENT BROTH AND SALINE SOLUTION 
MEDIUM  .................................................................................................................. 79 
3.7 USE OF DATA FROM NUTRIENT BROTH AND SALINE SOLUTIONS 
ON THE VAP MICROORGANISMS TO BUILD A MODEL FOR PREDICTION 
OF CLINICAL SAMPLES ........................................................................................ 84 
CHAPTER 4: GENERAL DISCUSSION ................................................................... 94 
Table of contents 
vii 
4.1 ANALYSES OF VOLATILES OF VAP MICROORGANISMS IN 
DIFFERENT MEDIA................................................................................................. 94 
4.2 SENSITIVITY OF DETECTION OF VAP MICROORGANISMS ............... 96 
4.3 DISCRIMINATION BETWEEN MICROORGANISMS WHEN PRESENT 
IN MIXED CULTURE USING VOLATILE PRODUCTION PATTERNS ............ 99 
4.4 USE OF VOLATILE PRODUCTION PATTERNS TO DISCRIMINATE 
BETWEEN DIFFERENT ANTI-FUNGAL TREATMENTS AGAINST 
A.FUMIGATUS AND C.ALBICANS ........................................................................ 100 
4.5 IDENTIFICATION OF VOLATILES PRODUCED DURING EXPOSURE 
TO ANTI-FUNGALS USING GC-MS AND SIFT-MS SYSTEMS ....................... 102 
4.6 COMPARISON OF DISCRIMINATION BETWEEN 5 
MICROORGANISMS USING NUTRIENT BROTH AND SALINE SOLUTION 106 
4.7 USE OF VOLATILE DATA SETS FROM NUTRIENT BROTH AND 
SALINE SOLUTIONS ON THE VAP MICROORGANISMS TO BUILD A 
MODEL FOR PREDICTION OF CLINICAL SAMPLES ...................................... 108 
CHAPTER 5: CONCLUSIONS AND FUTURE WORK ......................................... 111 
5.1 CONCLUSIONS ........................................................................................... 111 
5.2 FUTURE WORK ........................................................................................... 113 
REFERENCES  ............................................................................................................ 114 
APPENDICES  ............................................................................................................ 126 
APPENDIX A ORIGIN OF THE MICROORGANISMS TESTED .................... 126 
APPENDIX B TABLES ........................................................................................ 127 
APPENDIX C FIGURES ...................................................................................... 130 
APPENDIX D PUBLICATIONS, ORAL PRESENTATIONS AND POSTERS 135 
List of Figures 
viii 
LIST OF FIGURES  
Figure 1.1: Potential pathways of contaminated secretions to the distal airways from 
oropharyngeal and gastric bacteria. Scheme modified from Morehead and Pinto 
(2000). ...................................................................................................................... 5 
Figure 1.2: Relative sensitivity and specificity values for different criteria to diagnose 
VAP. Data obtained from Fábregas (1999) and Koenig (2006). (Key: BAL: 
Bronchoalveolar lavage; PSB: Protected specimen brush; TBA: 
Tracheobronchoalveolar aspirate; CPIS: Clinical pulmonary infection score). ....... 8 
Figure 1.3: Scheme of the olfactory human sense and its analogy with the e-nose. 
Adapted from Pearce et al. (2003). ........................................................................ 11 
Figure 1.4: Flow diagram of the different phases of research and the links. .................. 27 
Figure 2.1: NST 3320 system by AppliedSensor AB. .................................................... 39 
Figure 2.2: Measurement cycle in NST 3320 e-nose for one sensor (FE102A). ........... 40 
Figure 2.3: E-nose sensor response curve showing some measurable parameters. ........ 41 
Figure 2.4: Special vials with septa and open-top caps for the e-nose. .......................... 42 
Figure 2.5: Brief scheme of some multivariate data analysis. Modified from Gardner 
and Bartlett (1999) and Jurs et al. (2000). (Key: ART: Adaptive resonance theory; 
BP: Back propagation; CA: Cluster analysis; DA: Discriminant analysis; GAs: 
Genetic algorithms; LDA: Linear discriminant analysis; LVQ: Learning vector 
quantisation; PCA: Principal component analysis; PCR: Principal component 
regression; PLS: Partial least square; SOM: Self-organising map). ....................... 43 
Figure 2.6: Box and whisker plot of 5 replicates of blank samples for one sensor 
(MO117). ................................................................................................................ 45 
Figure 2.7: PCA score plot of K.pneumoniae after 72 hrs incubation at 37°C in NB. Red 
dotted line shows an outlier. (Key: Kp: K.pneumoniae: 10(2), 10(4) and 10(6): 10
2
, 
10
4
 and 10
6
 cells ml
-1
). ............................................................................................ 48 
Figure 2.8: PCA score plot of K.pneumoniae after 72 hrs incubation at 37°C in NB. 
MOSFET, humidity sensors and one outlier have been removed. (Key: Kp: 
K.pneumoniae: 10(2), 10(4) and 10(6): 10
2
, 10
4
 and 10
6
 cells ml
-1
). ..................... 49 
Figure 2.9: PCA score plot for all the replicates for acetone (Acet.), isopropanol (Ipa) 
0.1% and distilled water measured in 24 occasions over a period of 2 years. ....... 50 
List of Figures 
ix 
Figure 2.10: Bar graphs showing the mean responses of the replicates of 0.1% acetone 
over 24 different measurements for (a) 101A and 102A sensors and (b) 101 and 
102 MOS sensors. I: depicts the standard error bars. ............................................. 51 
Figure 3.2: PCA score plot of different media after 48 hrs incubation at 37°C. (Key: Ca: 
C.albicans; Kp: K.pneumoniae; BHIB: Brain Heart Infusion broth; TSB: Tryptone 
Soy broth; NB: Nutrient broth). .............................................................................. 53 
Figure 3.3: Dendrogram after 24 hrs incubation at 37°C. (Key: same as Figure 3.2). ... 53 
Figure 3.4: Dendrogram after 48 hrs incubation at 37°C. (Key: Ca: C.albicans; Kp: 
K.pneumoniae; BHIB: Brain Heart Infusion broth; TSB: Tryptone Soy broth; NB: 
Nutrient broth). ....................................................................................................... 54 
Figure 3.5: PCA score plot of Aspergillus fumigatus after 24 hrs incubation at 37°C in 
NB. (Key: Af: Aspergillus fumigatus: 10(2), 10(4) and 10(6): 10
2
, 10
4
 and 10
6
 
spores ml
-1
). ............................................................................................................ 55 
Figure 3.6: Dendrogram of different initial concentrations of A.fumigatus after 72 hrs 
incubation. (Key: same as Figure 3.5). ................................................................... 56 
Figure 3.7: PCA score plot of E.cloacae after 24 hrs incubation at 37°C in NB. Red 
dotted line shows an outlier. (Key: Ec: E.cloacae: 10(2), 10(4) and 10(6): 10
2
, 10
4
 
and 10
6
 cells ml
-1
). .................................................................................................. 57 
Figure 3.8:  Dendrogram of different concentrations of E.cloacae after 24 hrs incubation 
at 37°C in NB. (Key: same as in Figure 3.7). ......................................................... 57 
Figure 3.9: PCA score plot a mixture of two microorganisms at 24 hrs incubation at 
37°C in NB. (Key: Ec: E.cloacae; St: Staphylococcus species; 10(2), 10(3), 10(4), 
and 10(6): 10
2
, 10
3
, 10
4
, and 10
6
 cells ml
-1
). Red dotted circles: outliers. ............. 59 
Figure 3.10: PCA score plot of different mixtures of two microorganisms at 24 hrs of 
incubation at 37°C in NB. (Key: Ca: C.albicans; Ec: E.cloacae; 10(2), 10(3), 
10(4), and 10(6): 10
2
, 10
3
, 10
4
, and 10
6
 cells ml
-1
). Red dotted circles: outliers. ... 59 
Figure 3.11: Histogram of three different mixtures of E.cloacae and C.albicans after 72 
hrs incubation in NB at 37°C. (Key: 3+3: 10
3
+10
3 
cells ml
-1
; 2+4: 10
2
+10
4 
cells ml
-
1
; 4+2: 10
4
+10
2 
cells ml
-1
; I: Standard error bars). ................................................. 60 
Figure 3.12: Growth rates of C.albicans at 37°C with different concentrations of 
tebuconazole in saline solution+0.2% glucose and 0.2% peptone over a period of 6 
days. ........................................................................................................................ 62 
List of Figures 
x 
Figure 3.13: Growth rates of A.fumigatus at 37°C with different concentrations of 
tebuconazole on MEA over a period of 9 days. ..................................................... 62 
Figure 3.14: Radar plot of MOSFET sensors showing the distinctive responses for 
different samples of A.fumigatus with benomyl and tebuconazole effective doses of 
50% and 90% of growth inhibition (ED50, ED90) after 48 hrs incubation on MEA 
cultures at 37°C. (Key: ED50-T/B and ED90-T/B: ED50/ ED90 of 
tebuconazole/benomyl). .......................................................................................... 64 
Figure 3.15: 3D canonical plot of A.fumigatus after 48 hrs incubation on MEA. Key: Af: 
A.fumigatus; Ben ED50/ED90: Benomyl ED50/ED90; Teb ED50/ED90: 
Tebuconazole ED50/ED90. ....................................................................................... 65 
Figure 3.16: PCA score plot PCA C.albicans after 48 hrs incubation in NB at 25°C. 
(Key: Blank: NB without inoculum; Control: C.albicans without anti-fungal; 
Ca+ED50/90-T: C.albicans+ED50/90-Tebuconazole). ............................................. 66 
Figure 3.17: Dendogram of C.albicans after 24 hrs incubation at 37°C in saline solution 
+ 0.2%G-P. (Key: B: Blanks; Control: C.albicans without anti-fungal; 
TebED90/50: ED90/ED50 concentrations of tebuconazole; TebED90/ED50+Ca: 
ED90/ED50 concentrations of tebuconazole+C.albicans). ...................................... 67 
Figure 3.18: Average amount of different compounds detected after 48 hrs incubation 
using SIFT-MS. (Key: A.fumigatus: positive control; Af+TebED50/BenED50: 
A.fumigatus with ED50 of tebuconazole/benomyl; Teb/Ben ED50: negative control 
(MEA+ Teb/Ben ED50); I: standard error bars). ..................................................... 71 
Figure 3.19: Average amount of different compounds detected after 48 incubation using 
SIFT-MS. (Key: same as Figure 3.18; I: standard error bars). ............................... 72 
Figure 3.20: GC-MS ion chromatograms after 48 hrs incubation for three types of 
samples  (Key: TIC: Total ion current). ................................................................. 74 
Figure 3.21: GC-MS ion chromatograms after 48 hrs incubation for one blank of each 
type. (Key: TIC: Total ion current). ....................................................................... 75 
Figure 3.22:  Mean values of some compounds found in cultures of C.albicans with 
tebuconazole. (Key: Ca+ED50/90: C.albicans with ED50/ED90; ND: no detected 
values). .................................................................................................................... 76 
List of Figures 
xi 
Figure 3.23: GC-MS chromatograms for C.albicans control in blue and for C.albicans 
treated with ED50 of tebuconazole (Ca+ED50) in black after 24 hrs incubation. 
(Both chromatograms on same scale). .................................................................... 77 
Figure 3.24: GC-MS chromatograms for C.albicans treated with ED50 /ED90 of 
tebuconazole (Ca+ED50/ Ca+ED90) in black and blue respectively after 24 hrs 
incubation. (Both chromatograms on same scale). ................................................. 77 
Figure 3.25: GC-MS chromatogram for one blank sample after 24 hrs incubation. ...... 78 
Figure 3.26: GC-MS chromatogram for one unused tube. ............................................. 78 
Figure 3.27: PCA score plot after 24 hrs incubation at 37°C of five microorganisms in 
NB media. Dotted line circle indicates one probable outlier. ................................. 80 
Figure 3.28: Dendrogram of five different microorganisms after 24 hrs incubation at 
37°C in NB. (Key: Af: A.fumigatus; Ca: C.albicans; Ec: E.cloacae; Kp: 
K.pneumoniae; St: Staphylococcus species). .......................................................... 81 
Figure 3.29: PCA score plot after 24 hrs incubation at 37°C in saline solution+0.1% 
Glucose-0.1% Peptone. Data was normalised. ....................................................... 81 
Figure 3.30: PCA score plot after 24 hrs incubation at 37°C in saline solution+0.2% 
Glucose-0.2% Peptone. Data was normalised. ....................................................... 82 
Figure 3.31: PCA score plot after 24 hrs incubation at 37°C in saline solution+0.2% 
Glucose-0.2% Peptone. Red dashed line: outlier. .................................................. 82 
Figure 3.32: Dendrogram after 24 hrs incubation of five microorganisms in saline 
solution with 0.2% glucose and 0.2% peptone. (Key: Af: A.fumigatus; Ec: 
E.cloacae; Ca: C.albicans; Kp: K.pneumoniae; Sa: S.aureus). One outlier was 
removed. ................................................................................................................. 83 
Figure 3.33: PCA score plot after 24 hrs incubation at 37°C in saline solution+0.2% 
Glucose-0.2% Peptone.  This was a repeated experiment. ..................................... 83 
Figure 3.34: Dendrogram after 24 hrs incubation of five microorganisms in saline 
solution with 0.2% glucose and 0.2% peptone. (Key: B: Blanks; Af: A.fumigatus; 
Ec: E.cloacae; Ca: C.albicans; Kp: K.pneumoniae; Sa: S.aureus). This was a 
repeated experiment. ............................................................................................... 84 
Figure 3.35: Canonical plot for DA of training and validation set (highlight squares) in 
NB after 24 hrs incubation. Dotted circles show misclassified samples. Selected 
sensors: MOSFE102A, 104A, 102-3B, MOS113-5, 117. (Key: Af: A.fumigatus; 
List of Figures 
xii 
Ec: E.cloacae; Ca: C.albicans; Kp: K.pneumoniae; St: Staphylococcus species; B: 
Blanks). ................................................................................................................... 86 
Figure 3.36: Canonical 3D plot for DA of training and validation set (highlight squares) 
in NB after 24 hrs incubation. (Key: same as Figure 3.35). ................................... 86 
Figure 3.37: Canonical 3D plot for model B. Clouds correspond to training set samples. 
Highlighted squares correspond to validation set samples. Selected sensors for this 
model: MOSFET102B, MOS102, 104, 112, 114-6 (Key: Ca: C.albicans; Sa: 
S.aureus; Kp: K.pneumoniae; Ec: E.cloacae; Af: A.fumigatus; B: Blanks). .......... 89 
 
List of Tables 
xiii 
LIST OF TABLES 
Table 1.1: Aetiology of VAP in % obtained from diverse studies. (Key: MRSA: 
Methicillin-resistant Staphylococcus aureus; MSSA: Methicillin-sensitive 
S.aureus; ORSA: Oxacillin-resistant S.aureus; OSSA: Oxacillin-sensitive 
S.aureus; NS: Not stated). ........................................................................................ 3 
Table 1.2: Summary of features for three different criteria to diagnose VAP. ................ 7 
Table 1.3: Some microorganisms and the volatile organic compounds which they are 
known to produce reported by different research studies using GC-MS and 
headspace concentration techniques in different substrates. (Key: DG18: 
Dichloran-Glycerol agar; MEA: Malt Extract agar; TSB: Tryptone Soy broth). ... 10 
Table 1.4: Summary of the sensors technologies for e-noses. Adapted from Pearce et al. 
(2003) and Mahmoudi (2009). ............................................................................... 15 
Table 1.5: Overview of studies of volatile fingerprints using e-nose systems for 
discriminating between different microorganisms. (Key: YES: Yeast extract 
sucrose; HPLC: High Performance Liquid Chromatography). .............................. 22 
Table 2.1: Summary of mixtures for two microorganisms with their initial 
concentrations. ........................................................................................................ 31 
Table 3.1: Summary of effective doses for different anti-fungals, species, media and 
temperatures. (Key: MEA: Malt extract agar; NB: Nutrient broth; SS+0.2%G-P: 
saline solution 0.2% Glucose-0.2% Peptone). ........................................................ 63 
Table 3.2: Classification matrix after cross-validation test based on the DA model. 
A.fumigatus at 37°C on MEA after 48 hrs incubation. Accuracy prediction of 
76.66% (23/30). (Key: B: benomyl; T: tebuconazole). .......................................... 65 
Table 3.3: Summary of identified susbtances from GC-MS analyses. Microbial species 
were grown on NA at 37°C for 24 hrs. (Key: +++: 3,606-2,405 ng/l; ++: 2,404-
1,203 ng/l; +: 1,202-2 ng/l; -: not found)................................................................ 69 
Table 3.4: Confusion matrix showing the performance of the model in NB at 37°C after 
24 hrs incubation. Accuracy of 87.5% (21/24). (Key: Af: A.fumigatus; B: Blanks; 
Ca: C.albicans; Ec: E.cloacae; K.pneumoniae; St: S.aureus). ............................... 87 
Table 3.5: Summary of results for different models analysed by DA in saline solution.88 
List of Tables 
xiv 
Table 3.6: Confusion matrix showing the performance of model B in saline solution at 
37°C after 24 hrs incubation. Accuracy of 83.3% (20/24). (Key: Af: A.fumigatus; 
B: Blanks; Ca: C.albicans; Ec: E.cloacae; K.pneumoniae; St: S.aureus). ............. 89 
Table 3.7: Summary of results for two in vitro models for clinical samples prediction 
using DA. ................................................................................................................ 91 
Table 3.8: Summary of the attempts for classifying clinical samples using different 
standardisation methods, scale, latent variables (LV) with an in vitro model built in 
saline solution+0.2%G-P cultures after 24 hrs incubation at 37°C. ....................... 92 
Table 3.9: Summary of results after PLS-DA assessment in NB with different latent 
variables (LV) and scales. ...................................................................................... 93 
Table 4.1: Summary of the sensitivity achieved in different matrices from the literature.
 ................................................................................................................................ 98 
 
  
List of Abbreviations 
xv 
LIST OF ABBREVIATIONS 
AMDIS Automated Mass Spectral Deconvolution and Identification System 
software 
ANN Artificial Neural Networks 
ANOVA Analysis of variance 
ARDS  Acute Respiratory Distress Syndrome 
ART  Adaptive Resonance Theory 
ATCC  American Type Culture Collection 
ATD  Automated Thermal Desorption 
BAL  Bronchoalveolar Lavage 
BHIB  Brain Heart Infusion Broth 
BP  Back-propagation 
CA  Cluster Analysis 
CDC  Centers for Disease Control  
CFU  Colony Forming Units 
C-NS  Coagulase-negative Staphylococci 
CPIS  Clinical Pulmonary Infection Score 
DG18  Dichloran-Glycerol agar 
DS  Direct standardisation 
ED50/90  Effective Dose 50%/90%  
e-nose  Electronic nose 
List of Abbreviations 
xvi 
GAs  Genetic Algorithms 
GC  Gas Chromatography 
HAP  Hospital-acquired Pneumonia 
HPLC  High Performance Liquid Chromatography 
ICU  Intensive Care Unit 
IPA  Pronan-2-ol or Isopropanol 
LDA  Linear Discriminant Analysis 
LOO  Leave-one-out 
LV  Latent variable 
LVQ  Learning Vector Quantisation 
MC  Mac Conkey 
MDR  Multi-drug Resistant 
MRSA  Methicillin-resistant Staphylococcus aureus 
MS  Mass Spectrometry 
MSSA  Methicillin-sensitive Staphylococcus aureus 
MOS  Metal Oxide Semiconductor 
MOSFET Metal Oxide Semiconductor Field Effect Transistor 
MSD  Mass Selective Detector 
MVOC Microbial Volatile Organic Compound 
NA  Nutrient Agar 
NB  Nutrient Broth 
List of Abbreviations 
xvii 
NIST  National Institute of Standards and Technology 
NST  Nordic Sensor Technologies 
OD  Optical Density 
ORSA  Oxacillin-resistant Staphylococcus aureus 
OSSA  Oxacillin-sensitive Staphylococcus aureus 
PARC  Pattern Recognition  
PCA  Principal Component Analysis 
PCR  Principal Component Regression 
PDS  Piecewise Direct Standardisation   
PLS  Partial Least Square 
PLS-R  Partial Least Square Regression 
ppm  Parts per million 
ppb  Parts per billion 
QA  Quality Assurance 
QC  Quality control 
QCM  Quartz Crystal Microbalance 
RT  Retention Time 
SAW  Surface Acoustic Wave 
SBHIA Sabouraud Brain Heart Infusion Agar 
SDA  Sabouraud Dextrose Agar 
SIFT-MS Selected Ion Flow Tube-Mass Spectrometry 
List of Abbreviations 
xviii 
SOM  Self-organising Map (Kohonen) 
SPME  Solid-phase Microextraction 
TB  Tuberculosis 
TBA  Tracheobronchoalveolar aspirate 
TD-GC/MS Thermal Desorption GC-MS 
TIC  Total Ion Current 
TSB  Tryptone Soy Broth 
UTI  Urinary Tract Infection 
VAP  Ventilator Associated Pneumonia 
VOC  Volatile Organic Compound 
 
YES  Yeast Extract Sucrose (agar medium) 
 
 
List of Equations 
xix 
LIST OF EQUATIONS 
                        –                                            Equation 1 .................. 44 
         –                 –                                        Equation 2… ............. 45 
 
 
 
 
 
 
Literature Review 
1 
CHAPTER 1: LITERATURE REVIEW 
1.1 INTRODUCTION 
Ventilator associated pneumonia (VAP) is one of the significant infections in hospitals 
and has become of great medical importance because it is associated with antibiotic-
resistant pathogens and might result in high rates of morbidity, mortality and increased 
medical care costs. The diagnosis of VAP is still difficult since there is no accepted 
clinical criterion to definitely establish VAP and the specificity and sensitivity of all 
existing diagnostics are of very poor accuracy. Clinical signs of VAP are not specific 
and the scoring systems are not absolutely reliable for VAP diagnosis. 
Microorganisms are known to produce a wide range of different organic compounds 
which are released, with some of them being volatile. These microbial volatile organic 
compounds (MVOCs) may be used as fingerprints of microbial growth and perhaps to 
discriminate between different species. Sensor arrays have thus been developed trying 
to mimic the olfactory sense of mammals. Their ability to detect volatile fingerprints 
combined with pattern recognition systems would permit the early detection of specific 
microorganisms or groups of microorganisms. 
These sensor array systems, so called electronic nose (e-nose), have been examined for 
potential applications in many fields such as food quality and spoilage, cosmetics and 
beverages industries, environmental monitoring and more recently in medical 
diagnostics (Gardner et al., 2000a).  The use of e-nose systems in medicine for the early 
diagnosis of non-infectious diseases such as breast and lung cancers (D’Amico et al., 
2010; Peng et al., 2010), kidney disorders and infectious diseases has been recognised 
(Pavlou et al., 2002a; Boilot et al., 2002; Pavlou et al., 2004; Humphreys et al., 2011).  
Analytical approaches involving more complex devices such as gas chromatography 
associated with mass spectrometry (GC-MS) and selected ion flow tube mass 
spectrometry (SIFT-MS) have also been employed to detect volatile biomarkers in head 
space samples for similar applications. However, such approaches are more expensive 
and require a high level of expertise for analyses and interpretation of data sets. 
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1.2 VENTILATOR-ASSOCIATED PNEUMONIA 
 
VAP is the acquired pneumonia that occurs in patients who require mechanical 
ventilator support by endotracheal tube or tracheostomy for ≥ 48hours (Hunter, 2006). 
Therefore, VAP is considered a nosocomial disease because it is acquired in the health 
care environment with no evidence that it is present or incubated at the time of hospital 
admission. 
VAP can be caused by a range of individual or mixtures of microorganisms. Gram-
negative enteric rods (Enterobacteriaceae such as Klebsiella pneumoniae, Enterobacter 
species, Escherichia coli), Staphylococcus aureus and Pseudomonas aeruginosa are the 
predominant organisms responsible for this infection. However, many other 
microorganisms can cause VAP including Streptococcus pneumoniae, Haemophilus 
influenzae and Acinetobacter baumanii depending on the onset of the illness (Bouza et 
al., 2001). There are other opportunistic microorganisms such as Candida albicans and 
Aspergillus fumigatus which can play a role in immune-compromised patients. 
Polymicrobial infections appear to be especially high in patients with acute respiratory 
distress syndrome (ARDS) (Am. Thoracic Society, 2005).  
Five microorganisms have been chosen from the available clinical isolations in this 
current study as it was found in a previous study (Sahgal, 2008) that a four group 
system gave sufficient discrimination between microorganisms. One or two from each 
main group of microorganisms were chosen: one Gram-positive (S.aureus), two Gram-
negative (Enterobacter cloacae and K. pneumoniae) and two fungi (A.fumigatus and 
C.albicans).   
A list of microorganisms isolated in different VAP studies is shown in Table 1.1. Please 
note that in some cases, the sum of percentages is above 100% due to more than one 
microorganism being present in the same patient sample. 
   
 
 3 
Table 1.1: Aetiology of VAP in % obtained from diverse studies. (Key: MRSA: Methicillin-resistant Staphylococcus aureus; MSSA: Methicillin-sensitive 
S.aureus; ORSA: Oxacillin-resistant S.aureus; OSSA: Oxacillin-sensitive S.aureus; NS: Not stated). 
 
(a)  
No specification about 
initial treatment 
Streptococcus 
spp 
S.aureus P.aeruginosa Acinetobacter 
spp 
Enterobacteriaceae Anaerobic 
microbes 
Haemophilus 
spp 
S.maltophilia Fungi 
 
Others 
Rello et al. (2005)  (1) 11.6 15.9* 33.9 12.6 14.6 NS 8.6 2.6 NS 7.8 
Fagon et al. (2005)  (2) 12.1 20.4** 24.4 7.9 14.1 0.9 9.8 1.7 0.9 7.8 
Papazian et al. (1996)  (3) NS 21 27 5 36 NS 6 NS NS 3 
Timsit et al. (1996)  (4) 14.5 26.1 15.9 11.6 10.1 NS 13 NS NS 8.7 
Ibrahim et al. (2000) (5) 0.7 19.7* 23.7 3.3 16.3 NS 1.7 7 3.3 24.3§ 
Trouillet et al. (1998) (6) 14.7 21.3* 15.9 9 17.9 2.4 6.1 2.4 NS 10.1 
Hunter,(2006) (7) 2 35 31 4 11 NS 5 NS 7 10 
(b)  
With initial treatment 
Streptococcus 
spp 
S.aureus P.aeruginosa Acinetobacter 
spp 
Enterobacteriaceae  Anaerobic 
microbes 
Haemophilus 
spp 
S.maltophilia Fungi Others 
Kollef et al. (1998) (8) NS 23.1*** 36.5 5.8 15.4 NS NS 9.6 3.8 5.8 
Álvarez-Lerma et al. 
(1996 ) (9) 
2 20.1 43 18.8 15.4 NS 0.7 NS NS NS 
Luna et al. (1997) (10) 3.1 23.5 9.2 28.6 24.5 NS 1 NS 4.1 6.1 
* ORSA/OSSA; ** MRSA/MSSA; *** MRSA 
1. Microorganisms isolated from 301 VAP episodes.        6. Microorganisms isolated from 135 episodes of VAP. 
2. Microorganisms isolated by bronchoscopic techniques in 1689 episodes.  7. Microorganisms responsible for VAP in 420 episodes. 
3. Microorganisms isolated from cultures of PSB ≥103 CFU/ml.    8. Microorganisms isolated from mini-BAL cultures in 60 episodes. 
4. Microorganisms isolated from ≥103 CFU/ml for PSB and/or ≥104 CFU/ml  9. Microorganisms isolated in 565 episodes receiving inappropriate     
    for BAL in 56 episodes.             antibiotic.          
5. Microorganisms isolated in 185 episodes of late-onset of VAP.    10. Microorganisms isolated in BAL samples from 65 episodes of 
    § Others: 17% (multiple pathogens), 5% (other bacteria and viruses),        VAP patients. 
    and 2.3% (no growth).                     
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Identification of the microorganisms which may have the most adverse clinical impact 
on a patient, depends on the individual patient, the type of intensive care unit (ICU), 
duration of stay and on any previous antibiotic treatment (Chastre and Fagon, 2002). 
Several studies suggest that the time of onset determines which pathogens will infect 
and the prognosis of the disease (Kollef, 2005; Chastre and Fagon, 2002). For the latter 
authors H.influenzae, S.pneumoniae, methicillin sensitive S.aureus (MSSA) and some 
Enterobacteriaceae were common in early-onset VAP, while P.aeruginosa, 
Acinetobacter spp and methicillin resistant S.aureus (MRSA) were typically more 
common in late-onset infections. The latter species belong to the group of 
microorganisms which potentially can be multi-drug resistant (MDR).  These pathogens 
have a high and very variable range of mortality, between 0-50%, due to their specific 
risk factors, patterns of clinical resolution and resistance (Rello et al., 2005). 
The incidence of VAP is estimated at between 8-28% (Chastre and Fagon, 2002; Kollef, 
2005) and in all cases there has been a close relationship between VAP and the length of 
mechanical ventilation. Mortality rates due to VAP may reach values of up to 50%, 
especially in elderly populations, in severely ill patients, and those who may have 
received inappropriate previous drug therapy. However, some studies have not found 
any relationship between the high rates of mortality and VAP, but are mostly due to the 
underlying diseases (Am. Thoracic Society, 2005). 
Pneumonia is the inflammation of the lower parts of the lung tissue due to the invasion 
by pathogenic microorganisms. Its severity and outcome depends on the competence of 
the hosts’ immune system, on the virulence of the microorganisms, on the number of 
microorganisms present, and on the previous antibiotic therapy. There are a variety of 
mechanisms in healthy people to avoid lung infections such as the cough reflex, agents 
in saliva, mucus discharges and humoral and cellular immune responses. In hospitalised 
and mechanically ventilated patients these reactions are deeply compromised due to the 
illness itself and by the presence of the endotracheal tube in the upper airways. If the 
hosts’ immune system and the initial therapy fail, VAP can prolong the patients stay and 
influence the relative outcome of the disease. 
The way in which pathogenic bacteria reach the lung parenchyma (alveolar tissue in 
sensu stricto) in patients mechanically ventilated might be explained as follows: 
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bacteria residing in the oropharynx can settle between the endotracheal tube and the 
larynx walls creating a contaminated secretion pool that may be aspirated into the 
trachea and disseminated into the distal airways of lungs (Morehead and Pinto, 2000). 
Figure 1.1 shows this mechanism. VAP pathogens may also enter via other routes 
including the blood stream, by inhalation of infected aerosols, direct inoculation from a 
contaminated endotracheal tube or aspiration of gastric contents, although this is less 
common than oropharyngeal aspiration. 
The diagnosis of VAP is difficult because there is no specific and single clinical 
criterion. A large number of diseases, even non-infectious, may present similar clinical 
signs such as ARDS, nosocomial tracheobronchitis, congestive heart failure, atelactasis, 
pulmonary thromboembolism and pulmonary haemorrhage. Likewise, the lack of an 
accurate diagnostic test may result in a non-specific and sometimes unsuccessful 
treatment, which exposes the patients to high levels of toxicity, longer stays in hospital, 
and elevates the costs and risks of having resistant microorganisms (Solomkin, 2005). 
 
Figure 1.1: Potential pathways of contaminated secretions to the distal airways from 
oropharyngeal and gastric bacteria. Scheme modified from Morehead and Pinto (2000). 
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There have been various clinical strategies for VAP diagnosis such as CPIS (Clinical 
pulmonary infection score) developed in 1991 and modified by Pugin et al. (1991);  
Johanson criterion (Johanson et al., 1972) and Centers for Disease Control (CDC; 
Garner et al., 1988) usually based on clinical criteria and results of laboratory and other 
diagnostic tests. Table 1.2 summarises the criteria of those three systems. CPIS is the 
most widely used criterion based on 6 parameters: fever, tracheal aspirates, blood 
leukocytosis, oxygenation, radiographic infiltrates and semi-quantitative cultures of 
tracheal aspirates (Pugin, 2002). If a score of <6 an alternative diagnosis must be 
considered. However, some authors (e.g. Baughman, 2005) consider CPIS of little 
usefulness for daily evaluation due to the need of a waiting period for culture results, 
about 72 hrs until the identification of the pathogen and its antibiotic susceptibility 
testing, and for its low sensitivity and specificity. Also, CPIS has not been validated in 
immunosuppressed patients.  
Many studies have investigated the accuracy of the clinical diagnosis of VAP by 
comparing with quantitative culture isolation of either protected specimen brush (PSB) 
or bronchoalveolar lavage (BAL) samples. These approaches may vary depending on 
whether one, or more than one, clinical finding is chosen for the diagnosis. Also, 
depending on how many clinical features are selected the values of specificity and 
sensitivity may vary in different ways. For instance, one of the reported studies (Am. 
Thoracic Society, 2005) found that using the presence of chest infiltrates with all of the 
three parameters (clinical signs such as fever, leucocytosis or purulent tracheal 
secretions) increases the specificity but reduces the sensitivity. Figure 1.2 compares 
sensitivity and specificity of some methods used for VAP diagnosis. 
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Table 1.2: Summary of features for three different criteria to diagnose VAP. 
Johanson et al. (1972) CPIS (modified by Pugin et 
al., 1991) 
CDC
$
 (Garner et al., 
1988) 
* Chest radiograph infiltrates  and 
one of the following parameters: 
a) Leucocytosis (›12x109 ml-1); 
b) Temperature (›38.3°C); 
c) Presence of tracheobronchial 
secretions. 
* Suspicious of VAP when 
clinical score is ≥6: 
a) Temperature (°C); 
b) White blood cell count and 
number of band forms; 
c) Type of tracheobronchial 
secretions (purulent or not); 
d) Gram stain and semi-
quantitative culture of tracheal 
aspirates; 
e) Oxygenation: PaO2/FiO2, 
mmHg); 
f) Chest radiograph (If 
infiltrate, diffused or localised 
and its progression) 
 
* Nosocomial pneumonia 
when: 
a) Chest percussion: if 
dullness and any of: 
1. New purulent sputum 
or change character, 
2. Isolation of pathogen 
from blood culture or 
lower respiratory 
specimen 
b) Chest x-ray: if new or 
progressive infiltrate, 
consolidation, cavitation 
or pleural effusion and 
any of 1), 2) or 
3) Detection of IgM or 
increase of IgG for 
pathogen 
$
CDC developed a set of definitions for nosocomial infections which includes specific 
criteria for neonates and infants. 
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Figure 1.2: Relative sensitivity and specificity values for different criteria to diagnose 
VAP. Data obtained from Fábregas (1999) and Koenig (2006). (Key: BAL: 
Bronchoalveolar lavage; PSB: Protected specimen brush; TBA: 
Tracheobronchoalveolar aspirate; CPIS: Clinical pulmonary infection score). 
 
Regarding VAP treatment, the decisive points to be considered once the therapy for 
VAP is chosen are the antibiotic selection and its duration. The empiric antibiotic 
therapy has to be based on knowledge of the most common microorganisms and its 
local resistance pattern within the ICU (Koenig, 2006), on the duration of mechanical 
ventilation and on the previous treatment if there was one. The duration of the therapy 
has been lately reduced due to the observations that prolonged therapies lead to 
colonization with antibiotic resistant bacteria such as P.aeruginosa, S.aureus or 
Enterobacteriaceae. This can result in a relapse of VAP, mainly in the second week of 
treatment (Dennesen et al., 2001). An early effective diagnosis and therapy are crucial 
for good outcomes with less antibiotic use and therefore for reducing mortality.  
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1.3 VOLATILE FINGERPRINTS-I: ELECTRONIC NOSES 
1.3.1 WHAT IS AN ELECTRONIC NOSE? 
The human nose is used as a qualitative analytical tool for discrimination/detection of 
odours from food (fish, meat, cheese, etc), perfumes (cosmetics, soaps) and flavours. 
Human personnel can be highly qualified and trained to detect odours, but there may be 
problems because of a lack of sensitivity over time and the variation between 
individuals. It can also sometimes be unsafe or unhealthy and variable depending on the 
individual (Nagle et al., 1998). To avoid these difficulties, attempts have been made to 
build an artificial olfactory model which can mimic the olfactory sense of mammals and 
which can detect and discriminate the production of volatile compounds from its 
sources. It was in the 1960s when the development of instruments to detect odours 
started using mechanical noses based on redox reactions. It was not until the 1980s 
when integrated e-nose systems began appearing as research tools and commercial 
devices. The currently accepted definition of an e-nose, regarding the chemical sensor 
arrays used to detect odorant molecules, was proposed by Gardner and Bartlett in 1994:  
“An electronic nose is an instrument which comprises an array of electronic chemical 
sensors with partial sensitivity and an appropriate pattern recognition system, capable of 
recognising simple or complex odours”.  
The odorant molecules which interact with the surface of the sensors in an e-nose 
(equivalent to the stimuli in the olfactory system) are typically hydrophobic and volatile 
due to their molecular weight (30-300 Da), strength of the interactions between 
molecules and molecular shape (Gardner and Bartlett, 1994, 1999). 
Many of the odorant molecules are produced by microorganisms. A wide range of 
MVOCs are released from both primary and secondary metabolites and obtained from 
the breakdown of protein and carbohydrates during the metabolic pathways. These 
compounds can be alcohols, ketones, esters, lactones, aldehydes, sulphur and nitrogen-
based products.  These MVOCs can be characteristic and different for each species 
(Larsen, 1997; Magan and Evans, 2000). Table 1.3 summarises some MVOCs produced 
by different species of microorganisms. They also can vary depending on temperature, 
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the age of cultures, the nutritional status (Fiedler et al, 2001) and the different water 
availability of the substrates (Magan and Evans, 2000). 
 
Table 1.3: Some microorganisms and the volatile organic compounds which they are 
known to produce reported by different research studies using GC-MS and headspace 
concentration techniques in different substrates. (Key: DG18: Dichloran-Glycerol agar; 
MEA: Malt Extract agar; TSB: Tryptone Soy broth). 
Organism Volatile organic compound Authors  
Substrate 
Campylobacter jejuni 
Clostridium difficile 
Ethanoic, butanoic, pentanoic acid, 
benzaldehyde, ethanal, carbon 
disulphide, dimethyl disulphide, 
acetone, 2-butanone, 2,3-
butanedione, 6-methyl-5-hepten-2-
one, indole, 4-methylphenol. 
Garner et al., 
2007                      
Faeces                    
Stachybotrys chartarum 
Aspergillus penicillioides, 
Chaetomium globosum 
2-pentanol, 2-heptanone, 3-octanone, 
1-octen-3-ol, 2-methyl-1-butanol. 
Wady et al., 2003   
MEA/DG18 
Trichoderma harzianum Isoprene, 1,3,5-heptatriene, 2,6-
dimethyl-2,4,6-octatriene, 
sesquiterpenes. 
Fiedler et al., 
2001             
Beech wood 
Aspergillus fumigatus Heptane, undecane, isoprene, 2,4-
hexadiene, 1,3-octadiene, 2-methyl-
1,3-pentadiene, 2-methyl-1-butanol, 
3-methyl-1-butanol, 2-ethyl-1-
hexanol, 1-octen-3-ol. 
Fiedler et al., 
2001 
MEA 
Proteus mirabilis 
Klebsiella pneumoniae 
Pseudomonas aeruginosa 
Staphylococcus aureus 
Dimethyl disulphide, isobutanol, 
isopentanol, methyl ketones, 2-
heptanone, methylbutanal, 2-butanol. 
Zechman, et al., 
1986 
TSB 
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Typically, an e-nose consists of three parts: a sensor array, where the sensors measure 
electrical changes generated by adsorption of volatiles to the odour-sensitive chemical 
surface; a transducer which converts signals into readable values and the software for 
the analysis of the data. This structure has been copied from the olfactory organ of 
mammals in the sense that the active material of the sensors in an e-nose device 
(olfactory receptors) interacts with the volatiles creating a sensor response (electric 
signal or pattern) which is transmitted to the pre-processor (olfactory bulb) where the 
output is amplified and the noise is reduced. In the final stage the simplified signals 
(nerve impulses), as patterns of responses, are processed into the data-analysis system 
(hypothalamus and olfactory cortex in the brain). Figure 1.3 shows the diagrammatic 
analogy between the human olfactory sensing and e-nose system. 
 
Figure 1.3: Scheme of the olfactory human sense and its analogy with the e-nose. 
Adapted from Pearce et al. (2003). 
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1.3.2 TYPES OF ODOUR SENSORS 
Since the first model of an e-nose reported by Persaud and Dodd (1982), many advances 
have been made in the development of sensor technology. Some of the most important 
aspects of sensors are that they must be sensitive enough to the chemicals even at low 
concentrations in the ppm range and each sensor in the array must have partial 
sensitivity. Thus, response to a range of different volatiles rather than to a specific one 
is an advantage. This variable sensitivity leads to the production of distinct qualitative 
volatile fingerprints, enabling the identification of different patterns. 
The e-nose sensor technologies can be classified according to the sensor material and its 
transduction or conversion principle. Table 1.4 provides a summary of the main sensor 
transducer systems and their characteristics. 
(i) ELECTROCHEMICAL SENSORS 
a) Conductivity sensors: these exhibit a change in resistance when they are 
exposed to volatile organic compounds. There are two types of conductivity 
sensors: 
1. Conducting polymer sensors (CP sensors): This kind of sensors have 
reversible physiochemical properties in terms of change in conductivity 
under ambient temperature conditions when the active material (such as 
polypyrroles, triophenes) is exposed to the chemicals, which bond with 
the polymer backbone. They are extremely sensitive and the 
standardisation of sample presentation is crucial for avoiding problems 
with humidity and drift over time.  
2. Metal oxide semiconductor sensors (MOS sensors): In this case, the 
doped materials with which the volatile organic compound (VOC) 
interacts are oxides that can be made of tin, zinc, tungsten. Those 
materials are deposited between two metal contacts over a heating 
element which operates at high temperatures, 200-650˚C. When the 
sample interacts with the oxide material, oxidation occurs. The output 
signal is produced by a change in resistance caused by the reaction 
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between the adsorbed oxygen and the gas molecules. They are quite 
sensitive (5-500ppm) and this can be improved by using noble metals or 
changing the operating temperature. They are also resistant to humidity 
but they may have drift problems over time and they may be poisoned by 
irreversible binding by different compounds such as sulphur or weak 
acids. 
 
b) Metal oxide silicon field-effect sensors (MOSFET sensors): They consist of 
three layers: a semiconductor which can be made of silicon (Si) or silicon 
carbide (SiC); a thick oxide layer (SiO2) as insulator; and on top a thin catalytic 
metal layer made of platinum (Pt), iridium (Ir) or palladium (Pd). In these 
sensors, the contact between the gas molecules and the catalytic gate metal 
affects the voltage and thus change the capacitance through the transistor. The 
gas detection is recorded as a voltage change in the sensor signal. The sensitivity 
and selectivity can be determined by the choice of the operation temperature, 
gate metal and structure of the gate metal. The sensitivity of the sensors is 
normally high for low concentrations of the gases, while it becomes saturated for 
high concentrations of gases. MOSFET and MOS sensors operate at high 
temperatures and are considered to be less sensitive to humidity with less carry-
over from one measurement to another (Schaller et al., 1998). 
 
(ii) PIEZOELECTRIC SENSORS 
They can measure temperature, mass changes, pressure, force and acceleration. The e-
nose with piezoelectric sensors is designed to detect mass changes. There are two types 
of piezoelectric sensors: 
 
a) Quartz crystal microbalance (QCM sensors):  They consist of a resonating 
quartz disc which vibrates at a characteristic frequency (10-30 MHz). When the 
volatiles are absorbed there is an increase in the mass of the disc reducing the 
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resonance frequency. This reduction is inversely proportional to the mass of the 
odorant absorbed. 
b) Surface acoustic wave devices (SAW sensors): These sensors measure mass 
changes too but differ from the above ones in that they operate at much higher 
frequencies and require waves to travel over the surface of the device. They can 
be less sensitive than other piezoelectric sensors. 
 
(iii) OPTICAL SENSORS 
They are carbon nanotubes or glass fibres coated with a thin chemically active material 
which contains a fluorescent dye. When the volatiles interact with the dye under a light 
source of a determinate frequency, or narrow range of frequencies, the polarity light of 
the fluorescent dye is altered and then a shift is produced in the emission spectrum. This 
change of colour (or of fluorescence, chemo luminescence, absorbance or reflectance) 
can be measured. Optical sensors have wide biological applications though they present 
bleaching problems with sunlight. 
In the last few decades new sensor technologies have been developed in the field of 
biosensors which are devices that consist of a biological probe element (e.g. an 
antibody, a protein, an enzyme, or a whole organism) and a signal transducer. Based on 
any of the signal transduction methods mentioned earlier, the reaction between the 
analyte and the bioreceptor is converted into a measureable effect by the transducer. 
With the emergence of nanotechnology, biosensors have become micro-sized devices, 
namely nano-biosensors. Other categories of sensors are the calorimetric sensors based 
in the thermal signal transducer system where changes in temperature are detected or 
holograms used combined with biological materials in the so-called holographic 
biosensors which may detect metabolites such as glucose, urea or penicillin G (Marshall 
et al., 2004) due to the changes in the holographic reflection. 
In this study a hybrid sensor array formed by MOS and MOSFET sensors was used due 
to their sensitivity and higher resistance to humidity which has been shown to be a 
drawback with CP sensors. Furthermore, Sahgal (2008) found, when comparing both 
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systems, the hybrid sensor array gave better results in terms of earlier discrimination 
between different microbial species. 
 
Table 1.4: Summary of the sensors technologies for e-noses. Adapted from Pearce et al. 
(2003) and Mahmoudi (2009). 
Category Measures Material Sensitivity Principle  
Electrochemical  
Resistance 
Capacitance 
Resistance 
 
Oxides 
Catalytic metals 
Polymers 
 
5-500ppm 
ppm 
0.1-100ppm 
 
Changes in 
current or in 
potential 
MOS 
MOSFET 
CP 
Piezoelectric  
 
Piezoelectricity 
 
Polymer-coated 
resonating quartz 
disc 
 
1 pg mass 
change            
1ng mass 
change 
 
Changes in 
mass, 
density, 
viscosity 
and acoustic 
phenomena 
SAW 
 
QCM 
Optical  
 
Intensity/Spectrum 
 
 
Fluorescent dyes 
 
 
Low ppb 
 
Changes in 
light 
intensity 
Optical fibres 
Fluorescence 
Chemoluminescence 
 
 
1.3.3 APPLICATIONS 
The e-nose has been used to examine applications in a wide range of areas including 
food quality control, medical diagnoses, environmental monitoring, safety and security. 
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a. Food: E-nose technology has been applied in many fields, but the most frequently 
considered has been the analysis of raw or manufactured food products; freshness and 
maturity monitoring; shelf-life investigations; microbial detection and control of food 
packaging material. In this field, many studies have been performed in order to find the 
quality of raw materials like grains (Jonsson et al., 1997; Evans et al., 2000); to evaluate 
the olive oil oxidation during storage (Buratti et al., 2005); for freshness evaluation of 
meats or fish; to classify a wide range of beverages such as coffee, beer, wine (Di 
Natale et al., 1997); to recognise spoilage bacteria and yeasts in milk (Magan et al., 
2001); to detect spoilage fungi in bread (Keshri et al., 2002) and to monitor the ripening 
of Danish blue cheese (Trihaas et al., 2005). 
Today, there is significant interest in detecting the levels of mycotoxins produced by 
fungi in many food products. Thus, diverse studies using the e-nose technology have 
been carried out to differentiate between mycotoxigenic and non-mycotoxigenic strains 
of Fusarium, Aspergillus, Penicillium in food raw materials (Keshri and Magan, 2000; 
Sahgal et al., 2007) and in ham-based medium (Camardo et al., 2011). Discrimination 
between mycotoxin producers and non-producers strains is based, as some studies have 
reported, on the different volatile fingerprints produced because of the different 
biosynthetic pathways for mycotoxin production used.  
Food application has received significant attention because of the ease of consistent 
sample presentation, sample size that may be required, non-invasive technique and the 
lack of sample preparation. Thus potential exists in using this approach as part of a QA 
system (Magan and Sahgal, 2007).  
b. Medical: If the e-nose is able to recognise volatiles from bacterial and fungal growth 
on food substrates, it may also be able to detect and diagnose certain illnesses. There is 
a need for rapid, inexpensive and intelligent systems for clinical diagnosis.  E-nose 
technology could provide a tool for early detection and reduce the high costs and the 
time consuming nature of using molecular, microbiological cultures and serological 
tests in the detection of diseases like Helicobacter pylori (Pavlou et al., 2000) and 
tuberculosis (Pavlou et al., 2004). Furthermore, there has been an increasing need for 
early detection of microbial infections in the hospital environment. Dutta et al. (2005) 
distinguished between different types of S.aureus species: MRSA, MSSA and 
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coagulase-negative staphylococci (C-NS) from swab samples of infected patients using 
a sensor array. Other acquired diseases of great importance in hospitals are those related 
to prolonged mechanical ventilation like sinusitis, bronchitis and pneumonia (Rumbak, 
2005; Humphreys et al., 2011).  
Previous in vitro studies suggest it could be possible to diagnose microbial pathogens of 
medical importance such as anaerobic bacteria Clostridium spp and Bacteroides fragilis, 
and even to discriminate between different Clostridia based on volatiles produced 
(Pavlou et al., 2002b) and for diagnoses of bacterial contaminants in urinary tract 
infections (UTI) (Pavlou et al., 2002a). Also, diseases such as tuberculosis (Turner and 
Magan, 2004) and cancer pathologies have been monitored. For example, Machado et 
al. (2005) studied the exhaled breath from individuals with lung cancer and compared 
this with subjects with non-cancer diseases and a healthy group as non-cancer control 
volunteers. They demonstrated that the e-nose could identify the different characteristics 
of exhaled breath in patients with lung cancer in a non-invasive way. More recently, 
Peng et al. (2010) were able to differentiate between distinct cancer types by means of 
patient breath analysis using a nanosensor array. 
Some recent studies have demonstrated the capacity of a hybrid metal oxide/metal ion 
based sensor systems to discriminate between different species of Trichophyton which 
cause dermatophytosis (Sahgal et al., 2006). At present the diagnosis of these skin 
diseases takes up to 1-2 weeks. They were able to differentiate between species and 
distinct concentrations within 4 days of growth. This would permit a rapid diagnosis, 
the appropriate use of anti-fungal drugs and also monitoring their activity during the 
treatment. Naraghi et al. (2010) studied the potential of using an e-nose for 
discriminating between five anti-fungal treatments against two dermatophytes species 
within 96-120h. This approach is important due to the lack of accurate susceptibility 
testing, especially for dermatophytic fungi.  
 
c. Environmental: Pollution has become one of the main concerns among public 
opinion and for local governments. The water supply can be contaminated with faecal 
microorganisms and with chemical products discharged from industrial, agricultural and 
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animal farm activities. The traditional methods for detecting indicator microorganisms 
of pollution, such as microbiological cultures, can underestimate their presence in water. 
Sensor arrays have been used to monitor wastewater in treatment plants, sewage 
treatment works and to discriminate between different products from sources as diverse 
as leather and automotive industries.  
A wide spectrum of organisms, both bacteria and fungi, and chemical components such 
as pesticides and insecticides can contaminate water supplies (Canhoto and Magan, 
2005). E-nose systems have also been used to monitor the quality of potable water for 
testing cyanobacterial species (Gardner et al., 2000b) or detecting and differentiating 
between Streptomyces spp spores in reverse osmosis and tap water (Bastos and Magan, 
2006). Recently, Bastos and Magan (2007) showed that soil quality and microbial status 
could be differentiated using volatile production patterns under different environmental 
regimes. Other interesting applications such as control of health and safety air quality in 
the aircraft cabin environment have gained special interest (Spengler and Wilson, 2003). 
 
1.4 VOLATILE FINGERPRINTS-II: MICROBIAL DETECTION 
AND DISCRIMINATION STUDIES 
 
This section summarises previous research which has addressed microbial 
discrimination and sensitivity of detection issues, mixed cultures and anti-microbial 
screening using volatile fingerprints detected by e-nose systems. Table 1.5 provides an 
overview of some of the studies.  
Microbial detection has been investigated in detail in a range of food matrices relevant 
to the food industry, especially for QC systems. Needham et al. (2005) used a CP sensor 
array to examine microbial (one bacterium, Bacillus subtilis; one yeast, Pichia anomala; 
and one filamentous fungus, Penicillium verrucossum) and non-microbial spoilage 
(enzymatic) on bread analogue substrates. They were able to differentiate between 
microbial and non-microbial spoilage. However, poor discrimination was obtained 
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between the bacterium and the yeast. Magan et al. (2001) investigated the 
discrimination between five milk-spoilage microbial species three bacteria (two 
Pseudomonas spp and Bacillus cereus) and two yeasts (Candida pseudotropicalis and 
Kluyveromyces lactis) after 5 hrs incubation at 25°C with skimmed milk-based media. 
They found discrimination between control samples, unspoiled and that containing 
bacteria or yeasts.  
With the high demand for QC in the food industry, the e-nose technology has been 
successfully used to monitor the ripening of Danish blue cheese. Trihaas and Nielsen 
(2005) successfully monitored the maturation stage of Danish blue cheese which is a 
complicated process that depends on Penicillium roqueforti growth. They were able to 
classify the ripening age of the cheese from three different batches of two 
manufacturing units and from two different types of cheese using a CP e-nose sensor 
and multivariate methods for the data analysis. In another study, Trihaas et al. (2005) 
demonstrated that the e-nose technology with partial least square regression (PLS-R) 
and a correction of the e-nose features showed similar success as GC-MS in predicting 
25 aroma compounds from different manufacturing plants of Danish blue cheeses. Also 
e-nose systems have been able to identify closely related fungi to a species level as 
Karlshøj et al. (2007b) achieved in a study with 20 isolates of several cheese-associated 
species of genera Penicillium and Geotrichum and P.expansum a non-cheese-associated 
fungus. The isolates were inoculated on yeast extract sucrose agar (YES) and analysed 
daily by the e-nose for 7 days. They not only found correct identification of the different 
species but the e-nose showed a potential for predicting mycotoxin production on a 
synthetic substrate. The same group of researchers in another study (Karlshøj et al., 
2007a) built classification models for patulin prediction in Penicillium expansum 
spoilage of apples used for juice industry with the e-nose system and PLS regression 
analysis. 
Regarding quantitative analyses, Magan et al. (2001) found slight segregation when 
three concentrations of Pseudomonas aureofaciens were tested (10
6
, 3.5x10
8
 and 8x10
8 
CFU ml
-1
). Also Boilot et al. (2002) found that their CP sensor array was able to 
separate all six bacteria tested suspended in saline solution for direct e-nose analysis for 
a given concentration, but not between different concentration values. Gardner et al. 
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(1998) investigated the ability of a tailor-made array of six metal oxide, one temperature 
and one capacitive humidity sensors to predict the type and growth phase of two 
bacteria (Escherichia coli and S.aureus) grown in a standard nutrient medium using 
ANN. All the unknown S.aureus samples were correctly classified (100% accuracy) and 
92.2% of the E.coli. Lag phase samples were correctly predicted in only 14.3% of the 
cases, whereas log and stationary phases were discriminated in 95.1% and 73.1% 
respectively. 
The minimum number of microbial cells that may be detected in food substrates has 
been suggested to be in the range 10
3
-10
4
 CFUs for grain and milk and 10
3
 CFUs for 
bread and cheese (Magan and Sahgal, 2007). Regarding bacterial infections, Boilot et 
al. (2002) found 10
4
 CFU ml
-1
 was the threshold of detection when they checked for 
bacteria causing eye infections. Similar concentration (10
3
-10
4
) was found in skimmed 
milk experiments (Magan et al., 2001).  
Few studies have been undertaken using mixtures of microorganisms. Pavlou et al. 
(2000) studied the head space of pure cultures of H.pylori and a mixed infection of 
Proteus mirabilis, E.coli and Enterococcus faecalis by using a CP sensor array. Later, 
Pavlou et al. (2004) tested sputum samples from patients with the same CP sensor array. 
Samples consisted of three bacteria (Mycobacterium tuberculosis, M.avium, and 
P.aeruginosa), a mixture of these microorganisms and control sputum, all treated with 
lipase enzymes. The addition of specific enzymes may also enhance volatile head space 
generation when non-nutritional medium is employed or real samples are analysed 
(sputum, BAL, urine). 
The use of volatile fingerprints to investigate the efficacy of anti-microbials has not 
been examined extensively previously. Besides Naraghi et al. (2010) who were able to 
discriminate between the effects of ED50 and ED90 concentrations of itraconazole on 
Trichophyton spp within 96-120 hrs of growth based on volatile fingerprints, practically 
no other studies have been carried out to address anti-microbial efficacy of compounds 
against medically important microorganisms. 
This thesis has concentrated on VAP because it is one of the gravest respiratory diseases 
in which diagnosis represents one of the main concerns and problems. Practically no 
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detailed studies have been carried out to examine the potential use of e-nose systems for 
this purpose. It may well be possible to use the qualitative volatile fingerprints for early 
detection and discrimination of the key microbial species which may be involved in 
VAP. Humphreys et al. (2011) investigated the diagnosis of VAP by detecting 
microorganisms in bronchoalveolar lavage (BAL) fluid in a prospective comparative 
study of e-nose and microbiology using linear discriminant analysis (LDA) for the data 
analysis. 77% of the samples were correctly classified and 68% when patients on 
antibiotics were included. Sahgal (2008) performed an in vitro study with 13 bacterial 
and yeast species using a hybrid electrochemical sensor array. She found that the 
microorganisms were discriminated from control samples but not between species. 
When all the samples, including controls, were split into 4 groups i.e. Gram-positive, 
Gram-negative, fungi and controls better segregation was found and 83% of in vitro 
samples were accurately predicted. However, no detailed studies have been carried out 
to examine whether it is possible to use volatile fingerprints of the key species either in 
rich liquid culture media or in saline solution which is used for obtaining BAL samples 
and try to build a lab-based model to classify unknown clinical samples. Furthermore, 
as the early detection of which microorganisms may be involved is critical to drug 
treatment, it is also important to have knowledge of the potential efficacy of anti-fungal 
compounds on the fungal species which may be involved in VAP. 
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Table 1.5: Overview of studies of volatile fingerprints using e-nose systems for 
discriminating between different microorganisms. (Key: YES: Yeast extract sucrose; 
HPLC: High Performance Liquid Chromatography). 
References Results 
Needham 
et al., 2005 
- Differentiation between microbial (fungal and bacterial) and non-
microbial spoilage (enzymatic) of bakery products in bread analogue 
substrates.                                                                                                        
- No discrimination between the bacterium (B.subtilis) and the yeast 
(P.anomala). 
Magan et 
al., 2001 
- Discrimination of unspoiled milk from that containing spoilage bacteria 
or yeasts in skimmed milk-based medium.                                                                 
- Threshold of detection: 10
3
-10
4  
CFU ml
-1 .
                                                                                                
- Relatively good quantitative differentiation between 3 concentrations of 
P.aureofaciens (106, 3.5x108 and 8x108 CFU ml-1). 
Trihaas 
and 
Nielsen, 
2005 
- Accurate classification of the maturation stage of three batches of two 
manufacturing Danish blue cheese units and two different types of other 
Danish blue cheeses. 
Trihaas et 
al., 2005 
- Prediction of 25 identified compounds by e-nose in Danish blue cheeses 
from different units. 
Karlshøj et 
al., 2007b 
- Correctly identification of closely cheese-associated fungi grown on 
YES medium.                                                                                                 
- Potential for mycotoxin production prediction. 
Karlshøj et 
al., 2007a 
- Prediction models for patulin concentration in apples on the basis of e-
nose analysis and correlated to HPLC patulin quantification. 
Boilot et 
al., 2002 
- Good discrimination between bacteria suspended in saline solution for 
one given concentration but not for separating different concentrations of 
the same bacterium.                                                                                       
- Threshold of detection: 10
4
 CFU ml-1. 
Gardner et 
al., 1998 
- Two bacteria (E.coli and S.aureus) were successfully discriminated by 
type and growth phase (lag, log and stationary).                                           
- Low prediction of the lag phase samples (14.3%). 
Pavlou et 
al., 2004 
- Effective discrimination between infected human sputum samples with 3 
microorganisms and a mixed infection. 
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References Results 
Pavlou et 
al., 2000 
- Good separation of in vitro samples with Helicobacter pylori and 
gastroesophageal isolates. 
Naraghi et 
al., 2010 
- Clear separation between inoculated and un-inoculated itraconazole 
treatments against two dermatophytes (Trichophyton rubrum and 
T.mentagrophytes), and the negative controls grown at 25°C on SDA after 
96h incubation. 
Humphreys 
et al., 2011 
- 68% correct classification of BAL samples from patients diagnosed with 
VAP on antibiotics. 
Sahgal, 
2008 
- 83% accuracy prediction of 16 microbial species involved in VAP based 
in a 4-group model. 
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1.5 VOLATILE FINGERPRINTS-III: GC-MS AND SIFT-MS 
TECHNIQUES 
 
Techniques such as gas chromatography (GC), gas chromatography linked with mass 
spectrometry (GC-MS) and selected ion flow tube-mass spectrometry (SIFT-MS) have 
been used to analyse volatile compounds. SIFT-MS was developed in 1976 for real-time 
quantification of gas analysis of ambient air, exhaled breath and the head space above 
liquids (Španěl and Smith, 2007a, 2007b). Head space analysis of liquid samples such 
as urine to detect nephrotoxicity (Boudonck et al., 2009), blood to detect bacterial 
growth (Scotter et al., 2006) and human sweat to investigate stimulant compounds for 
mosquitoes causing malaria (Meijerink et al., 2000) have also been examined.   
A large number of studies have been carried out to identify MVOCs growing on a 
diversity of matrices using chromatographic techniques but only a few have investigated 
these compounds from microorganisms involved in VAP. Humphreys (2010) used GC-
MS for patient’s breath analysis in order to identify patients with VAP. Scotter et al. 
(2005) used SIFT-MS to find the fingerprints of volatiles from medically important 
fungi (Aspergillus flavus, A.fumigatus, C.albicans, Mucor racemosus, Fusarium solani 
and Cryptococcus neoformans) grown on a variety of laboratory media (SDA, BHIB, 
Columbia agar, blood agar). Others (Wady et al., 2003) identified MVOCs present in 
diverse building materials and from isolated and sub-cultured pure moulds cultures 
(Stachybotrys chartarum, Aspergillus penicillioides and Chaetomium globosum) related 
to allergic status using GC-MS and solid-phase microextraction (SPME). Finally, there 
has been interest in monitoring mycotoxigenic fungal strains of Penicillium roqueforti 
using SPME with GC-MS by the detection of some metabolites formed in the 
biosynthesis of the mycotoxins (Demyttenaere et al., 2003). 
In this study, both methods, GC-MS and SIFT-MS, have been used to analyse and 
identify specific biomarkers patterns from in vitro bacterial and fungal species which 
may be involved in VAP in order to assess which volatile compounds the e-nose 
potentially responded to and therefore to explain the e-nose results.  
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1.6 AIMS AND OBJECTIVES 
 
The overall aim of the present study was to examine the potential for using qualitative 
volatile fingerprints of specific microorganisms involved in VAP infections using the 
hybrid sensor e-nose to discriminate between different species; to build an in vitro 
model based on these data sets to interpret samples from VAP patients to enable better 
and more accurate treatments to be applied. 
The detailed programme of work involved in this project was: 
 To evaluate the potential of a hybrid e-nose array based on MOS and 
MOSFET sensors for detecting and discriminating volatile production 
patterns between different microorganisms involved in VAP infections (e.g.,  
K.pneumoniae, Staphylococcus species, E.cloacae, C.albicans and 
A.fumigatus). 
 To investigate and compare nutritional media which can be used to optimise 
discrimination between VAP microorganisms in vitro. 
 To determine the relative sensitivity for the detection of different 
concentrations of these VAP causing microorganisms over 24-96 hr periods 
 To analyse the ability of the e-nose to distinguish between mixtures of 
different microorganisms. 
 To determine the volatiles produced by these microorganisms using GC-MS 
and SIFT-MS techniques and correlate these with the results with the e-nose  
 To evaluate the potential of using the e-nose to discriminate efficacy of 
different anti-fungal agents using volatile fingerprints. 
 To compare the use of a simulated lung fluid medium (saline solution 
amended with 0.2 % Glucose-0.2% Peptone) to discriminate between VAP 
causing microorganisms. 
The thesis layout consists of Chapter 2, which presents all the relevant Materials and 
Methods including the e-nose operation and statistics tools for data analysis, and GC-
MS and GC-MS linked with SIFT device used; Chapter 3 describes the series of results 
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obtained in relation to (a) analyses of volatiles produced by VAP microorganisms in 
different media, (b) sensitivity of detection, (c) mixed cultures, (d) effect of anti-
fungals, (e) GC-MS and SIFT-MS analyses, (f) use of saline solution as a lab-based 
medium and (g) development of statistical models for prediction of clinical samples; 
Chapter 4 contains the Discussion of the different key components of the research in the 
context of the available literature; and Chapter 5 summarises the overall Conclusions 
and possible avenues for future work. Figure 1.4 summarises the different phases of the 
work which is presented in this thesis and the links between them. 
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Figure 1.4: Flow diagram of the different phases of research and the links.
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CHAPTER 2: MATERIALS AND METHODS 
2.1 BACTERIAL AND FUNGAL CULTURES 
In vitro studies were carried out with five microorganisms, two Gram-negative bacteria 
(K.pneumoniae, E.cloacae), one Gram-positive bacterium, (a Staphylococcus species 
for the initial experiments, S.aureus for the later ones), one yeast (C.albicans) and one 
filamentous fungus (A.fumigatus). Appendix A explains the origin of the 
microorganisms used. The five microorganisms were chosen from clinical isolations at 
Gloucestershire Hospitals NHS Foundation Trust, with the exception of the A.fumigatus 
isolate, in order to have at least one representative specimen from each group: 
filamentous fungi, yeasts, and Gram-negative and Gram-positive bacteria. All of them 
may have a role in the cause of VAP. 
The bacterial strains were cultured on Nutrient Agar plates (NA; Oxoid, UK). 
C.albicans was cultured on Sabouraud Agar (SA; Oxoid, UK) and A.fumigatus on Malt 
Extract Agar (MEA; Oxoid, UK). All of the cultures were stored at 4°C for at least 2 
weeks until they were sub-cultured on the respective same solid medium and incubated 
at 37˚C to obtain fresh 3-7 day old cultures either for storage or for experiments. Shaker 
incubators were used for liquid culture studies. An orbital incubator DJB (Weiss 
Gallenkamp, UK) was used in the Phase I and Phase II experiments and this was 
replaced by an IKA® KS4000 (Germany) for the Phase III experiments with saline 
solutions. 
API 20 E® (bioMérieux SA, France) strips were used to check the identification of the 
Gram-negative bacteria. Gram stains were prepared regularly for all bacteria and 
microscopic observations were made for A.fumigatus and C.albicans. 
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2.2 ANALYSES OF VOLATILES OF VAP MICROORGANISMS 
IN DIFFERENT MEDIA 
 
Three different liquid media were tested: Brain Heart Infusion Broth (BHIB; Oxoid, 
UK), Nutrient Broth (NB; Oxoid, UK) and Tryptone Soy Broth (TSB; Oxoid, UK). 
Table B.1 (Appendix B) summarises the composition of these three media. 
For liquid culture experiments, 250 ml flasks were used. For controls, 200 ml of 
medium and for microbial treatments (e.g. K.pneumoniae or C.albicans) 150 ml of 
medium was used. All the flasks, sealed with cotton wool and aluminium foil were 
autoclaved prior to inoculation. A cell suspension was prepared by taking loops of cells 
and placing them in 10 ml of saline solution in a Universal bottle. The concentration 
was determined using a haemocytometer (Helber chamber, Marienfeld GmbH & Co. 
KGM, Germany). The cell concentration was diluted as required by addition of sterile 
saline solution to obtain a target final concentration of 10
4
 cells ml
-1
 of microorganism 
in each flask. The flasks were incubated at 37˚C in the orbital incubator at 150 rpm for 
three days. Daily, 5 ml sub-samples were taken from each replicate of each treatment 
and placed in sterile special 30 ml vials sealed with a screw cap containing a teflon 
septum before placing in the autosampler of the e-nose. 
 
2.3 SENSITIVITY OF DETECTION OF VAP MICROORGANISMS 
 
This study was performed exclusively in NB. Initial cell suspension of each 
microorganism (E.cloacae, K.pneumoniae, C.albicans, Staph. species and A. fumigatus) 
were prepared in saline solution and the concentration of cells calculated using the 
haemocytometer and serial dilutions were made to obtain: 10
2 
cells/spores ml
-1
, 10
4 
cells/spores ml
-1
 and 10
6
 cells/spores ml
-1
 for each microorganism. For A.fumigatus, a 
spore suspension was prepared in sterile saline containing a drop of Tween-80 (Acros 
Chemicals, Belgium). The conical flasks were incubated in the orbital incubator at 37°C 
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for three days. Five replicates per treatment were used and uninoculated media served as 
controls. 5 ml of each sample were placed in the e-nose specific sterile 30 ml vials for 
volatile fingerprints analyses every 24 hours for three days. 
 
2.4 DISCRIMINATION USING VOLATILES IN MIXED 
CULTURES 
 
For these experiments the following microorganisms were used (a) a Staphylococcus 
strain and E.cloacae and (b) C.albicans and E.cloacae. Experiments were performed in 
NB. The cell suspensions were determined and diluted as required in saline solution to 
obtain 10
2
, 10
3
, 10
4 
and 10
6 
cells ml
-1
 concentrations of each one. In the first set of 
experiments: 10
2 
+ 10
4 
cells ml
-1
, 10
3 
+ 10
3 
cells ml
-1
, 10
4 
+ 10
2 
cells ml
-1
, and 10
6
 cells 
ml
-1
 of
 
Staphylococcus species and E.cloacae were used and the bacteria alone or NB 
medium serving as positive and negative controls. Table 2.1 summarises the mixtures 
and the proportions for each microorganism. This experiment was repeated once. A 
second experiment was carried out to examine mixtures of the yeast and a bacterium. 
Thus, C.albicans and E. cloacae were mixed in the same proportions as detailed above. 
All the treatment flasks were incubated at 37°C in an orbital incubator for three days 
and sub-samples removed and analysed every 24 hrs as described previously. 
From the literature, positive cultures from suspicious VAP patient samples have more 
than 10
3
, 10
4 
or 10
5
 CFU ml
-1
 depending on the type of sample: BAL, mini-BAL and 
tracheal aspirate. This experiment could have been planned mixing different initial 
amounts of each microorganism. However, as an initial approach, two mixtures with 
different concentrations and one mixture with equal amounts of each microorganism 
were prepared in the range of 10
2
 and 10
6
 CFU ml
-1
 also single cultures with the highest 
concentration were analysed. 
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Table 2.1: Summary of mixtures for two microorganisms with their initial 
concentrations.  
Mixtures Staphylococcus 
spp/C.albicans 
(CFU ml
-1
) 
Enterobacter cloacae 
(CFU ml
-1
) 
1 10
2 
10
4 
2 10
4 
10
2 
3 10
3 
10
3 
4 10
6 
- 
5 - 10
6 
 
Colony counting of the two species was done by spread plating 100 µl on agar media in 
order to check how many cells grew of each microorganism after 72 hrs incubation at 
37°C. To do that it was necessary to use one selective medium for Gram-negative 
bacteria, such as Mac Conkey (MC; Oxoid, UK) and one non-selective one, NA. The 
total number of colonies on MC corresponded to the Gram-negative bacterium 
population whereas the colonies on NA minus the ones grown on MC corresponded to 
the other microorganism (Staphylococcus species or C.albicans). 
 
2.5 DISCRIMINATION BETWEEN SPECIES IN NUTRIENT 
BROTH AND SALINE SOLUTION 
 
For the experiments in NB it was used the same as it was described in previous sections 
(Oxoid, UK). 100 ml of medium was placed in 250 ml flasks for autoclaving. 
Afterwards, for the experiments with five microorganisms (E.cloacae, K.pneumoniae, 
C.albicans, Staphylococcus strain and A.fumigatus), cell/spore suspensions were made 
in sterile saline+Tween-80. The number of cell/spores was counted with the 
haemocytometer and diluting until achieving the final concentration of 10
4
 cell/spores 
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ml
-1
. The inoculum was added to a four replicates of each microorganism and no 
inoculum was added to the blank samples (negative controls). All the samples were 
incubated in agitation at 37°C for 72 hrs and daily analysed by the e-nose. 
Saline solution (0.85% NaCl) was obtained by diluting one tablet of saline solution 
(Oxoid, UK) in 500 ml of distilled water.  This was combined with either 0.1% or 0.2% 
of D-(+)-Glucose (Sigma, Germany) and Bacteriological Peptone (Lab M, UK). These 
were compared to determine the best combination which would support growth such 
that volatile production patterns could be used for discrimination between the five test 
microorganisms: E.cloacae, K.pneumoniae, C.albicans, S.aureus and A.fumigatus. The 
pH of the media was 6.6. Three experiments using saline solution with 0.2% glucose 
and 0.2% peptone were performed on different days. Cell suspensions were made in 
sterile saline solution and spore suspensions in sterile saline solution+Tween-80. Cell 
concentrations were determined using the haemocytometer and diluted appropriately to 
obtain final concentration of 10
4
 cells/spores ml
-1
 per flask and per microorganism. The 
inocula were added to five replicates of the medium before incubation in the orbital 
incubator at 37°C for 72 hrs. Also five replicates without inoculum were incubated as 
negative controls. Samples were taken every 24 hrs as described previously for e-nose 
analysis.  
 
2.6 USE OF VOLATILE PRODUCTION PATTERNS TO 
DISCRIMINATE BETWEEN DIFFERENT ANTI-FUNGAL 
TREATMENTS AGAINST A.FUMIGATUS AND C.ALBICANS 
 
2.6.1 EFFECT OF ED50/ED90 ANTI-FUNGALS ON GROWTH 
The fungal strains used in this study were A.fumigatus and C.albicans. 
Three anti-fungal agents were tested in this study: fluconazole (PLIVA Pharma Ltd, 
UK), tebuconazole (Folicur® SE, Bayer CropScience, Germany) and benomyl 
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(Benopron®, Probelte SA, Spain). Fluconazole solution was obtained ready for use in a 
concentration of 2 mg ml
-1
. 1mg ml
-1
 stock solutions were prepared for tebuconazole 
and benomyl in sterile reverse osmosis water containing 100% of the active ingredient.  
For A.fumigatus different concentrations of the anti-fungals were incorporated into 
molten MEA in the range 0.1, 0.5, 1, 2.5, 5 and 10 mg ml
-1
 for tebuconazole and 
benomyl. The concentrations of spores were determined as described previously in 
saline+Tween-80 sterile solution. With a sterile loop, a drop of approximately 5 mm 
wide from a suspension of 10
6
 spores ml
-1
 was inoculated in the middle of five 
replicates in 9 cm Petri plates per treatment and incubated at 25°C and 37°C. Five 
replicate control plates were used for comparison. The diametric growth of the colonies 
in all treatments were measured daily in two directions at right angles to each other over 
a period of 9 days. Using the growth rate data at different concentrations and by making 
comparisons with the control growth data it was possible to calculate the ED50 and ED90 
values of the anti-fungals treatments that inhibited 50% and 90% growth respectively. 
The ED50/ED90 were calculated by plotting in the relatives growth rates (mm day
-1
) to 
compare to treatments using Microsoft® Excel.  
For C.albicans studies were carried out in NB and saline-based solution liquid cultures. 
In NB, the anti-fungal concentrations of 0.1, 1 and 5 mg ml
-1
 of fluconazole and 
tebuconazole were added to the broth media. Three replicates 250 ml flasks were used 
for each treatment and control. Each replicate was inoculated with 1.5 ml of an initial 
spore suspension of 10
6
 cells and incubated on an orbital incubator at 25°C as described 
previously. In saline solution experiments (with 0.2% glucose-0.2%peptone) the media 
were modified with tebuconazole to obtain concentrations of 0.02, 0.05, 0.15, 0.25, 0.5, 
1, 1.5, 2 and 5 mg ml
-1
. A cell suspension was prepared in saline solution as described 
previously to obtain an inoculum of 10
4
 cells ml 
-1
. This experiment was carried out for 
6 days at 37°C. 
Growth was monitored by measuring the optical density (OD, 640 nm wavelength) in a 
spectrophotometer (Camspec MS350, UK) for both NB and saline solution experiments. 
The optical densities were taken for more than 3-4 days or more depending on the 
concentration of anti-fungal. 
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Baranyi’s sigmoid function (Baranyi, 1993; Baranyi, 1994) was used to find the 
maximum growth rate of each treatment for C.albicans with tebuconazole in saline 
solution. The raw data was obtained by measuring optical density per each treatment 
and control over time. These data sets were fitted to the Baranyi’s sigmoid function 
(Baranyi, 1993; Baranyi, 1994) by using DMFit version 2.1 model (Institute of Food 
Research, UK) and the maximum growth rates (μmax) were obtained for each treatment. 
The different μmax were plotted in an Excel chart to allow the calculation of the anti-
fungal concentrations where the growth was inhibited by 50% and 90%. The Baranyi 
model was selected because this minimises the subjectivity in the calculation of the 
growth rate. 
 
2.6.2 EFFECT OF ED50/ED90 OF ANTI-FUNGALS ON VOLATILE 
PRODUCTION PATTERNS AND DISCRIMINATION BETWEEN 
TREATMENTS 
 
For A.fumigatus, the ED90 and ED50 concentrations for tebuconazole and benomyl were 
added to molten MEA and poured into 9 cm Petri plates. Five replicates of each 
treatment were prepared.  All the plates except for blank samples were inoculated with 
0.1 ml of a spore suspension of 10
6
 spores ml
- 1
 and spread plated on the agar surface 
with a sterile glass spreader. Five control MEA plates were also prepared as blanks. All 
the replicates were incubated at 25 and 37ºC. For the e-nose measurements of volatile 
fingerprints, four 2 cm diameter agar plugs were sampled using a sterile cork borer and 
placed in the 30 ml sterile vials, sealed with septa and screw caps. A destructive 
sampling regime was used such that every 24 hrs a different set of replicates were 
analysed over a 96 hrs period. Please note that no analysis of treatments was done after 
24 hrs incubation because very little growth had occurred in the anti-fungal cultures 
(Figure C.1, Appendix C). 
C.albicans was inoculated in: (1) NB with the ED50 and ED90 of tebuconazole and 
fluconazole; and (2) for saline solution amended with 0.2% of D-(+)-Glucose and 0.2% 
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Bacteriological Peptone with the ED50 and ED90 of tebuconazole in 250 ml conical 
flasks. Each flask or replicate contained 100 ml of medium. Cell suspensions were 
prepared in sterile saline solution and serial dilutions were made where necessary. Each 
replicate was inoculated with 10
6
 cells ml
-1
 in NB or 10
4
 cells ml 
-1 
in saline solution. 
The treatments were sampled every 24 hrs for 72 hrs and samples placed in the 30 ml e-
nose vials for analysed as described previously. 
 
2.7 GC-MS AND SIFT-MS EXPERIMENTS 
 
Several analyses were carried out using two different mass spectrometric techniques, 
GC-MS and SIFT-MS: (1) Volatiles from five microorganisms grown on NA 
(A.fumigatus, C.albicans, K.pneumoniae, E.cloacae and Staphylococcus species) were 
analysed using GC-MS and SIFT-MS techniques; (2) Volatiles from A.fumigatus 
growing on MEA treated with the ED50 concentrations of the two fungicides, 
tebuconazole and benomyl, were analysed using GC-MS and SIFT-MS techniques; (3) 
Volatiles from C.albicans treated with tebuconazole in saline solution amended with 
0.2% of glucose and 0.2% of peptone were analysed using a different GC-MS system. 
In all experiments, negative and positive control samples were also analysed. 
(a) Sampling procedure for GC-MS and SIFT-MS 
 
In the first set of experiments five microorganisms used previously were cultured on 9 
cm Petri dishes with NA. Appropriate cell/spore suspensions were prepared per 
microorganism and 0.1 ml of each suspension was spread out on the plates in sterile 
conditions. Three plates per microorganism and negative controls were placed per bag 
and incubated at 37°C. Only one bag per microbial species was analysed once after 24 
hrs incubation. 
For the analysis of the head space above A.fumigatus cultures, 0.1 ml of the initial 
suspension was spread out with a sterile spreader on MEA plates (9 cm Petri dishes) to 
reach a final concentration of 10
6
 spores ml
-1
. Three replicates were prepared of 
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A.fumigatus without anti-fungal compound; three for treated samples (A.fumigatus with 
ED50 concentrations of two anti-fungals, tebuconazole and benomyl); and two replicates 
for blank samples (MEA untreated and MEA treated with ED50 concentrations of both 
anti-fungals). A total of fifteen samples were analysed after 48 hrs and 72 hrs of 
incubation at 37°C respectively.  
For the chromatographic analyses, plastic bags were constructed from Nalophan rolls, 
210 mm width and long enough to accommodate three plates per bag (about 600 mm 
length). One side of each bag was attached to a ¼ inch Swagelok fitting and tightly 
closed with two tie-wraps. The other side was left open in order to place the plates when 
ready then sealed with one more tie-wrap. Afterwards, the bags were filled with air 
BOC zero grade and left them for incubation. 
In both sets of experiments, the cultures were left with their lids on. After each 
incubation period, the bags containing the solid cultures were taken out from the 
incubator, removed the lids without opening the bags and placed in a preheated oven at 
37°C for 5 minutes before connecting the bag fitting through the wall of the oven to the 
inlet capillary of the SIFT-MS. After these 5 minutes, each bag end was connected first 
to the SIFT-MS instrument for the analysis and later to a pump in order to capture the 
volatiles in the automated thermal desorption (ATD) tubes for the posterior analysis by 
GC-MS. The SIFT-MS used was a Model Profile 3, manufactured by Instrument 
Science Ltd. (UK). Then the head space samples passed through the heated capillary (at 
60° C) and into the flow tube where the three precursor ions reacted with the sample. 
This process was recorded during 60 seconds to generate mass spectra at m/z values 
between 10 and 200. The count rates of the precursor ions (H3O
+
, NO
+
 and O2
+
) and the 
resulting product ions of the reactions are determined by a mass spectrometer 
downstream. This can be operated in two modes: a) The full-scan mode (FSM) which 
provides the spectrum of all ions across a chosen mass range (m/z); b) The multi-ion 
monitoring mode (MIM) which determines the count rates for targeted compounds in 
the sample. It is possible to calculate the concentrations of trace gases by SIFT-MS at 
the parts per billion (ppb) and parts per million (ppm) levels knowing the reactions and 
the corresponding constants rates, the flow rates and the pressures in the instrument. 
Some of those parameters are constant such as carrier gas flow rate and others such as 
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the rate coefficients and ion products have been provided from SIFT-MS studies of 
diverse types of compounds with the three precursor ions (Turner et al., 2009). The 
present study was carried out at a helium carrier gas pressure of 0.345 Torr L s
-1
 (equals 
roughly to 27 ml min
-1
) at room temperature (23-27° C). 
0.5 l of each sample was collected into the ATD tubes using a pump which was taking 
out the headspace from the bags during 5 min at a 100 ml min
-1
 flow rate.  The volatiles 
captured in the ATD tubes were analysed using a Perkin Elmer system which comprises 
a TurboMass mass spectrometer 4.1 (Software version) and an AutoSystem XL GC 
equipped with an Automatic Thermal Desorption system ATD 400 (Perkin Elmer, 
Wellesley, MA, USA). The carrier gas was CP grade helium (BOC gases, Guildford, 
UK) passed through a combined trap for removal of hydrocarbons, oxygen and water 
vapour. ATD tubes were desorbed by purging for 2 min at ambient temperature then for 
5 min at 300°C.  A wall-coated Zebron XB624 chromatographic column (30m x 0.4mm 
x 0.25mm) was used (Phenomenex, Torrance, CA, USA). The ATD tubes contained 
two parts:  50% Tenax TA and 50% of Carbotrap (Markes International Limited, UK) 
and were stored at 4°C once they were conditioned by purging with He gas for 2 min at 
25°C followed by 1 hour at 320°C. 
 
(b) Sampling procedure for alternative GC-MS system 
 
Side-arm flasks were used for culturing C.albicans in 100 ml of saline solution (0.85 % 
NaCl) medium amended with 0.2% of D-(+)-Glucose and 0.2% of Bacteriological 
Peptone and ED50 and ED90 of tebuconazole. Saline solution was obtained by dissolving 
one tablet of saline solution in 500 ml of distilled water. An initial suspension of 
C.albicans was prepared in sterile saline solution and 0.1 ml was inoculated in each 
replicate to reach 10
4
 cells ml
-1
. Three replicates per treatment and positive controls and 
two replicates for negative controls were incubated at 37°C for 24 hrs. Only ED90 
treatments were incubated one day more and analysed.    
At the moment of the sample collection, the side-arm of each flask was connected 
through transparent Silicone tubing to the steel sorption tubes containing Tenax 
TA/Carbopack in series. With the help of a pump every sorption tube was sampled with 
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the head space from each flask at a flow rate of 100 ml min
-1
 during 10 minutes. A cork 
was perforated and a Pasteur pipette was placed to allow air replacement in all the 
flasks. 
The samples collected from every flask were analysed by thermal desoprtion (TD) and 
GC-MS system. The chromatographic device was formed by a Markes TD-100 two-
stage thermal desorber linked to an Agilent 6890 GC (Agilent Technologies UK 
Limited, UK), fitted with a capillary column, Agilent DB-5 (60mx0.50mmx0.25mm) 
and coupled to a 5973 mass selective detector (MSD). The sorption tubes were 
conditioned in the TD-100 by heating to 320°C in a flow of 50ml/min for 15 minutes. 
For the analysis, all the samples were run with 0.5 µl of the internal standard (IS, D8-
toluene) followed by an empty sorption tube and purged each with dry gas at 80 ml/min 
for approximately three minutes. A maximum of 20 samples are run before running an 
unused tube. After checking by visual inspection the chromatograms and named the 
compounds using the internal library or the NIST library the concentrations of the most 
abundant compounds were calculated. The concentrations in ng l
-1
 were calculated 
either using the calibration curve for the specific compounds or using toluene 
calibration factor. 
 
2.8 ELECTRONIC NOSE SYSTEM USED 
 
Two e-noses manufactured by AppliedSensor AB (Sweden), NST 3320 system, were 
available for the sample analyses. Both consist of a non-specific sensor array of 12 
MOS sensors, 10 Field Effect sensors (FE sensors) and a capacitance-based relative 
humidity sensor. The AppliedSensor FE sensor technology is based on the field effect 
generated by gases in metal oxide semiconductor field-effect transistor (MOSFET) 
devices with catalytic metals. The unique difference between both e-noses is the 
absence of a CO2 sensor in one of them. Figure 2.1 shows the e-nose used in this study, 
the one not provided with the CO2 sensor. Table B.2 (Appendix B) shows the sensors 
and the wide range of volatile compounds detected. The e-nose also has a control 
software package for analysing the collected data.  
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Figure 2.1: NST 3320 system by AppliedSensor AB. 
 
2.8.1 OPERATING PRINCIPLE OF THE E-NOSE SYSTEM 
 
The NST 3320 e-nose system comprises a 12 position carousel autosampler unit and a 
sampling system. The samples consisted of 30 ml glass vials sealed with screw open-top 
caps with septa. The sampling system consists of two needles, one for collecting the 
sample gas and other for replacing the head space with a clean air (reference gas) that 
has been filtered through two gas filters: a drying column of silica gel which acts as a 
main moisture trap and a hydrocarbon filter which is divided in two parts, one is a 
highly efficient moisture filter and the other is an active carbon adsorbent. The air enters 
the system at a flow rate of 60 ml min
-1
. The sample phase comprises three more phases 
in which the temperatures can be set. These phases are: the idle, the standby and the 
incubation phase. All the samples are maintained at 37°C during standby and incubation 
phases and at room temperature during the idle phase. 
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All the measurements realised by the e-nose are performed in cycles during which the 
sensors are exposed to the sample head space. One measurement cycle lasts 4 min and 
20 seconds and comprises 30 seconds of baseline, 30 seconds for the sample phase and 
200 seconds for the recovery phase including 60 seconds for flushing. Before and after 
the sampling phase a reference gas is passed over the sensor surface in order to prepare 
it for measurement.  Figure 2.2 shows the measurement cycle in the NST 3320 e-nose 
system. For each cycle, for each sample, several characteristic parameters are calculated 
and represented as a curve (Figure 2.3). Some of the parameters are: divergence (the 
maximum response from the baseline), adsorption (rate of increase in response), 
desorption (rate of decrease in response) and area (area under the curve). 
 
Figure 2.2: Measurement cycle in NST 3320 e-nose for one sensor (FE102A). 
Baseline
(30 sec)
Sample
(30 sec)
Recovery
(200 sec)
Flush
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Figure 2.3: E-nose sensor response curve showing some measurable parameters. 
 
Many others parameters can be calculated such as baseline, response, absolute response, 
on derivative, on integral, off derivative, off integral, difference and as many parameters 
as slopes are on the curve. In this current study the measurement mostly used has been 
the response which is calculated as the subtraction of the absolute response minus the 
baseline values which are calculated as an average over a certain time interval in order 
to minimise the signal-to-noise ratio. 
 
2.8.2 SAMPLE PREPARATION FOR E-NOSE ANALYSES 
 
The 30 ml glass vials were cleaned and sealed with aluminium foil, autoclaved and 
heated overnight in a dry oven. Septa were autoclaved separately in aluminium foil 
sealed beakers. The open top caps were cleaned and dried but not autoclaved. There was 
no contact between the caps and the samples. 
Each sample was placed in the 30 ml glass vials and sealed with screw caps containing  
teflon septa (teflon layer towards the sample) (Figure 2.4). The samples were left for 
one hour at 37°C in the incubator in order to generate the head space with the volatiles 
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from the samples. Afterwards, the head space generated was analysed using the e-nose. 
The same media without inoculum were used as controls. Four or five replicates per 
treatment were tested. 
In all cases the 30 ml vials were kept for 1 hr at the same temperature as the samples 
were incubated in order to increase head space volatile organic compound prior to 
sampling. 5 ml of sample were always analysed using the e-nose. 
 
Figure 2.4: Special vials with septa and open-top caps for the e-nose. 
 
2.8.3 E-NOSE DATA ANALYSIS 
In order to understand the signal processing in the e-nose instrumentation it is necessary 
to consider how the data were obtained. The input signal is represented as a 
concentration vector, a matrix with one row and as many columns as components in the 
odorant. After contact with the sensor material, the input signal is converted in an 
electrical signal, for example, a difference in voltage. Then, the output signal from the 
sensor array is transformed in a new vector called array response vector. 
The data collected from an e-nose based on more than one (response) variable are 
analysed using multivariate data analysis. These techniques permit the classification of 
data to determine the relationships between the sensor responses (independent variables) 
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and odour classes (dependent variables) (Pearce et al., 2003). Several methods can be 
used which may be either unsupervised or supervised. With unsupervised methods the 
unknown samples are discriminated but not classified by the differences between their 
measurements. The supervised methods permit classification of the unknown samples, 
also called the validation set, using a set of previously classified samples, the so called 
training set. Multivariate data methods can be subdivided into two approaches: 
statistical, also known as parametric, and neural networks, referred as non-parametric 
approach. For each two groups there is a possible quantitative data analysis and a 
qualitative technique commonly known as pattern recognition (PARC). The statistical 
multivariate analysis looks for the relationships between data in a probabilistic way. 
Artificial neural networks (ANN) solve multivariate problems using the human 
reasoning with an artificial neural network. Figure 2.5 shows some multivariate 
techniques broadly used in multidimensional data analysis and mainly in the e-nose 
field. 
 
Figure 2.5: Brief scheme of some multivariate data analysis. Modified from Gardner 
and Bartlett (1999) and Jurs et al. (2000). (Key: ART: Adaptive resonance theory; BP: 
Back propagation; CA: Cluster analysis; DA: Discriminant analysis; GAs: Genetic 
algorithms; LDA: Linear discriminant analysis; LVQ: Learning vector quantisation; 
PCA: Principal component analysis; PCR: Principal component regression; PLS: Partial 
least square; SOM: Self-organising map). 
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In the present study, the data obtained from the e-nose were analysed using Principal 
Component Analysis (PCA) and Cluster Analysis (CA) as exploratory techniques to 
investigate the trend of the data. Discriminant analysis (DA) was utilised to build a 
model for validation samples also partial least square for DA (PLS-DA). These 
multivariate methods, also the standardisation, scale and cross-validation methods are 
explained below. 
Principal Component Analysis (PCA): This is a statistical multivariate method, 
unsupervised or untrained that allows reducing the dimensionality of data trying to 
capture maximum variance with a fewer number of variables. These new variables are 
called principal components (PCs). Then, after the analysis, each PC is sorted by its 
amount of variance in decreasing order. The simplification of the data permits the 
display of multivariate data sets in two dimensions (2 PCs) or three dimensions (3 PCs) 
in space instead of n-dimension space, making it easier to analyse the data without 
losing too much information. Other advantage of PCA is also classification and outlier 
detection (Wold et al., 1987). PCA is also a linear technique since there is a linear 
relationship between the independent and the dependent variables or in other cases there 
has been a linearisation of the data. The e-nose software package provides the PC 
analysis and performs a pre-processing of the array signals in default as the data 
obtained from the e-nose is previously mean-centred. Other scale alternatives are 
available from the NST Senstool software such as normalisation, auto-scale, unit 
variance and the combination of unit variance and normalisation. Standardisation and 
diverse types of range-scale are others scale methods to use. Range-scale between <+1 
and >-1: 
 
    
          
         –        
                                   Equation 1 
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And range-scale between 0 and +1: 
 
 
    
     –          
         –        
                                 Equation 2 
                                                    
 
The PC analyses are based on covariance matrixes instead of correlation matrices 
because they are more appropriate when the differences are sought in the amount of 
variability between the variables. 
In order to improve the PCA results, sometimes it was necessary to remove replicates 
considered outliers if they were located far away from the mean group. Most of the 
time, outliers corresponded to the first measured sample. The first measurement of each 
cycle often gives outliers when the instrument has been switched off for some time. The 
criteria for considering an outlier was: first, the outlier was identified visually when it 
was located outside the expected group and secondly, an outlier is a data point well 
outside the range of others in the box and whisker plots for most of the variables as it is 
shown in Figure 2.6. 
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Figure 2.6: Box and whisker plot of 5 replicates of blank samples for one sensor 
(MO117). 
Materials&Methods 
46 
Cluster Analysis (CA): This is another unsupervised multivariate technique that 
classifies the data into clusters (groups). In every cluster the samples share some 
common trait according to some defined distance measure. In this way, data considered 
similar are clustered or partitioned into the same cluster, and data considered different 
are sorted in different clusters. The result of this analysis is a graphic called a 
dendrogram or tree-diagram. There are various ways of computing distances and several 
types of clustering methods. Statistica version 7/8 (StatSoft, USA) was used to calculate 
the dendrograms choosing the Euclidean distances with the Ward’s procedure in all 
cases. 
Discriminant Analysis (DA): The general purpose of this multivariate technique is to 
find which variables discriminate better between different groups and then to use those 
variables to predict new cases (unknown samples). Computationally, DA is very similar 
to analysis of variance (ANOVA) and regression analysis, with the difference that the 
DA dependent variable is a categorical variable rather than numerical. JMP® 8.0.2 
(SAS Institute Inc., USA) was used for DA. 
Partial Least Square for Discriminant Analysis (PLS-DA): Is a multivariate 
discrimination method used to classify samples. It combines PLS regression and PCA. 
From PCA, the dimensionality of the data is reduced but keeping the characteristics of 
the data that contributes mostly to its variance; and from PLS the most discriminant 
variables are sought attempting to maximise the separation between groups of 
observations. Therefore, PLS-DA tends to increase the covariance between the input 
data and the output class. PLS Toolbox 3.5, Eigenvector Research Inc., USA) was 
employed in Matlab 7.3 (Mathworks Inc., USA) was used for PLS-DA analyses. 
Monte Carlo simulation: This type of model assesses for the accuracy of a model by 
simulating the prediction several times (replications) showing whether the model 
predicts well by chance or not. The data generated from the simulation can be seen as 
probability distributions (or histograms). 
Cross validation methods: Are used to estimate how well a model can predict a new 
data set. In these methods the data set is partitioned into subsets. The analysis is 
performed on one subset (training set) and validated on the other subset (validation set). 
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This has to be done several times, or rounds, with different partitions. Leave-one-out 
(LOO) is one of the methods to validate models where only one sample is removed 
every time.  
Multiplicative Drift Correction (MDC):  This method implemented for changes over 
time in NST Senstool was performed based in the measurements of the blanks samples 
related with the more frequently analysed samples (i.e., saline solution with no 
inoculum).  The ratio between the first and the second sets of measurements (the 
average of the response signals) is calculated for each sensor. Then the calibration is 
made by multiplying all the signals parameters with the appropriate ratio.      
Piecewise direct standardisation (PDS): Is an adjustment method for enabling the 
comparison of measurements that may differ. This approach develops a model for 
predicting a new set of measurements from previous ones made in a standard 
instrument. This is normally motivated when different instruments have been used, also 
when it may want to use a historical database. 
 
2.8.4 OPTIMISING SENSOR COMBINATIONS 
In order to optimise the discrimination observed in the PCA score plots, it was 
sometimes necessary to follow some steps. Firstly, all the e-nose measurements are 
plotted in a PCA plot with all the sensors to obtain an initial impression of the sensor 
responses.  This facilitated the identification and removal of outliers from the data set. 
This also enabled the  selection of the most discriminating sensors either by examining  
the loading plots or  the correlation table selecting the sensors with highest correlation 
values (positive or negative) in relation to each class or group of samples.  
All the PCA score plots shown in this thesis have been built using all the sensors, MOS, 
MOSFET and humidity sensors. In some cases, specific sensors or groups of sensors 
were removed to obtain better discrimination. For instance, the following example 
shows how the discrimination between groups can be improved by removing sensors. In 
the experiment with different initial concentrations of K.pneumoniae (10
2
, 10
4
, 10
6
 CFU 
ml
-1
) grown in NB, after 72 hrs incubation the PCA with all the sensors shows (Figure 
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2.7) little discrimination among inoculated samples. However, by removing MOSFET 
and humidity sensors, and an outlier which corresponded to the first measurement of 
one of the cycles, the PCA showed (Figure 2.8) better discrimination with three clusters: 
the same clusters for blanks and two additional groups, one for the lowest initial 
concentration and a second for the rest of inoculated samples. 
  
 
Figure 2.7: PCA score plot of K.pneumoniae after 72 hrs incubation at 37°C in NB. 
Red dotted line shows an outlier. (Key: Kp: K.pneumoniae: 10(2), 10(4) and 10(6): 10
2
, 
10
4
 and 10
6
 cells ml
-1
).  
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Figure 2.8: PCA score plot of K.pneumoniae after 72 hrs incubation at 37°C in NB. 
MOSFET, humidity sensors and one outlier have been removed. (Key: Kp: 
K.pneumoniae: 10(2), 10(4) and 10(6): 10
2
, 10
4
 and 10
6
 cells ml
-1
).  
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2.8.5 CONTROL OF SENSOR RESPONSES 
One of the most common problems of gas-sensor technology is known as sensor drift. 
This means these sensors may not always give us exactly the same measurement over 
time (Pearce et al., 2003). Sensor drift can be due to ageing of the sensors, or by contact 
with sulphur compounds which bind to the sensor surfaces, hampering their working 
order. If the drift is caused by condensation of vapours which do not poison the sensors’ 
surfaces, it can be reversible. 
By using always the same reference substances over time it is possible to check the 
stability of response for each sensor  therefore, in order to ensure that the hybrid sensor 
array did not drift significantly over time, two diluted substances (isopropanol and 
acetone, 0.1% concentration) and distilled water were analysed on a regular basis. 
Figure 2.7 shows the PCA score plot of 24 measurements over a period of 24 months. 
Figure 2.8 a, b shows an example of the mean of the sensor responses of 0.1% acetone 
in 24 different days over that period for four different sensors: MOSFET 101A, 102A, 
MOS 101 and 102. The mean percentage of the standard error was 7.04, 8.22, 1.86 and 
3.18% for those sensors respectively. Table B.3 (Appendix B) resumes the mean of 
responses, the standard deviations and the percentages of the deviation for all the 
sensors and for all three compounds analysed over time.  
 
Figure 2.9: PCA score plot for all the replicates for acetone (Acet.), isopropanol (Ipa) 
0.1% and distilled water measured in 24 occasions over a period of 2 years. 
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a) 
 
b) 
 
Figure 2.10: Bar graphs showing the mean responses of the replicates of 0.1% acetone 
over 24 different measurements for (a) 101A and 102A sensors and (b) 101 and 102 
MOS sensors. I: depicts the standard error bars. 
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CHAPTER 3: RESULTS 
3.1 ANALYSIS OF VOLATILES OF VAP MICROORGANISMS 
IN DIFFERENT MEDIA 
 
A comparison was made of the various test media for the generation of the volatile 
fingerprints which would be best for discriminating between the various VAP 
microorganisms using the e-nose. For this study two of the species were examined 
(C.albicans and K.pneumoniae). It was possible to obtain discrimination after 24 hrs on 
NB, as shown in the PCA plot in Figure 3.1. Figure 3.2 shows the discrimination 
between the different media types tested after 48 hrs incubation. TSB and BHIB did not 
show any discrimination between species until after 48 hrs incubation. The CA confirms 
the relative clustering of the different treatments after 24 and 48 hrs (Figures 3.3 and 
3.4). This shows that after 48 hrs there were more distinct clusters, with differences 
between the blanks being detected.  
Figure 3.1: PCA score plot of different media after 24 hrs incubation at 37°C. (Key: 
Ca: C.albicans; Kp: K.pneumoniae; BHIB: Brain Heart Infusion Broth; TSB: Tryptone 
Soy Broth; NB: Nutrient Broth). 
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Figure 3.2: PCA score plot of different media after 48 hrs incubation at 37°C. (Key: 
Ca: C.albicans; Kp: K.pneumoniae; BHIB: Brain Heart Infusion broth; TSB: Tryptone 
Soy broth; NB: Nutrient broth). 
 
Figure 3.3: Dendrogram after 24 hrs incubation at 37°C. (Key: same as Figure 3.2). 
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Figure 3.4: Dendrogram after 48 hrs incubation at 37°C. (Key: Ca: C.albicans; Kp: 
K.pneumoniae; BHIB: Brain Heart Infusion broth; TSB: Tryptone Soy broth; NB: 
Nutrient broth). 
 
3.2 SENSITIVITY OF DETECTION OF VAP MICROORGANISMS 
 
A series of experiments were carried out to evaluate the sensitivity for detection of the 
various VAP microorganisms, including the bacteria, yeast (C.albicans) and the 
filamentous fungus A.fumigatus. Overall, the sensitivity of detection was different 
depending in which microorganism was tested. After 24 hours of incubation of 10
2
, 10
4
 
and 10
6
 spores ml
-1
 as initial concentrations of A.fumigatus it was observed with the PC 
analysis (Figure 3.5) that the lowest concentration tested (10
2 
spores ml
-1
) was not 
differentiated and it was clustered together with the negative control samples. Also 
samples with the initial concentration of 10
4
 spores ml
-1
 were classified close to them. 
Only 10
6
 cells ml
-1
 samples were identified from the beginning as a clear separate 
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cluster. Discrimination between negative controls and the rest of the samples was 
achieved after 72 hrs incubation. Over time, a separation between concentrations, with 
respect the negative controls was observed, until all the A.fumigatus treatments were 
clustered together (72h). Therefore, the lowest concentration 10
2
 spores ml
-1
 was 
discriminated from blank after 72 hrs incubation.  Figure 3.6 shows the dendrogram 
after 72 hrs incubation obtained for A.fumigatus. 
 
 
Figure 3.5: PCA score plot of Aspergillus fumigatus after 24 hrs incubation at 37°C in 
NB. (Key: Af: Aspergillus fumigatus: 10(2), 10(4) and 10(6): 10
2
, 10
4
 and 10
6
 spores 
ml
-1
). 
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Figure 3.6: Dendrogram of different initial concentrations of A.fumigatus after 72 hrs 
incubation. (Key: same as Figure 3.5). 
 
For the yeast, C.albicans, there was no discrimination between the negative controls and 
the other test concentrations. Only 10
6
 cells ml
-1
 samples were clustered separately after 
24 hrs incubation. After 48 hrs, 10
2
 cell ml
-1
 samples were classified separated from 
blank and control samples but together with the rest of inoculated groups. (Figure C.2, 
Appendix C).  
The PC analyses of the data from both Gram-negative bacteria showed different 
behaviour when compared to the yeast. After 24 hrs incubation it was possible to 
distinguish between the controls, 10
2
 cells ml
-1
 and the higher concentration treatments 
(10
4
 and 10
6
 cells ml
-1
). Figure 3.7 shows the PCA score plot of E.cloacae after 24 hrs 
incubation and Figure 3.8 the dendrogram. Similar patterns of discrimination were 
obtained for K.pneumoniae (Figure C.3, Appendix C). 
Finally, after 72h, all the microorganisms showed the same distinct clusters with all of 
the concentrations grouped together, and the negative control samples in a separate 
group. 
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Figure 3.7: PCA score plot of E.cloacae after 24 hrs incubation at 37°C in NB. Red 
dotted line shows an outlier. (Key: Ec: E.cloacae: 10(2), 10(4) and 10(6): 10
2
, 10
4
 and 
10
6
 cells ml
-1
). 
 
Figure 3.8:  Dendrogram of different concentrations of E.cloacae after 24 hrs 
incubation at 37°C in NB. (Key: same as in Figure 3.7). 
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It should be noted that the Staphylococcus strains demonstrated very poor growth. After 
48 hrs incubation, the PCA plots showed three clusters, one with the negative controls 
and a second with the 10
2
 cells ml
-1
 samples, very close to each other.  
 
3.3 DISCRIMINATION USING VOLATILES IN MIXED 
CULTURES 
 
Attempts were made to discriminate between mixed populations of cells of two 
different VAP microorganisms using qualitative volatile production patterns. The first 
set of experiments included a mixture of Staphylococcus strain and E.cloacae in 
different concentrations. The analyses of the head space from the cultures were taken 
every 24 hours for 72 hrs. At each sampling time the same pattern of clustering was 
obtained: one cluster of negative control samples (NB, without any inoculum), one 
cluster with the Staphylococcus strain grown alone, and another cluster with the rest of 
the mixtures and also E.cloacae alone. This can be seen in the PCA plot after 24 hrs 
incubation (Figure 3.9). This experiment was repeated with the same results.  
The second experiment involved using a mixture of C.albicans and E.cloacae. The 
same pattern of volatile production clusters was observed over the 72 hrs incubation 
period. The PCA plot is shown in Figure 3.10. This shows that the negative control 
samples were in one cluster, C.albicans growing alone, in a second cluster and the rest 
of the mixed microbial treatments in a third cluster, including E.cloacae alone.  
In both PCA plots, the red dotted circles include the outliers which correspond to the 
first measurement performed per cycle. 
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Figure 3.9: PCA score plot a mixture of two microorganisms at 24 hrs incubation at 
37°C in NB. (Key: Ec: E.cloacae; St: Staphylococcus species; 10(2), 10(3), 10(4), and 
10(6): 10
2
, 10
3
, 10
4
, and 10
6
 cells ml
-1
). Red dotted circles: outliers. 
Figure 3.10: PCA score plot of different mixtures of two microorganisms at 24 hrs of 
incubation at 37°C in NB. (Key: Ca: C.albicans; Ec: E.cloacae; 10(2), 10(3), 10(4), and 
10(6): 10
2
, 10
3
, 10
4
, and 10
6
 cells ml
-1
). Red dotted circles: outliers. 
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In order to assess the proportion of each microorganism present after the incubation 
period, the number of CFUs for each species in the mixture was determined after 72 hrs 
using two different solid media (NA and McConkey). It was found that in all the 
mixtures the Gram-negative bacterium E. cloacae was the predominant microorganism 
even when it was inoculated with the lowest initial concentration (Figure 3.11). 
 
 
Figure 3.11: Histogram of three different mixtures of E.cloacae and C.albicans after 72 
hrs incubation in NB at 37°C. (Key: 3+3: 10
3
+10
3 
cells ml
-1
; 2+4: 10
2
+10
4 
cells ml
-1
; 
4+2: 10
4
+10
2 
cells ml
-1
; I: Standard error bars). 
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3.4 USE OF VOLATILE PRODUCTION PATTERNS TO 
DISCRIMINATE BETWEEN DIFFERENT ANTI-FUNGAL 
TREATMENTS AGAINST A.FUMIGATUS AND C.ALBICANS 
 
(a) Effect of ED50/ED90 anti-fungals on growth 
Initial studies were carried out to obtain dose response curves for the efficacy of 
different concentrations of tebuconazole, fluconazole and benomyl when used against 
C.albicans and A.fumigatus. These could be used to determine the ED90 and ED50 
concentrations to use in subsequent experiments to evaluate volatile production patterns 
for discriminating between treatments.  
Figure 3.12 shows, as an example, the effect of different concentrations of tebuconazole 
on temporal growth of C.albicans over periods of 160 hrs at 37°C in saline solution 
containing a low concentration of additional glucose and peptone. Similar curves were 
obtained for the other fungicides examined. For A.fumigatus, the effect of different 
concentrations of tebuconazole on growth rates is shown in Figure 3.13 which shows 
that a higher concentration of this fungicide was needed to control this fungal pathogen 
(5-10ppm). Similar experiments were carried out with benomyl and fluconazole (see 
Figures C.4 and C.5 respectively, in Appendix C). 
That data set was used to calculate the ED50 and ED90 concentrations required to control 
these two pathogens. Table 3.1 summarises all the ED50 and ED90 values of the different 
anti-fungals required for the two species at 25°C and 37°C. It should be noted that 
benomyl was not effective against C.albicans and fluconazole had no efficacy against 
A.fumigatus at 25°C/37°C or C.albicans at 37°C. 
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Figure 3.12: Growth rates of C.albicans at 37°C with different concentrations of 
tebuconazole in saline solution+0.2% glucose and 0.2% peptone over a period of 6 
days. 
 
Figure 3.13: Growth rates of A.fumigatus at 37°C with different concentrations of 
tebuconazole on MEA over a period of 9 days. 
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Table 3.1: Summary of effective doses for different anti-fungals, species, media and 
temperatures. (Key: MEA: Malt extract agar; NB: Nutrient broth; SS+0.2%G-P: saline 
solution 0.2% Glucose-0.2% Peptone).  
Anti-fungals Species ED50 ED90 Temp Medium 
Tebuconazole A.fumigatus 
A.fumigatus 
C.albicans 
C.albicans 
1.553 µg ml
-1 
1.934 µg ml
-1
 
0.175 µg ml
-1 
0.135 µg ml
-1
 
4.240 µg ml
-1 
6.850 µg ml
-1
 
1.985 µg ml
-1 
1.893 µg ml
-1
 
25°C 
37°C 
25°C 
37°C 
MEA 
MEA 
NB 
SS+0.2%G-P 
Benomyl A.fumigatus 
A.fumigatus 
C.albicans 
 
0.451 µg ml
-1
 
1.239 µg ml
-1
 
Not effective 
1.012 µg ml
-1
 
2.248 µg ml
-1
 
Not effective 
25°C 
37°C 
25°C 
MEA 
MEA 
NB 
Fluconazole A.fumigatus 
A.fumigatus 
C.albicans 
C.albicans 
Not effective 
Not effective 
0.078 µg ml
-1 
Not effective 
Not effective 
Not effective 
3.829 µg ml
-1 
Not effective 
25°C 
37°C 
25°C 
37°C 
MEA 
MEA 
NB 
SS+0.2%G-P
 
 
 
(b) Effect of ED50/ED90 of anti-fungals on volatile production patterns and 
discrimination between treatments 
 
The ED50 and ED90 concentrations were then used to carry out fully replicated 
experiments with which included positive and negative blanks using the e-nose to 
evaluate the volatile production patterns. This showed that discrimination between 
treatments could be observed after 48 hrs incubation for A. fumigatus in the presence of 
two fungicides (benomyl, tebuconazole) at 37ºC. PCA plot is shown in Figure C.6 
(Appendix C). A radar plot (Figure 3.14) has been included to show the different 
responses from MOSFET sensors for each treatment. No good discrimination was 
achieved at 25ºC at any time (data not shown).  
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Figure 3.14: Radar plot of MOSFET sensors showing the distinctive responses for 
different samples of A.fumigatus with benomyl and tebuconazole effective doses of 
50% and 90% of growth inhibition (ED50, ED90) after 48 hrs incubation on MEA 
cultures at 37°C. (Key: ED50-T/B and ED90-T/B: ED50/ ED90 of 
tebuconazole/benomyl). 
 
 
DA was performed for A.fumigatus experiment to assess the accuracy of a possible 
model. Figure 3.15, shows discrimination between controls, ED50 treatments, ED90 
treatments gathered with blank samples. A cross-validation method, LOO, was used to 
assess the accuracy of the training set in this study. However, more sets of 
measurements would be needed in order to remove a complete set of replicates each 
time instead of one single sample which might have inflated the accuracy of the model. 
Table 3.2 shows the classification matrix resulting from the cross-validation test. A total 
of seven samples were misclassified (23.33%). This misclassification occurs between 
the blanks and ED90 treatments.  
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Figure 3.15: 3D canonical plot of A.fumigatus after 48 hrs incubation on MEA. Key: 
Af: A.fumigatus; Ben ED50/ED90: Benomyl ED50/ED90; Teb ED50/ED90: 
Tebuconazole ED50/ED90. 
 
Table 3.2: Classification matrix after cross-validation test based on the DA model. 
A.fumigatus at 37°C on MEA after 48 hrs incubation. Accuracy prediction of 76.66% 
(23/30). (Key: B: benomyl; T: tebuconazole). 
Actual Rows 
by Predicted 
Columns 
Blank Control Af+ED50-B 
           
Af+ED50-T Af+ED90-B Af+ED90-T 
Blank 2 0 0 0 3 0 
Control 0 5 0 0 0 0 
Af+ED50-B 0 0 5 0 0 0 
Af+ED50-T 0 0 0 5 0 0 
Af+ED90-B 0 0 0 0 3 2 
Af+ED90-T 0 0 0 0 2 3 
 
 
 
A.fumigatus
Blanks
Af+Teb ED50
Af+Teb ED90
Af+Ben ED90
Af+Ben ED50
Af+Teb ED50
en ED90
Af+Teb E 90 Blanks
A.fumigatus
Af+Ben ED50
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Regarding C.albicans with fluconazole at 25°C in NB, there was no discrimination 
between control samples and ED50 values at any time. Data showed in Figure C.7 
(Appendix C). The experiments with C.albicans amended with tebuconazole were 
chronologically performed, initially, at 25ºC in NB and then at 37º C in saline 
solution+0.2% glucose-0.2% peptone. In NB, there was slight discrimination between 
treatments (control, ED50 and ED90) after 48 hrs incubation as it can be seen in Figure 
3.16, also Figure C.8 (Appendix C) depicts the CA for this analysis. However, in the 
saline solution there was no discrimination at any time. Figure 3.17 shows the CA after 
24 hrs incubation in saline solution where three clusters could be distinguished: a 
control group, one for all the blanks (negative controls) and a third for both anti-fungal 
treatments together. 
These studies were complimented with analyses of volatiles using GC-MS and SIFT-
MS to identify compounds might be related to the differences found. 
 
 
Figure 3.16: PCA score plot PCA C.albicans after 48 hrs incubation in NB at 25°C. 
(Key: Blank: NB without inoculum; Control: C.albicans without anti-fungal; 
Ca+ED50/90-T: C.albicans+ED50/90-Tebuconazole). 
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Figure 3.17: Dendogram of C.albicans after 24 hrs incubation at 37°C in saline solution 
+ 0.2%G-P. (Key: B: Blanks; Control: C.albicans without anti-fungal; TebED90/50: 
ED90/ED50 concentrations of tebuconazole; TebED90/ED50+Ca: ED90/ED50 
concentrations of tebuconazole+C.albicans). 
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3.5 IDENTIFICATION OF VOLATILES USING GC-MS AND 
SIFT-MS SYSTEMS 
 
3.5.1 ANALYSIS OF VOLATILES OF 5 MICROORGANISMS GROWN 
ON NUTRIENT AGAR 
Initially, studies were carried out to identify the MVOCs produced by all five VAP 
microbial species (A.fumigatus, C.albicans, K.pneumoniae, E.cloacae and 
Staphylococcus strain). One replicate of all the microbial species were grown on NA in 
Petri dishes at 37°C for 24 hrs in nalophan bags before head space sampling was carried 
out. Firstly, SIFT-MS system was used to identify key substances and afterwards, 
analysis of the headspace by TD-GC/MS (Thermal Desorption GC-MS) was performed. 
As part of the TD-GC/MS method, AMDIS (Automated mass spectral deconvolution 
and identification system software) and NIST (National Institute of Standards and 
Technology) library data bases were used to search for the substance identification. 
Results were obtained in order of increasing retention time (RT) with one worksheet for 
each sample. For each peak detected on the chromatogram, the three most likely 
substances were listed in decreasing order of probability. Semi-quantitative estimation 
of the substances was made using the internal standard, D8-Toluene, added to all the 
TD tubes at a concentration of 50 ng . Table 3.3 summarises the key substances in 
samples obtained from the reports using the AMDIS software. Please note that 
substance such as styrene (C8H8) might have originated from the polystyrene Petri 
dishes as it is present in all the samples, although in different amounts. From Table 3.3 
it can be seen that various sulphur-containing substances were found only in 
A.fumigatus such as 2,4-dithiapentane (C3H8S2); or in larger concentration, such as 
dimethyl disulphide (C2H6S2) also found in all the samples. However, the TD 
methodology used in this study is not particularly suited to sulphur compounds so the 
quantification data must be interpreted with caution. Other substances appeared to 
discriminate between samples, e.g., 1,4-pentadiene (C5H8) present only in A.fumigatus 
and E.cloacae; 2-methyl-3-isopropylpyrazine (C8H12N2) and 4,4-dimethyl-1-pentene 
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(C7H14) in A.fumigatus; mercaptoacetone (C3H6OS) in C.albicans; 2-methyl-1-propanol 
(C4H10O) in K.pneumoniae  and E.cloacae cultures. The ketone, 2-pentanone (C5H10O) 
was found in all the species except in the Staphylococcus strain. 
3-methyl-butanal (C5H10O) was not observed in A.fumigatus and 3-methyl-1-butanol 
(C5H12O) was found in high concentrations in E.cloacae but not in blank medium and 
A.fumigatus. Benzaldehyde (C7H6O) was found in C.albicans and Staphylococcus 
species, also in blank medium. 3-methylfuran (C5H60) was only found in small amounts 
in cultures of A.fumigatus and E.cloacae. 
 
Table 3.3: Summary of identified susbtances from GC-MS analyses. Microbial species 
were grown on NA at 37°C for 24 hrs. (Key: +++: 3,606-2,405 ng/l; ++: 2,404-1,203 
ng/l; +: 1,202-2 ng/l; -: not found). 
Compound ID 
 
Blank 
Medium 
Aspergillus 
fumigatus 
Enterobacter 
cloacae 
Candida 
albicans 
Staph 
species 
Klebsiella 
pneumoniae 
Sulphur dioxide - + - + + - 
2,4-dithiapentane - + - - - - 
1,4-Pentadiene - + + - - - 
Furan, 3-methyl- - + + - - - 
1-Propanol, 2-
methyl- 
- - + - - + 
1-Butanol, 3-
methyl 
- - +++ ++ ++ + 
Butanal, 3-
methyl- 
+ - + + + + 
2-Pentanone - + + + - + 
Mercaptoacetone - - - + - - 
Styrene + +++ +++ ++ +++ + 
Dimethyl 
disulphide 
+ +++ ++ + + + 
Benzaldehyde + - - + + - 
2-Methyl-3-
isopropylpyrazine 
- + - - - - 
1-Pentene, 4,4-
dimethyl- 
- + - - - - 
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SIFT-MS analysis was also performed. Only a few compounds were found distinctive 
between samples: ammonia (NH3) was present in larger amount in C.albicans; 
methanethiol, also known as methyl mercaptan (CH4S) in A.fumigatus; acetone was 
mainly found in K.pneumoniae, A.fumigatus and C.albicans; and propanol which was 
found in blank medium and bacterial species and barely found in fungal species. See 
Appendix C (Figure C.9) for the bar chart for this analysis. 
 
3.5.2 IDENTIFICATION OF VOLATILES PRODUCED DURING 
EXPOSURE TO ANTI-FUNGALS 
 
(a) A.fumigatus grown in presence of ED50 concentrations of tebuconazole and 
benomyl 
Volatile fingerprints were also analysed from A.fumigatus cultures on MEA, with and 
without ED50 concentrations of tebuconazole and benomyl. MIM mode was used to 
extract the data on selected compounds: hydrogen sulphide, dimethyl disulphide, 
methanethiol, isoprene, methyl pentadiene, methanol, ethanol, propanol, acetonitrile, 
hydroxide cyanide, formaldehyde, acetaldehyde, acetone and ammonia.  These 
substances were selected because most of them are considered common metabolites. 
Isoprene is an intermediate in the synthesis of cholesterol in animal cells but it is also 
produced by several bacterial and fungal species. Sulphur-containing compounds such 
as sulphides can be detected by SIFT-MS but not by the GC-MS method used which is 
not especially suited for those substances; also ammonia can be detected by the SIFT-
MS technique. Microorganisms can produce acetaldehyde, ethanol and propanol in 
fermentative conditions.  
Only the most abundant and most distinctive compounds extracted from the analysis 
were selected to build the bar graphs in Figures 3.18 and 3.19 for 48 hrs and 72 hrs 
incubation, respectively. In these bar graphs some compounds such as: dimethyl 
disulphide (C2H6S2), isoprene (C5H8), methanol (CH4O), acetone (C3H6O), methyl 
pentadiene (isomer not known) and ethanol (C2H6O) were found as possibly 
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discriminating compounds. There were no differences between the rest of the 
compounds targeted in the SIFT-MS analysis. 
This experiment was repeated three times in total. However, the results obtained were 
not consistent.  During the second set of experiments the capillary column was blocked, 
and during the third a significant decrease of the number of counts. This was found to 
be related to the overheating of the SIFT-MS device. 
 
 
 
 
Figure 3.18: Average amount of different compounds detected after 48 hrs incubation 
using SIFT-MS. (Key: A.fumigatus: positive control; Af+TebED50/BenED50: 
A.fumigatus with ED50 of tebuconazole/benomyl; Teb/Ben ED50: negative control 
(MEA+ Teb/Ben ED50); I: standard error bars). 
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Figure 3.19: Average amount of different compounds detected after 48 incubation 
using SIFT-MS. (Key: same as Figure 3.18; I: standard error bars). 
 
Chromatograms obtained from the TD-GC/MS system were also analysed using the 
data base AMDIS and NIST MS programmes. The analysis was firstly qualitative as 
visual inspection was made and quantitative of each treatment by using the internal 
standard as a calibration factor. The quantitative data analysis is not shown because it 
was not conclusive due to the differences between replicates in some treatments, the 
large number of peaks, the noise in the chromatograms and the lack of identification of 
the internal standard in some samples. However, the chromatograms of all treatments 
after 48 hrs incubation were compared in terms of treatments and over time (48, 72 hrs).  
The names and the RT of some compounds and, especially the internal standard (D8-
toluene; 13.9-14 min), have been indicated in the chromatograms. 
Figure 3.20 shows the chromatograms resulting from GC-MS analysis of all the 
treatments (control, A.fumigatus +tebuconazole and benomyl ED50 concentrations) after 
48 hrs incubation.  Overall, the chromatograms are quite similar. The component 2-
methyl-1,3-pentadiene (C6H10) appeared to be present  with a larger  peak in the Af+Teb 
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ED50 treatment than in the others. This would correspond with what was observed in the 
SIFT-MS analyses. 
Figure 3.21 compares the volatiles obtained from an empty bag, one replicate for Ben 
ED50 (Teb ED50 was omitted because of the high background) and one negative control 
(MEA without any anti-fungal).  In these cases some compounds had evident peaks in 
the blank samples (MEA and Ben ED50) which did not appear in the empty bag head 
space such as the aldehydes 2 and 3-methyl-butanal (C5H10O) and dimethyl disulphide 
(C2H6S2). Comparing both sets of chromatograms it is possible to identify different 
compounds from the head space of A.fumigatus such as 2-methyl-1-propanol (C4H10O) 
and 3-methyl-1-butanol (C5H12O) which were not found in the blank samples. 
Components such as dimethyl disulphide, sulphur dioxide (SO2), acetaldehyde (C2H4O), 
pentane (C5H12), acetone (C3H6O), isopropanol (C3H8O), benzene (C6H6) among others 
were all found in the blanks and fungal treatments.  The chromatograms from all 
treatments after 72 hrs incubation showed the same trend as was found at 48 hrs 
incubation (data no shown). 
Unfortunately not many differences were found between treatments to explain the good 
discrimination achieved using the e-nose when the quantitative analysis of the GC-MS 
studies was performed. Some compounds targeted with SIFT-MS system were not 
identified in the chromatograms such as isoprene, methanol and ethanol and the rest did 
not show the same pattern. This was probably due to the difficulty of the GC-MS 
system to identify lower molecular weight species. Compounds such as 3 and 2-methyl 
butanal, 2-methyl propanal (C4H8O) were predominantly found in blank media, whereas 
3-methyl-butanol, 2-methyl-1-propanol and pentadiene were found exclusively in 
control and treatment samples. Acetone, sulphur dioxide and dimethyl disulfide were 
found in all samples, negative controls and treatments. The analysis of the results was 
partially inconclusive due to the large variance between replicates especially for Af+Ben 
ED50. 
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Figure 3.20: GC-MS ion chromatograms after 48 hrs incubation for three types of 
samples  (Key: TIC: Total ion current). 
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Figure 3.21: GC-MS ion chromatograms after 48 hrs incubation for one blank of each 
type. (Key: TIC: Total ion current). 
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(b) C.albicans grown in presence of ED50/ED90 concentrations of tebuconazole 
  
This experiment involved C.albicans with ED50 and ED90 concentrations of 
tebuconazole in saline solution amended with 0.2% glucose and 0.2% peptone. Three 
replicates of the control and for both anti-fungal treatments were analysed using the 
GC-MS as detailed in Section 2.7b. Two replicates of the same medium without 
inoculum were used as negative controls.   
The chromatograms showed that some alcohols were  more abundant in the controls 
such as ethanol (C2H6O), 2-methyl-1-propanol (C4H10O), 2 and 3-methyl-1-butanol 
(C5H12O), whereas some aldehydes such as 3 and 2-methyl-butanal (C5H10O) and 2-
methyl-propanal (C4H8O) were found in slightly higher amounts in the ED50 treatments 
(Figure 3.22). In order to compare between treatments, two GC-MS spectra were 
combined in the same graph. Figure 3.23 shows the comparison between one control 
and one ED50 treatment and in Figure 3.24 between both treatments (ED50 and ED90). 
 
 
Figure 3.22:  Mean values of some compounds found in cultures of C.albicans with 
tebuconazole. (Key: Ca+ED50/90: C.albicans with ED50/ED90; ND: no detected 
values). 
0
500
1000
1500
2000
2500
3000
3500
Positive control
Negative control
Ca+ED50
Ca+ED90
C.albicans + Tebuconazole
n
g/
l
ND ND ND ND
NDND ND ND ND
ND
NDND NDND ND
Results 
77 
 
Figure 3.23: GC-MS chromatograms for C.albicans control in blue and for C.albicans 
treated with ED50 of tebuconazole (Ca+ED50) in black after 24 hrs incubation. (Both 
chromatograms on same scale). 
 
 
Figure 3.24: GC-MS chromatograms for C.albicans treated with ED50 /ED90 of 
tebuconazole (Ca+ED50/ Ca+ED90) in black and blue respectively after 24 hrs 
incubation. (Both chromatograms on same scale). 
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Others volatile compounds were not significantly different between treatments: acetone 
and acetic acid were also detected in the blank samples (Figure 3.25). Note that 
compounds found in unused tubes were not included. An example is shown in Figure 
3.26. These included trifluorobenzene (C6H3F3), benzene (C6H6), internal standard, 
heptamethyl cyclotetrasiloxane (HMCTS; C7H22O4Si4), acetone (C3H6O), acetaldehyde 
(C2H4O). 
 
Figure 3.25: GC-MS chromatogram for one blank sample after 24 hrs incubation. 
 
Figure 3.26: GC-MS chromatogram for one unused tube. 
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3.6 COMPARISON OF DISCRIMINATION BETWEEN 5 
MICROORGANISMS USING NUTRIENT BROTH AND 
SALINE SOLUTION MEDIUM 
 
Because clinical samples are obtained from patients in saline solution it was necessary 
to compare the discrimination based on the best nutritional medium with saline solution 
for evaluating the ability to directly use saline samples for analyses. 
Experiments with NB were carried out a number of times with very similar results in 
terms of VAP microorganism discrimination using the e-nose. Thus after 24 hrs 
incubation with an initial cell/spore concentration of 10
4 
ml
-1
, it was possible to clearly 
differentiate between four different clusters: one with the two Gram-negative bacteria, a 
second one with C.albicans, a third one with the Staphylococcus strain and a fourth one 
with the blanks and the A.fumigatus treatments. Figure 3.27 shows the PCA obtained 
and Figure 3.28 the dendrogram based on the volatile fingerprints obtained. After 48 
hours, A. fumigatus could be distinguished from the blank samples but was placed very 
close to the Staphylococcus strain and C.albicans clusters. The discrimination did not 
improve after 72 or 96 hrs incubation (data not shown). 
Since saline solution is relatively poor nutritionally, it was decided to examine the 
addition of two concentrations of glucose and peptone, 0.1% and 0.2% and examine the 
potential for discrimination between three microorganisms: C.albicans, K.pneumoniae 
and S.aureus. The final concentration for all the microorganisms was 10
4 
cells/spores 
ml
-1
.  The analysis of the head space of samples and treatments using the e-nose after 24 
hrs incubation at 37°C showed better discrimination between microorganisms utilising 
0.2% glucose and 0.2% peptone. Figures 3.29 and 3.30 show the PCA score plots for 
both concentrations.  
Subsequently, the head space of the five VAP microbial species grown in saline 
solution amended with 0.2% of glucose and 0.2% peptone at 37°C were analysed daily 
with the e-nose. After the first 24 hrs incubation, the PC analysis showed four clusters 
(Figure 3.31): one for both Gram-negative bacteria, a second one for C.albicans, a third 
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one for S.aureus and a fourth one for A.fumigatus very close to blank samples. Figure 
3.32 shows the clustering obtained for this data set. The experiment was repeated with 
very similar results (Figures 3.33 and 3.34). These measurements were used later to 
build a laboratory based model (Section 3.7). 
 
 
 
 
Figure 3.27: PCA score plot after 24 hrs incubation at 37°C of five microorganisms in 
NB media. Dotted line circle indicates one probable outlier. 
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Figure 3.28: Dendrogram of five different microorganisms after 24 hrs incubation at 
37°C in NB. (Key: Af: A.fumigatus; Ca: C.albicans; Ec: E.cloacae; Kp: K.pneumoniae; 
St: Staphylococcus species). 
 
Figure 3.29: PCA score plot after 24 hrs incubation at 37°C in saline solution+0.1% 
Glucose-0.1% Peptone. Data was normalised. 
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Figure 3.30: PCA score plot after 24 hrs incubation at 37°C in saline solution+0.2% 
Glucose-0.2% Peptone. Data was normalised. 
 
Figure 3.31: PCA score plot after 24 hrs incubation at 37°C in saline solution+0.2% 
Glucose-0.2% Peptone. Red dashed line: outlier. 
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Figure 3.32: Dendrogram after 24 hrs incubation of five microorganisms in saline 
solution with 0.2% glucose and 0.2% peptone. (Key: Af: A.fumigatus; Ec: E.cloacae; 
Ca: C.albicans; Kp: K.pneumoniae; Sa: S.aureus). One outlier was removed. 
 
Figure 3.33: PCA score plot after 24 hrs incubation at 37°C in saline solution+0.2% 
Glucose-0.2% Peptone.  This was a repeated experiment. 
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Figure 3.34: Dendrogram after 24 hrs incubation of five microorganisms in saline 
solution with 0.2% glucose and 0.2% peptone. (Key: B: Blanks; Af: A.fumigatus; Ec: 
E.cloacae; Ca: C.albicans; Kp: K.pneumoniae; Sa: S.aureus). This was a repeated 
experiment. 
 
3.7 USE OF DATA FROM NUTRIENT BROTH AND SALINE 
SOLUTIONS ON THE VAP MICROORGANISMS TO BUILD 
A MODEL FOR PREDICTION OF CLINICAL SAMPLES  
 
The data sets obtained above were used to develop and build a model to enable 
unknown clinical samples to be evaluated based on volatile fingerprints.  DA was the 
method chosen to select a reduced number of variables (sensors) with a training set of 
samples in order to build the model for classifying a validation set. Once the model was 
built it was necessary to assess the accuracy of the predictive model using a cross-
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validation method. For this, leave-one-out (LOO) was used for the validation of the 
model due to the number of samples needed to perform this cross-validation method. 
Besides the mean-centred scale already performed by the software on the e-nose 
measurements, other scale methods were examined including range-scale and 
normalisation. It was also necessary to perform some kind of standardisation between 
sets of samples because they were taken on different days. To do this, the measurements 
from blank samples (nutrient broth; saline solution amended with 0.2% of glucose and 
peptone) were used to compensate for the measurement variations between different 
sets using MDC, explained in Section 2.8.3. 
For the NB model, two different days of measurements made after 24 hrs incubation at 
37°C, were used to perform the multivariate analysis. One day for the training set 
(n=30), the second one for validation purposes (n=24). A set of selected sensors (listed 
below) was found the best for “unknown” sample prediction. Three samples out of the 
24 “unknown” samples were misclassified; this gave 87.5% accuracy prediction. Table 
3.4 shows the confusion matrix for this model. Cross-validation LOO was used to check 
the accuracy of the training set. Every time one sample was removed and identified 
using the rest of the training set for classification. The mean of the conditional 
probability of misclassification (-2loglikelihood) was 2.3E-06. Figures 3.35 and 3.36 
depict the canonical plots in 2D and 3D respectively for the DA performed with the data 
obtained in NB. A total of 8 sensors were selected to build the model as they were most 
discriminating: MOSFET 102A, 104A, 102-3B and MOS 113-5, 117.    
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Figure 3.35: Canonical plot for DA of training and validation set (highlight squares) in 
NB after 24 hrs incubation. Dotted circles show misclassified samples. Selected sensors: 
MOSFE102A, 104A, 102-3B, MOS113-5, 117. (Key: Af: A.fumigatus; Ec: E.cloacae; 
Ca: C.albicans; Kp: K.pneumoniae; St: Staphylococcus species; B: Blanks). 
 
Figure 3.36: Canonical 3D plot for DA of training and validation set (highlight squares) 
in NB after 24 hrs incubation. (Key: same as Figure 3.35). 
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Table 3.4: Confusion matrix showing the performance of the model in NB at 37°C after 
24 hrs incubation. Accuracy of 87.5% (21/24). (Key: Af: A.fumigatus; B: Blanks; Ca: 
C.albicans; Ec: E.cloacae; K.pneumoniae; St: S.aureus). 
Actual Rows 
by Predicted 
Columns 
Af B Ca Ec Kp St 
Af 4 0 0 0 0 0 
B 0 4 0 0 0 0 
Ca 0 0 3 0 0 1 
Ec 0 0 0 4 0 0 
Kp 0 0 0 1 3 0 
St  0 0 1 0 0 3 
 
 
The analysis of volatiles from microbial cultures in saline solution amended with 
glucose and peptone by using the e-nose was done three times on three different days. 
Several models were tried after the collection of that data. Table 3.5 summarises all 
these models with their classification results and the number of samples per set, training 
and validation sets. For models C, D, E and F, one replicate of A.fumigatus was 
removed from all the analyses. 
With model A used as a training set, a group of measurements done with 5 
microorganisms as a training set and only 3 microorganisms as “unknown samples”, the 
percentage of misclassified was zero. Blank sample replicates were also analysed. A 
second model was investigated (model B) with 5 microorganisms in the validation set. 
The prediction accuracy was 83.3%. Four samples over twenty four were misclassified. 
Table 3.6 shows the confusion matrix and Figure 3.37 shows the 3D score plot for this 
analysis. The selected sensors for this model were the following seven: MOSFET102B, 
MOS102, 104, 112, 114-6. 
The accuracy of the results obtained from the DA were checked using the LOO cross-
validation method which might be considered an overly optimistic method as only one 
sample is being removed each time. To assess the accuracy of a training set by 
removing a complete set of replicates instead of one single replicate every time it is 
necessary to have at least two sets of replicates from the same class. This was only 
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possible with model G. In this model the accuracy was not good as only 50% of the 
samples were classified, although the misclassification occurred between A.fumigatus 
and blank samples after 24 hrs incubation. Please note that for the attempt at clinical 
sample prediction one of the in vitro models was used and a more robust cross-
validation method such as Monte Carlo simulation was utilised. 
 
 
Table 3.5: Summary of results for different models analysed by DA in saline solution.   
Model Training set Validation set 
% 
misclassified 
-2loglikelihood 
(mean) LOO 
method for cross 
validation 
 
Number 
of 
samples 
Total nr. 
microorg 
Number 
of 
samples 
Total nr. 
microorg 
A 24 5 16 3 0 17.7 
B 24 5 24 5 16.6 (4/24) 0 
C 23 5 
40 
(16+24)* 
5 27.5 (11/40) 0 
D 24 5 
39 
(23+16)* 
5 20.5 (8/39) 8.33e-18 
E 
39 
(23+16)* 
5 24 5 20.8 (5/24) 1.16e-02 
F 
40 
(24+16)* 
5 23 5 39.1 (9/23) 2.15e-06 
G 
48 
(24+24)* 
5 16 3 50 (8/16) 6.44 
* When sets are composed of two different days of measurements.  
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Table 3.6: Confusion matrix showing the performance of model B in saline solution at 
37°C after 24 hrs incubation. Accuracy of 83.3% (20/24). (Key: Af: A.fumigatus; B: 
Blanks; Ca: C.albicans; Ec: E.cloacae; K.pneumoniae; St: S.aureus).  
Actual Rows 
by Predicted 
Columns 
Af B Ca Ec Kp Sa 
Af 3 0 0 1 0 0 
B 2 2 0 0 0 0 
Ca 0 0 4 0 0 0 
Ec 0 0 0 4 0 0 
Kp 0 0 0 0 4 0 
Sa 0 0 0 0 1 3 
 
 
 
Figure 3.37: Canonical 3D plot for model B. Clouds correspond to training set samples. 
Highlighted squares correspond to validation set samples. Selected sensors for this 
model: MOSFET102B, MOS102, 104, 112, 114-6 (Key: Ca: C.albicans; Sa: S.aureus; 
Kp: K.pneumoniae; Ec: E.cloacae; Af: A.fumigatus; B: Blanks). 
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Unfortunately, no promised patient samples materialised during the course of this PhD 
for analyses. Thus necessitated the use of a previous data set from patients which was 
originally analysed by Sahgal (2008). Based on the microbiological results obtained 
from the hospital laboratory (standard microbiological culturing), attempts were made 
to predict which VAP microorganisms may be present in the clinical samples using the 
laboratory-based models and DA. In this previous study, blind BAL samples were taken 
by the clinician from patients with mechanical ventilation for more than 72 hrs at 
Gloucestershire Hospitals NHS Foundation Trust.  Ethical approval was obtained at the 
time of the study. Every sample was divided in two parts, for microbiological and e-
nose analyses. The sampling procedure was described by Sahgal (2008) and it is in the 
recent publication by Humphreys et al. (2011). 
In vitro data sets from both NB and saline solution were utilised to attempt the 
prediction of clinical samples (validation set; n=88). The clinical data set was split into 
four groups: Gram-positive (n=11), Gram-negative (n=8), fungi (n=13) and blanks (no 
growth; n=56). Samples with mixed cultures were removed for the analysis. For NB, 
three sets of data obtained on different days done on two e-noses were gathered to 
complete a training set of ninety four samples. With no standardisation between e-noses 
performed, forty one samples were misclassified, giving an accuracy of 53.41%. For 
saline solution two sets of data measured in the same e-nose were checked for the 
prediction (n=40) of clinical samples analysed in a different e-nose.  Thirty two samples 
were wrongly predicted, giving an accuracy of 63.63%. Table 3.7 summarises these 
results.  
Subsequently, the PLS-DA technique in collaboration with Dr. Michael Cauchi from 
Bioinformatics Group was attempted to classify the set of clinical samples with a single 
set of laboratory-based model. First of all it was necessary to standardise the two e-nose 
systems using a technique called piecewise direct standardisation (PDS) or direct 
standardisation (DS). The same set of standards was measured on both instruments. A 
mathematical model is then generated (different window sizes were investigated for 
PDS) and then the mathematical model used to predict what responses the samples 
would have attained on the instrument being standardised. These responses are then 
used to classify the clinical samples which were divided into four groups instigating a 4-
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way classification: Gram-positive, Gram-negative, Fungi and No Growth; a fifth group 
comprising mixed microorganisms was omitted because there were an insufficient 
number of samples. Different scale methods were tested and the percentage of correctly 
classified samples was calculated in each case. Table 3.8 summarises all these results. 
 
Table 3.7: Summary of results for two in vitro models for clinical samples prediction 
using DA. 
CLINICAL SAMPLES (n=88) 
Data base with in vitro samples  in 
SS+0.2%G-P (n=40) 
Data base with in vitro samples in NB 
(n=94) 
Number of 
misclassified 32/88 41/88 
Accuracy of 
prediction  63.63% 53.41% 
    
 
 
The maximum overall of classification success was 63.6% when some selected sensors 
(MOSFET 101A, 103A, 101-2 B, MOS 104, 111, 113 and 118) were used for the 
analysis. However, this approach failed in terms of sensitivity, i.e., only the no growth 
samples were 100% predicted whereas the rest of the groups were misclassified.  The 
rest of the analyses show very variable percentages of prediction with a loss of 
classification in some of the groups. 
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Table 3.8: Summary of the attempts for classifying clinical samples using different 
standardisation methods, scale, latent variables (LV) with an in vitro model built in 
saline solution+0.2%G-P cultures after 24 hrs incubation at 37°C. 
Standardisation 
between devices 
% Overall 
classification 
success 
LV Scale % Gram 
pos 
classif. 
success 
% Gram 
neg 
classif. 
success 
% Fungi 
classif. 
success 
% No 
growth 
classif. 
Success 
PDS:  
Window 1 
27.3 3 MC 45.4 0 61.5 19.6 
60.2 1 None 0 0 0 94.6 
35.2 5 MC 72.7 0 0 41.0 
63.6 1 None 0 0 0 100 
PDS:  
Window 5 
61.4 3 MC 0 0 38.4 87.5 
35.2 7 None 0 0 53.8 42.8 
PDS: 
Window 11 
60.2 3 MC 0 0 23.0 89.2 
PDS: 
Window 17 
60.2 3 MC 0 0 23.0 89.2 
DS: 
Direct only 
9.0 3 MC 0 100 0 0 
42 4 MC 0 0 46.1 55.3 
 
 
Also PLS-DA was used to attempt the prediction of clinical samples using the data 
generated in NB. Standardisation between devices was necessary. The results are 
summarised in Table 3.9. The best overall accuracy prediction was 52.27% with 13 or 
14 LV with normalisation of the values. Only no growth group achieved a respectable 
73.2% of accuracy prediction.  
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Table 3.9: Summary of results after PLS-DA assessment in NB with different latent 
variables (LV) and scales.  
Samples LV Scale Overall Gram 
positive 
Gram 
negative 
Fungi No growth 
NB 12 RS1
* 
12.5% 0 87.5% 30.8% 0 
NB 13 Norm 52.27% 0 0 38.56% 73.2% 
NB 14 Norm 52.27% 0 0 38.56% 73.2% 
NB 11 None 38.64% 0 0 0 60.7% 
* RS1: Range scale equation 2 (Section 2.8.3). 
 
Monte Carlo simulation technique was utilised in all the cases to assess the significance 
of the results in order to ensure that the overall classified was not due to chance. Figure 
C.10 in Appendix C shows as a matter of example the simulation results displayed in a 
histogram obtained with one model in saline solution used to classify clinical samples. 
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CHAPTER 4: GENERAL DISCUSSION 
 
4.1 ANALYSES OF VOLATILES OF VAP MICROORGANISMS 
IN DIFFERENT MEDIA 
Initially studies were carried out to determine the impact that different nutritional media 
would have on volatile production patterns produced by VAP microorganisms. This was 
done to optimise a medium which would give better discrimination under conditions 
which are preferential for growth of these species. Furthermore, media used to isolate 
the microbial species from different medical matrices may not be best for volatile 
fingerprint production. For example, Sahgal (2008) found earlier discrimination (72 hrs 
incubation) between different dermatophytes using Sabouraud Brain Heart Infusion 
Agar (SBHIA) which is less commonly used in medical microbiology laboratories than 
Sabouraud Dextrose Agar (SDA). 
The studies in this thesis demonstrated that for an individual bacterial or fungal species 
markedly different volatile fingerprints were produced depending on the substrate. NB 
was better for early discrimination of C.albicans and K.pneumoniae and this might be 
due to more active growth and utilisation of nutrients than in the other media tested. The 
aim was to have a medium which would enable differentiation between VAP species 
within 48-72 hrs based on volatile fingerprints by analyses of the head space. Previous 
studies, predominantly on food matrices or food analogues have tried to simulate 
nutritional make up of the food type. For example, Needham et al. (2005) used flour or 
bread-based media to discriminate between spoilage moulds and bacteria within 48-72 
hrs which are important in bakery products. Bread analogue was also prepared by 
mixing flour with others components for early detection of two Eurotium spp. and 
Penicillium chrysogenum (Keshri et al., 2002). Needham and Magan (2003) used wheat 
and maize-based media to try and discriminate between mycotoxin and non-mycotoxin 
producing strains of mycotoxigenic fungi. A similar approach was used successfully to 
taxonomically discriminate between ochratoxin A production by strains from the 
Aspergillus section Nigri group on grape juice medium (Cabañes et al., 2009) and for 
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Penicillium nordicum strains and ochratoxin A production in ham-based media 
(Camardo et al., 2011). In the latter case a much longer incubation time (>7 days) was 
required because of the slow growth rate to use volatile production patterns to be 
successfully used to discriminate between them. Other mycotoxigenic fungal strains 
such as Fusarium spp. were successfully discriminated from the uninoculated controls 
and from the non-mycotoxigenic strains after 48 hrs incubation in wheat meal agar 
before using the analysis of volatile fingerprints (Keshri and Magan, 2000). Other 
mycotoxins such as patulin were investigated by Karlshøj et al. (2007a) using an e-nose. 
They collected and analysed the head space of apples infected with Penicillium 
expansum used in the apple juice industry and built a model with PLS regression 
analysis for patulin prediction. Magan et al. (2001) found that by using milk-based 
media it was possible to discriminate between 5 different spoilage microbial species 
(three bacteria, two Pseudomonas spp. and Bacillus cereus; two yeasts, Candida 
pseudotropicalis and Kluyveromyces lactis) within 72 hrs. Others studies have 
investigated the differentiation of spoilage fungal species in more general agar media. 
Malt peptone agar was used to discriminate between seven species of Agaricus and 
between others homobasidiomycetes mushrooms (Keshri et al., 2003) after 14 days 
incubation at 25°C using a CP sensor array. A variety of food substrates have been 
investigated during the ripening/maturation process. Trihaas and Nielsen (2005), for 
example, assessed the quality and state of ripening of two types of Danish blue cheese 
by using an e-nose and multivariate analysis.  
Laboratory media have been used for detection of medically important pathogens, 
including H. pylori, P.mirabilis and S.aureus (Pavlou et al., 2000). Pavlou et al. (2004) 
used Tween albumin medium for discriminating four bacteria (M.avium, 
M.tuberculosis, M.scrofulaceum and P.aeruginosa) and successfully classified 96% of 
the 15 randomly selected samples from the in vitro analysis using a CP sensor array and 
multivariate analyses and neural network methods. More complex media have been 
prepared by mixing BHIB, cooked meat broth, urea, some sugars and several amino 
acids to discriminate between four groups of UTI pathogens and correctly classify seven 
“unknowns” samples by using DA and cross-validation (Pavlou et al., 2002a). 
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In environmental applications, the analysis of volatile fingerprints has permitted the 
detection of water contaminants (Canhoto and Magan, 2005) and different soils 
environmental conditions such as temperature, moisture and nutrient addition (Bastos 
and Magan, 2007) in water and soils samples, respectively. 
 
4.2 SENSITIVITY OF DETECTION OF VAP MICROORGANISMS 
 
In the present study it was shown that the time necessary for achieving the minimum 
threshold of detection of specific microorganisms was achieved either earlier or later 
depending on the species and the length of incubation. For A.fumigatus (10
2
 spores ml
-1
) 
it was possible after 72 hrs growth for discrimination from blank samples. Previously, 
Sahgal (2008) using four different concentrations (10
1
, 10
3
,10
5 
and 10
7
 spores ml
-1
) of 
two dermatophytes and found that only after 72 hrs growth and for the two highest 
concentrations was there discrimination. This is probably due to the much slower rate of 
growth of dermatophytes when compared to species such as A.fumigatus.  
For C.albicans cultures, the discrimination between blank samples and 10
2 
cells ml
-1
 
was achieved after 48 hrs incubation. For K.pneumoniae and E.cloacae it was found 
that discrimination could be obtained at 10
2 
cells ml
-1
 after 24 hrs, while the volatiles 
produced by 10
4
-10
6
 cells ml
-1
 were grouped together. However, results for the 
Staphylococcus species were not possible to interpret because of the very slow growth 
of this strain, regardless of concentration used. 
 
Previous studies on a milk-based medium by Magan et al. (2001) examined the 
potential for discrimination between three very close but high concentrations (10
6
, 
3.5x10
8
 and 8x10
8
 cells ml
-1
) of Pseudomonas aureofaciens after 60 min incubation. 
They also showed discrimination between butanol-skimmed milk control, skimmed 
milk control and Candida pseudotropicalis (8x10
8
 cells ml
-1
) in skimmed milk medium 
after 60 min incubation and for S. aureus and Kluyveromyces lactis (yeast) after 2 and 5 
hrs incubation respectively using a 14 CP sensor array. This discrimination was 
achieved with a very high initial concentration of 10
8
 in milk which is unrealistic and 
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would have significantly enhanced the volatile production and contributed to the 
discrimination after subsequently short incubation time. Furthermore, only two 
microorganisms were tested. 
 
Probably, concentrations of cells/spores in the range of 10
3
-10
4 
 ml
-1
 over the incubation 
period is enough to produce volatiles which can be detected by e-nose systems. This 
range has been corroborated in studies of different microorganisms in food substrates. 
Keshri et al. (2002) found discrimination between moulds in bread analogues after 48 
hrs  incubation with initial spore concentration of about 10
3 
CFU g
-1
. Although during 
this study the population, in terms of CFUs ml
-1
, was not enumerated for each e-nose 
measurement, it was similar to the range of sensitivity that was found in the present 
studies.  However, it would be useful to take into account and check the growth phase 
of individual microorganisms. Table 4.1 summarises and compares the available 
information on relative sensitivity of microorganisms in different matrices.   
There is also evidence that volatile production patterns may be modified temporally as a 
microbial species grows. Thus, the volatile fingerprints may be different depending on 
the growth phase, influencing the threshold of detection of the e-nose system. Gardner 
et al. (1998) investigated the classification of bacterial growth phases. Classification of 
the lag phase had the lowest prediction rate (14.3%) compared with more successful 
prediction of log (95.1%) and stationary (73.1%) phases.  Pavlou et al. (2002b) 
achieved good  discrimination between anaerobic  bacterial strains (Clostridium spp. 
and Bacteroides fragilis) from blank samples grown in blood agar medium with an 
initial inoculum of 10
6
 cells ml
-1 
initially in the lag phase bacteria, using an electronic 
nose system and PCA and neural networks for data analysis. However, they reported 
good discrimination after 16 hrs incubation in anaerobic conditions at 37°C. 
Unfortunately, measurements in subsequent growth phases were not reported.  Pavlou et 
al. (2004) reported good discrimination after 5-6 hrs incubation at 37°C between 
Mycobacterium spp. and P.aeruginosa using cultures in the stationary phase, but not 
based on CFUs ml
-1
. 
It is important to obtain knowledge of the relative thresholds of sensitivity of different 
VAP causing microorganisms, based on volatile fingerprint discrimination, to enable 
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information to be obtained on whether the different bacteria/fungi can be detected at 
levels similar to which they may be isolated from patients. The threshold values for 
cultured clinical samples with significant infection is normally around 10
3
-10
5 
CFU ml
-1
 
which is similar to the observed threshold of sensitivity using the e-nose systems used 
in in vitro experiments. 
 
Table 4.1: Summary of the sensitivity achieved in different matrices from the literature. 
Matrix/Microbial spp. Microbial 
population 
CFUs ml
-1
 
Incubation 
period        
(hours) 
References 
Skimmed milk 
medium                     
P.aureofaciens, 
P.fluorescens, 
B.cereus, 
C.pseudotropicalis, 
K.lactis 
10
3
-10
4 
2-5 Magan et al. (2001) 
Bread analogue  
Eurotium spp., 
P.chrysogenum 
10
3
 CFU g
-1
 40 Keshri et al. (2002) 
Water sample            
E. aerogenes, E.coli, 
P.aeruginosa 
10
2
-10
4 
24 Canhoto and Magan 
(2003) 
Saline solution  
S.aureus, 
H.influenzae, 
S.pneumoniae, E.coli, 
P.aeruginosa, 
M.catarrhalis  
10
4
 No incubation in 
saline solution 
Boilot et al. (2002) 
SBHI agar
* 
Trychophyton spp. 
10
5
-10
7 
96 Sahgal (2008) 
Blood agar 
Clostridium spp., 
B.fragilis 
10
6 
16       
(anaerobic 
incubation) 
Pavlou et al. (2002b) 
* SBHI: Sabouraud brain heart infusion. 
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4.3 DISCRIMINATION BETWEEN MICROORGANISMS WHEN 
PRESENT IN MIXED CULTURE USING VOLATILE 
PRODUCTION PATTERNS   
 
In the present study, mixtures of bacteria (E.cloacae and a Staphylococcus strain) and of 
a bacteria + yeast (E.cloacae + C.albicans) mixture were examined. These studies 
showed that one of the species, E.cloacae, was predominant in all the mixed groups 
after 24 hrs incubation at 37°C in NB. This was supported by the clustering pattern seen 
in the PCA analyses where control samples of E.cloacae were grouped with the rest of 
mixed concentrations. 
The detection and discrimination of species in mixtures is a complex issue which is still 
being studied. It is important to identify the causative species assuming that the 
organisms recovered from the cultures in large numbers are the presumed etiological 
agent (Baltimore, 2003).  In the present studies it appeared that interactions between 
microorganisms in mixed culture are complex. The initial concentration of individual 
species in a mixture is critical and the competitiveness of an individual species varies 
depending on this. Thus relative concentrations may result in dominance by certain 
species over others. This suggests that because of the competitiveness of E.cloacae, 
identifying key volatile biomarkers of this more competitive species is important to 
assist in effective discrimination using volatile fingerprints. Very few studies have been 
done using natural mixtures of microorganism. However, one previous study which 
examined sputum samples from patients with a CP sensor array has been done (Pavlou 
et al. 2004). Samples consisted of three different bacteria individually (Mycobacterium 
avium, M.tuberculosis and P.aeruginosa), a mixture of these microorganisms and 
controls, all treated with lipase enzymes. They found clear discrimination between 
treatments after 6 hrs incubation at room temperature with the mixed group being 
separated from the others. In this case it was not possible to establish any relationship 
between any of the controls with the mixed group. 
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Hence mixed infections are not rare; the identification of mixture cultures in the 
analyses of natural samples is important where groups of positive, negative bacteria and 
fungi may be present in different concentrations. Thus, background data may well be 
critical in developing models which can be reliably used to assist with choosing the 
right treatment. However, in this study clinical samples with a mixture of microbes were 
removed from the statistical analyses which led to the need for further studies on the 
actual volatile profiles from microbial mixtures where both antagonistic and perhaps 
additive/synergistic effects may occur. 
 
4.4 USE OF VOLATILE PRODUCTION PATTERNS TO 
DISCRIMINATE BETWEEN DIFFERENT ANTI-FUNGAL 
TREATMENTS AGAINST A.FUMIGATUS AND C.ALBICANS 
 
The present study suggests that it is possible to discriminate between effective and non-
effective concentrations of anti-fungal compounds for A.fumigatus using VOCs. 
Volatile fingerprints appear to be a good indicator for differentiation between 
treatments. Thus, regardless of the anti-fungal compound investigated, differentiation 
was found after 48 hrs between positive (control) growing cultures of A.fumigatus, 
those treated with the ED50 and ED90 concentrations. The rapid discrimination achieved 
for A.fumigatus at 37ºC contrasts with the poorer discrimination achieved at 25ºC. This 
species is a thermophile and thus grows much slower at 25 than 37
o
C. Because all the 
pathogens investigated were isolated from human specimens, 37°C was the selected 
temperature to work with in most of the experiments using the e-nose. Another 
important factor is the age of the culture and the anti-fungal effect as reported by 
Naraghi et al. (2010). They found better discrimination between treatments after 120 
rather than 96 hrs when the dermatophytes were treated with griseofulvin instead of 
itraconazole.  
This approach of using volatile fingerprints to try and discriminate between the efficacy 
of different concentrations of anti-microbials has not been examined extensively 
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previously. Certainly no information is available with regard to A.fumigatus. Recently 
Naraghi et al. (2010) examined and compared the effect of anti-fungal and anti-oxidant 
compounds for efficacy against dermatophytic Trichophyton species. They were able to 
discriminate between the effects of ED50 and ED90 concentrations of itraconazole on 
Trichophyton species based on volatile production patterns using a similar hybrid sensor 
array e-nose as used in the present study. Indeed, other studies by Sahgal and Magan 
(2008) demonstrated the use of volatile production patterns to discriminate, at both a 
species and strain level, dermatophyte species causing human and animal skin diseases.  
Fluconazole among others triazoles, has been widely used to treat aspergillosis disease 
but it has been observed, as found in this study, a high percentage of failures in the 
treatments not always due to the drug resistance itself but to the underlying disease 
(Verweij et al., 2007). The mechanisms of the resistance acquisition are not yet clear; 
patients may be infected by triazole-resistant strains due to prolonged therapies or due 
to azole exposure in the environment (Snelders et al., 2009). 
Good performance of classification was found when DA was performed on the data sets 
for A.fumigatus treatments. However, it was not tested against other groups of in vitro 
samples as validation sets. This study has been an attempt to evaluate the ability of the 
e-nose to monitor fungal therapies but more studies are needed. This approach could be 
complimentary to existing standard susceptibility tests currently used, which often does 
not give reliable results (Sohnle and Hahn, 2002). Another important area where this 
approach could be useful would be in detection of a build up of resistance to existing or 
new drugs. Background information could be kept on individual strains of specific 
species and compared with existing data on volatile fingerprints and type strain 
information to identify which and how many strains may be developing resistance.  
The experiments with C.albicans and anti-fungals (tebuconazole and fluconazole) were 
performed in liquid broth medium. Probably, the volatile profiles production was not 
different enough for treatment discrimination using the e-nose. It may be interesting to 
examine volatile production by A.fumigatus in liquid broth cultures.  However, in this 
case, the best discrimination between treatments may be delayed because A.fumigatus 
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grows in biomass pellets in an agitated liquid medium and contact with anti-fungals 
may be different from that in solid media.  
The lack of good discrimination between C.albicans treatments at 37°C (in saline 
solution) may be due to the relative interaction between the yeast cells and the anti-
fungal treatments resulting in very little difference in VOCs produced in the head space 
of such cultures. The e-nose was capable of distinguishing between the controls, blank 
medium and “a third group of samples” (C.albicans + ED50, ED90) but no discrimination 
within the latter group. An attempt has been made to relate these to GC-MS volatile 
production patterns.  These studies have shown that potential does exist to use volatile 
fingerprints as a rapid screening method to identify compounds which might have 
capacity as anti-fungal treatments.  
 
4.5 IDENTIFICATION OF VOLATILES PRODUCED DURING 
EXPOSURE TO ANTI-FUNGALS USING GC-MS AND SIFT-
MS SYSTEMS 
 
The aim of the GC-MS and SIFT-MS studies was to investigate the pattern of volatile 
metabolites that could explain the differences between species or groups of 
microorganisms and between anti-fungal treatments rather than specifically isolated 
compounds, then to link the e-nose results with possible volatile biomarkers. In the 
initial experiments, 5 VAP microorganisms grown on NA standard medium were used. 
In a second experiment, A.fumigatus was grown on MEA cultures amended with the 
ED50 concentrations of two anti-fungals (tebuconazole and benomyl). A third 
experiment was done to examine the head space of cultures of C.albicans in saline 
solution (with 0.2% glucose and 0.2% peptone) amended with tebuconazole ED50 and 
ED90 values. 
Some of the VOCs reported in different studies (Table 1.3), regardless of the medium 
used for culturing, were found in the present GC-MS and SIFT-MS analyses such as: 
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dienes (1,4-pentadiene), methyl pentadienes, isoprene, amyl alcohols (2-methyl-1-
butanol, 3-methyl-1-butanol) and in small concentrations some alkanes (heptane, 
undecane) in fungal cultures; and dimethyl disulphide, acetone, 2-butanone in bacterial 
cultures. As the interest was to find those compounds significantly different between 
species/treatments, only the most distinctive substances have been specifically 
mentioned. 
In the first experiment with 5 VAP microorganisms some compounds were found which 
were characteristic of specific species which might allow discrimination for the others. 
SIFT-MS data showed differences mainly with regard to ammonia, acetone and 
methanethiol between species. In the GC-MS analyses, there were some distinctive 
substances: 1,4-pentadiene which was only present  in A.fumigatus and E.cloacae; 4,4-
dimethyl-1-pentene, 2-methyl-3-isopropylpyrazine in A.fumigatus; mercaptoacetone in 
C.albicans; 2-methyl-1-propanol only present in K.pneumoniae and E.cloacae cultures. 
Using SIFT-MS analysis a few compounds were found distinctive between samples: 
ammonia was present in larger amount in C.albicans; methanethiol in A.fumigatus; 
acetone was mainly found in K.pneumoniae, A.fumigatus and C.albicans; and propanol 
which was found in blank medium and bacterial species and barely found in fungal 
species.  
This first study using SIFT-MS and GC-MS systems was a preliminary study to the 
later MVOCs investigations. Further studies should be carried out using liquid instead 
of solid media for the analysis of volatiles because e-nose analyses were made initially 
in NB and not in NA. It is difficult to compare both techniques due to their different 
characteristics and furthermore due to the different media used that probably affected 
the different volatiles released from the cultures. 
Subsequent experiments carried out with A.fumigatus on MEA cultures treated with the 
ED50 concentrations of two anti-fungals (tebuconazole and benomyl) at 37°C using 
SIFT-MS supported the discrimination achieved between treatments and controls using 
the hybrid e-nose system. Not many differences were detected between treatments and 
control samples, except in terms of an increase in the production of some volatile 
compounds (methyl pentadiene, ethanol) when using tebuconanzole as a treatment, 
especially after 72 hrs growth. Other volatile compounds were more abundant when 
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benomyl was used to inhibit fungal growth (methanol and isoprene). The 
complementary data obtained from GC-MS system was examined qualitatively and 
quantitatively. Some compounds were in all the treatments except blank samples such 
as 2-methyl-1-butanol and 3-methyl-1-butanol. These were previously found in 
A.fumigatus cultures by Fiedler et al. (2001), while  2-methyl-1-propanol also found in 
cheese-associated fungi (Karlshøj et al., 2007b); also dienes (pentadiene and methyl 
pentadiene) were mostly present in control and treatments samples but no large 
differences were found between anti-fungal treatments and control samples.  
Compounds such as isoprene, ethanol and methanol identified with SIFT-MS system 
were not clearly identified using GC-MS analysis. This was probably due to the 
difficulty of the analytical system to identify lower molecular weight species.  It is 
already known that some Gram-negative and Gram-positive bacteria species release 
isoprene. However, only a few fungi such as Eurotium amstelodami have been studied 
(Kuzma et al., 1995). Dienes such as methyl pentadiene and isoprene, present in human 
exhaled breath samples, have been investigated in fungal and bacterial cultures as well. 
Wang et al. (2004) identified 2-methyl-1-butanol, 4-methyl-1,3-pentadiene and 
dimethyl polysulphide in the growth of Pseudomonas species and related bacteria with 
SIFT analyses and Fiedler et al. (2001) reported isoprene and 2-methyl-1,3-pentadiene 
in cultures of A.fumigatus grown on MEA. Higher amounts of isoprene have been 
reported in exhaled breath from individuals under psychological and oxidative stress 
(Smith et al., 1999) and compounds such as 1,4-pentadiene have been tentatively 
identified as one of the breast cancer biomarkers (Phillips et al., 2010). This study might 
open new ways to investigate the presence of such volatile hydrocarbons when fungal 
species grow under stress conditions as occurs in many human disease states. 
The lack of clear key compounds for the discrimination between treatments in 
A.fumigatus did not correspond with the good differentiation achieved with the 
responses of the e-nose hybrid sensor array to the produced volatile fingerprints.  This 
might be due to the complexity of chromatographic analyses or could be interpreted by 
the effect of the addition of the anti-fungal compounds.  The experiment with an 
alternative GC-MS system for measuring volatiles produced by C.albicans cultures 
grown in liquid medium for 24 hrs showed some shared compounds with those 
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produced by A.fumigatus. Compounds such as 2 and 3-methyl-1-butanol and 2-methyl-
1-propanol were found to be much more abundant in positive controls rather than in the 
rest of the treatments. However, no specific and important differences were found 
between treatments which could explain the lack of discrimination using the analysis of 
the head space for volatile profiles.  
Not many studies have analysed which biomarkers are present in fungal cultures when 
treated with anti-fungal compounds. Willger et al. (2008) investigated the metabolism 
of A.fumigatus in low oxygen environments in lung tissues. They found ethanol 
production when glucose was the main source of carbon indicating that cultures of 
A.fumigatus, which is an obligate aerobic filamentous fungus, switched to alcohol 
fermentation pathways.  They also suggested that A.fumigatus used fermentation in 
order to grow in microaerophylic and hypoxic environments. In the present study, the 
stress conditions of the anti-fungal treatment might have affected the biosynthetic 
pathways resulting in alternative pathways being used and resulting in a modified set of 
volatile compound end products.  
The findings of biomarkers with SIFT-MS techniques would permit the acquisition of 
more knowledge about the volatiles released from each microorganism in normal 
conditions and under different stressful situation such as drug therapy. This might lead 
to the discrimination of clinical samples with trained models using the e-nose which 
may be more user friendly, may not need pre-processing steps to obtain results, perhaps 
in real time.  However, it is necessary to optimise the processing of the clinical samples 
in order to obtain good identification and discrimination of microbial growth under 
antibiotic therapies. 
GC-MS and SIFT-MS data analysis has been widely used to look for a number of 
biomarkers in breath samples. The biomarkers could be used to detect disease, monitor 
disease progression or monitor therapy such as glucose for insulin resistance, 
methacetin for liver function, ethanol for law enforcement and urea for H.pylori 
infection among others (Risby and Solga, 2006). Breath analysis advantages are 
various; the lack of invasiveness and the easy collection of samples at the patient’s site 
with the only requirement that the patient must be breathing spontaneously or 
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mechanically supported. However, breath analysis has shown some disadvantages due 
to the presence of some confounding factors such as diet, age, smoking habits, patient’s 
cardiopulmonary status and sample contamination from air. 
In the current work it appears that some compounds may be present in higher 
concentrations in some treatments or in some microorganisms when in vitro samples 
were studied. Humphreys (2010) tried to identify specific markers in 58 breath samples 
from patients with more than 72 hrs intubation. At the same time BAL samples were 
taken and split into two parts for posterior analyses; for microbiological cultures, and 
for e-nose analysis. Breath samples from patients with microbial growth, non-microbial 
growth and healthy volunteers were compared. After appropriate analysis of data using 
AMDIS and the NIST library no compounds seemed to be clear VAP biomarkers. 
However, it was found that some were evidently increased in breath samples containing 
microbial growth, including isoprene; acetone (higher amounts in non-contaminated 
samples rather than healthy volunteers) and acetaldehyde with respect to the controls. It 
is difficult to determine which compounds from the breath analyses are exogenous or 
endogenous and, within these, which ones are indicative of infection/inflammation in 
body tissues. Bergeron et al. (1998) found high levels of pro-inflammatory cytokines 
and nitric oxide in BAL samples from experimental pneumococcal infections in mice. If 
some of these compounds are detectable and may form a volatile pattern correlating 
with the e-nose volatile profiles for specific samples, then these findings could 
potentially lead to the use of the e-nose system to analyse breath samples from VAP 
patients in a non-invasive, less time consuming and reliable way of diagnosis. 
 
4.6 COMPARISON OF DISCRIMINATION BETWEEN 5 
MICROORGANISMS USING NUTRIENT BROTH AND 
SALINE SOLUTION 
 
The currently but invasive method of sampling procedure for VAP diagnosis is the 
obtaining of BAL specimens which are performed in sterile saline solution. For this 
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reason experiments with saline solution were carried out and the results were compared 
with those carried out in NB medium. All the 5 VAP microorganisms were tested in 
both media and the discrimination based on the volatile fingerprints was found to be 
very similar. In both media, with an initial concentration of 10
4
 cells/spores ml
-1
 and 
after 24 hrs incubation four different clusters were observed: one with the two Gram-
negative bacteria, a second one with C.albicans, a third one with the Staphylococcus 
strain (or S.aureus) and a fourth one with the blanks and the A.fumigatus samples. 
The capability of the e-nose sensor array system to detect and distinguish between 
microorganisms has been tested in many studies, using many different media. Urine, 
sputum or breath samples have been analysed either directly or after culturing in 
commercial or more complex media. For example, Gardner et al. (1998) distinguished 
between E.coli and S.aureus, a Gram-negative and a Gram-positive bacterium in 
standard nutrient medium (blood agar) in 12 hrs incubation but the initial concentration 
used was not reported. 
No attempt had previously been made to use saline solution as a basal laboratory 
medium for growing microorganisms for head space volatile analyses. Boilot et al. 
(2002) showed that using a CP e-nose it was possible to discriminate between six 
different bacteria (S.aureus, H.influenzae, E.coli, P.aeruginosa, M.catarrhalis, 
S.pneumoniae) responsible of eye infections in saline solution. However, in this case, all 
the bacterial strains were grown in commercial agar media overnight and then 
suspended in saline solution for analysis.  
In this study, saline solution as a culture medium was successfully used for microbial 
discrimination. It could be possible that initial culture on agar media facilitated the 
discrimination at earlier stages. Casalinuovo et al. (2006) suggested that bacterial agar 
cultures could produce more volatiles than broth cultures. In their experiment, they 
analysed the head space from four microorganisms (K.pneumoniae, C.albicans, 
P.aeruginosa, E.coli) cultured on agar and in broth media, after 24 hrs incubation with 
an initial concentration of 10
6
 CFU ml
-1
. They were able to discriminate between 
bacteria in agar cultures and yeasts in both cultures but they concluded that the volatile 
production patterns from bacterial broth cultures were not detectable by the e-nose used, 
an acoustic wave sensor which can display the volatiles in chromatograms. In my study, 
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agar media were only used to grow fresh cultures for inoculation of saline solution 
treatment media. I obtained good discrimination in broth cultures, NB and saline 
solution with five very similar microorganisms to the ones used in this previous study 
and with a different e-nose. However, they used a higher initial concentration than in 
my studies on saline and NB broth.  Previously, Sahgal (2008) investigated the 
discrimination between twelve microorganisms distributed in eight different genera 
using NB and a similar e-nose. After the analysis with PCA and DA, she found that not 
all of the microbial species could be distinguished. She was able to split them into four 
groups:  Gram-positive, Gram-negative, fungi and controls. This was achieved with a 
classification accuracy of 82.6%.  
The grouping distribution by microorganism found in the current work was modified 
with longer incubation periods. There was poorer discrimination between 
microorganisms as the incubation period was extended.  Volatile fingerprints may vary 
depending not only on the initial number of microorganisms, but also on the time of 
growth. Presumably, the analysis of head space at 24 hrs incubation occurred when the 
most of the bacterial species and the yeast, reached the stationary phase of growth. 
Some authors (Gardner et al., 1998) investigated the discrimination between two 
bacteria and its growth phase by using an e-nose with six metal-oxide sensors and ANN. 
They found that 80.7% of all tests were correctly classified and only bacterial growth in 
the lag phase failed in terms of prediction with 14.3% of good classification. Clearly, 
the best discrimination between microorganisms has to be reached when they are 
actively growing, i.e., during log and stationary phases, when more volatiles are present 
in the head space. These results are consistent with what was found in the current 
studies. 
4.7 USE OF VOLATILE DATA SETS FROM NUTRIENT BROTH 
AND SALINE SOLUTIONS ON THE VAP 
MICROORGANISMS TO BUILD A MODEL FOR 
PREDICTION OF CLINICAL SAMPLES 
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Two statistical models were built and then used to try and predict the groupings for the 
clinical samples using DA: one for NB data and another for saline solution (amended 
with 0.2% glucose and 0.2% peptone). Both models used the e-nose data analysed from 
24 hrs incubation at 37°C for the 5 VAP microorganisms. These models showed good 
accuracy of prediction when they were tested as a validation set. Later, these models 
were used to predict a set of clinical samples which had been analysed using a different 
e-nose. Furthermore, PLS-DA was used to predict the groupings into which the clinical 
samples fell, based on the in vitro model.  
Alternative scaling methods were investigated although the raw data provided by the e-
nose software was already scaled by the mean-centred method. Jurs et al. (2000) 
suggested there is no guideline for choosing the most appropriate method and it is 
necessary to explore and choose the most suitable pre-processing method for the later 
analysis with multivariate techniques. Also, the fact that different data sets were 
measured on different days led to the use of a simple and quick standardisation process. 
Haugen et al. (2000) suggested that if changes in the measurements are observed over 
time, the responses of calibration substances closely related to real samples might be 
used to correct the differences between measured samples on different days. 
Multiplicative drift correction (MDC) was used in the present study to correct the signal 
differences over time using the closest calibration substance available, the blanks of 
each medium. 
After all these considerations, the models for clinical classification were applied. The 
results were not very good for clinical samples resulting in an overall prediction of 
63.6% and 53.4% in NB and saline solution respectively, using DA and 63.6% and 
52.3% for each medium when using PLS-DA and standardisation of the e-nose devices.  
Most importantly, looking at the % of classification success per each group in which the 
clinical samples were divided, the models with highest overall classification, i.e. > 60%, 
had good prediction only in “no growth” group. Certainly, the results with saline 
solution using DA failed in terms of sensitivity. Only the large group of “no growth” 
samples was successfully predicted.  The different number of training vectors for each 
group might have made tighter associations between some vector responses with the 
largest classes (Gardner et al., 1998). This is especially true for non-linear methods such 
General Discussion 
110 
as ANNs where it is necessary to have more samples than variables (Sahgal, 2008) but 
even more importantly than the number of samples is having an adequate number of 
representative and reproducible samples for each class (Kodogiannis et al., 2002), 
especially in neural network models. The use of non-parametric methods such as ANN 
might have improved the classification of unknown samples in this study if more data 
for the training set was available and if it had been more homogeneous.  
The relative success of using an in vitro model for clinical sample prediction might be 
due to the use of very heterogeneous data sets. Most of the clinical samples were taken 
from patients under antibiotic therapy which might have affected the accuracy of the e-
nose results compared with the microbiological outcomes. As Sahgal (2008) found, 
false negative cultures may be identified as positive by the analysis of the volatiles with 
the e-nose.  
It is also important to ascertain whether the discrimination between samples is due to 
the microbial metabolism or due to the products of the host’s immune system. If it is 
due to the microbial activity per se, there is the need of improving the liberation of 
volatiles with biochemical precursors as Pavlou et al. (2002b) suggest or with specific 
enzymes (Pavlou et al., 2004).   
It was unfortunate that during this project no new clinical sample sets could be provided 
by clinicians to facilitate the testing of the in vitro models more extensively, to enable 
the outcomes of this being tested against what was found microbiologically using 
microbiological analyses. This would have even been more interesting if these could 
have been divided based on whether they had antibiotic or anti-fungal treatments.  
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CHAPTER 5: CONCLUSIONS AND FUTURE WORK 
5.1 CONCLUSIONS 
 Due to the high importance of the control of the sensor responses, it is necessary to 
monitor the consistency of the sensors over the period of study. Good consistency of 
the responses of the sensors was observed.  It is also important to analyse a set of 
reference samples prior to each experiment. 
 Three enriched commercial media were tested for discrimination of two 
microorganisms, a yeast and a Gram-negative bacterium. NB showed earlier 
discrimination between both species after 24 hrs incubation. This medium was 
selected for carrying out subsequent experiments. 
 The sensitivity for the detection of three different initial concentrations of five VAP 
microorganisms was tested. 10
2
 CFU ml
-1
 as initial concentration may be 
discriminated from blank samples after: 24 hrs for bacteria; 48 hrs for yeast; and 72 
hrs for filamentous fungus. 
 In mixtures of two microorganisms: There was predominant growth of one of the 
microorganisms (E.cloacae) when two are mixed together; the volatile pattern 
production might permit the identification of the predominant species. 
 ED50 and ED90 concentrations of different anti-fungal compounds were determined 
for control of A.fumigatus and C.albicans based on growth studies on agar and 
liquid broth media, respectively.  
 Good discrimination between fungal samples treated with anti-fungal (A.fumigatus+ 
ED50 and ED90 Benomyl/Tebuconazole) at 37°C on solid medium after 48h of 
incubation) but not at 25°C; poor results for the yeast grown in liquid medium 
(C.albicans+ ED50 and ED90 Tebuconazole) at 37°C in saline solution. 
 SIFT-MS analyses showed that some compounds were present in higher amount in 
certain treatments when the fungus A.fumigatus was grown on solid medium 
amended with different concentrations of anti-fungal which could explain the good 
discrimination in the e-nose. 
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 The head space from 5 VAP microorganisms grown on NA was analysed using 
SIFT-MS system and some key components were found: 1,4-pentadiene present 
only in A.fumigatus and E.cloacae; 4,4-dimethyl-1-pentene, 2-methyl-3-
isopropylpyrazine and methyl mercaptan in A.fumigatus; mercaptoacetone and 
phenylethyl alcohol in C.albicans; aletamine in E.cloacae; and 2-methyl-1-propanol 
in K.pneumoniae cultures.  
 Similar analyses in liquid medium with C.albicans showed no differences between 
treatments which were confirmed by the lack of discrimination achieved with the e-
nose. 
 Very good discrimination between 5 VAP microorganisms grown in NB and saline 
solution (amended with 0.2% glucose and 0.2% peptone) laboratory-based model. 
Potential exists for using the  laboratory-based model for examining clinical samples 
to try to classify the contamination with Gram-positive, Gram-negative and fungal  
infections. 
 To build a laboratory-based model to predict microbial contents of clinical samples 
using volatile fingerprints it was  necessary to: (1) standardise  measurements when 
several sets of samples are analysed at different times; (2) develop a  scaling 
approach to reduce the differences between groups. 
 Two in vitro models were tested, i.e., NB and saline solution amended with 0.2% of 
glucose+0.2% peptone for clinical samples prediction divided in 4-groups. Similar 
accuracy was obtained using DA and PLS-DA methods: 63.6% for both techniques 
in saline solution; 52.3% with PLS-DA and 53.4% with DA in NB. 
 The maximum overall accuracy classification was 63.6% using in vitro model in 
saline solution. The sensitivity achieved was very poor, only the largest group of 
“no growth” was mostly well predicted. 
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5.2 FUTURE WORK 
 
 To use the e-nose analyses to build two models for prediction of unknown samples 
using ANNs and compare their results, one with clinical samples of patients, 
another with in vitro samples. 
 To investigate the improvement of volatile profiles released from clinical samples 
either by adding specific compounds or filtering and adding little amounts of 
biochemical precursors as sources of nitrogen and energy and incubate for a short 
period of time. 
 Finding which enzymes might be added to clinical samples in order to intensify 
volatile fingerprint patterns also in samples from patients who are being treated 
with antibiotics. 
 To analyse more combinations of microbial mixtures using the e-nose and 
chromatographic systems, also with microbiological techniques in order to find 
their interactions and results in numbers and in volatile profiles.  
 To investigate the effect of antibiotic therapy on the volatile production using the e-
nose in liquid media with filamentous fungus, also with bacteria in order to 
correlate with clinical samples.  
 To analyse VAP patients’ breath and compare with other results such as the 
analysis of the BAL samples with the e-nose and BAL cultures. These analyses 
have not been done before and might eventually give some information about 
volatiles. 
 Determining the possible biomarkers for discrimination in liquid media from 
microbial cultures using GC-MS, this could explain the discrimination between 
groups of microorganisms and the lack of distinction within same type of microbes, 
e.g. Gram-negative. 
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APPENDICES  
APPENDIX A ORIGIN OF THE MICROORGANISMS 
TESTED 
 
A.1 Microbial Isolates 
COLLECTION: Microbiology Department, Cheltenham General Hospital 
SOURCE: Clinical isolates from patients 
SITE ORIGIN: Lung, BAL fluid aspirate 
a)  Klebsiella pneumoniae (16129695)* 
b) Staphylococcus species (16129695)* 
c) Enterobacter cloacae (16191218)* 
d) Candida albicans (16191218)* 
 
COLLECTION: American Type Culture collection 
ATCC® NUMBER: 6538™ 
ISOLATION: Human lesion 
e) Staphylococcus aureus sbsp. aureus Rosenbach 
 
COLLECTION: Applied Mycology group, Cranfield Health 
f) Aspergillus fumigatus (Af293) 
* Hospital’s microbiology laboratory identification number  
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APPENDIX B TABLES 
 
Table B.1: Typical formula for three different media (g l
-1
). BHIB: Brain heart infusion 
broth; TSB: Tryptone soya broth; NB: Nutrient broth. 
 
BHIB                                 
g/l 
TSB                                
g/l 
NB                            
g/l 
Calf brain 
infusion 
12.5 Pancreatic 
digest of 
casein 
17 Meat extract 1 
 Calf heart 
infusion solids 
5 Enzymatic 
digest of soya 
bean (with 
papain) 
3 Yeast 
extract 
 
2 
 
Proteose peptone 10 Di-potassium 
hydrogen 
phosphate 
5 Peptone 5 
Glucose 2 Glucose 2.5 Sodium 
chloride 
5 
Sodium chloride 5  
Di-sodium 
phosphate 
2.5 
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Table B.2: Sensors and detected compounds in NST 3320 instrument 
Sensor Important detected compounds 
MOSFET 101A Hydrogen, amine 
MOSFET 102A Amine, ester 
MOSFET 103A Amine, aldehyde, alcohol 
MOSFET 104A Hydrogen 
MOSFET 105A Hydrogen, amine 
MOSFET 101B Amine, aldehyde, ester, alcohol, ketone 
MOSFET 102B Hydrogen, amine, alcohol 
MOSFET 103B Amine, aromate, aldehyde, ester, alcohol, ketone 
MOSFET 104B Hydrogen 
MOSFET 105B Hydrogen, amine, aldehyde, ester, alcohol, ketone 
MOS 101 Air contaminants (hydrogen, carbon monoxide) 
MOS 102 Hydrocarbons 
MOS 104 Alcohol, organic solvents 
MOS 110 Hydrocarbons 
MOS 111 Methane 
MOS 112 Propane, butane 
MOS 113 Hydrogen 
MOS 114 Organic solvents 
MOS 115 Alcohol 
MOS 116 Freon 
MOS 117 
MOS 118 
Ammonia 
Organic solvents, alcohol, hydrogen 
Humidity sensor Relative humidity at 70˚ C 
CO2 (optional) CO2 
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Table B.3: Summary of mean, standard deviations and % of variations of the sensor 
responses over a period of 24 months. 
Sensors 
0.1% acetone 0.1% ipa Distilled water 
Mean Stdev % Mean Stdev % Mean Stdev % 
FE101A 63.75 4.49 7.04 66.60 4.93 7.40 63.87 4.33 6.78 
FE102A 90.14 7.41 8.22 93.39 7.95 8.51 89.48 7.29 8.14 
FE103A 162.71 14.85 9.13 169.80 16.15 9.51 162.99 14.81 9.09 
FE104A 44.63 8.20 18.37 48.23 8.85 18.34 46.35 9.14 19.72 
FE105A 20.64 5.35 25.94 23.25 6.71 28.84 21.86 4.95 22.67 
FE101B 78.40 11.02 14.05 81.84 11.89 14.53 78.01 9.32 11.95 
FE102B 111.75 8.81 7.89 114.61 9.73 8.49 111.10 9.18 8.26 
FE103B 133.94 13.01 9.71 140.06 14.88 10.63 135.95 13.65 10.04 
FE104B 37.48 0.83 2.20 39.01 0.65 1.66 37.90 0.85 2.23 
FE105B 6.43 2.14 33.29 8.22 2.70 32.84 7.16 2.04 28.45 
MO101 415.40 7.71 1.86 390.35 8.26 2.12 126.57 22.60 17.85 
MO102 259.03 8.23 3.18 223.90 8.11 3.62 112.58 7.99 7.09 
MO104 264.59 20.78 7.85 163.61 25.44 15.55 29.79 7.97 26.76 
MO110 237.44 15.58 6.56 198.65 14.93 7.51 106.48 6.83 6.42 
MO111 96.09 6.98 7.26 83.36 6.01 7.22 82.36 6.25 7.59 
MO112 133.65 8.19 6.13 106.49 8.16 7.66 74.65 8.05 10.79 
MO113 14.43 2.69 18.66 6.89 1.41 20.43 1.74 0.51 29.25 
MO114 421.09 6.49 1.54 384.64 14.08 3.66 49.10 17.05 34.73 
MO115 296.23 38.94 13.14 329.70 30.44 9.23 168.30 18.17 10.80 
MO116 396.46 9.65 2.43 394.98 10.03 2.54 168.44 20.79 12.34 
MO117 425.61 13.57 3.19 381.81 22.13 5.80 73.24 17.19 23.47 
MO118 319.47 31.64 9.91 274.64 30.04 10.94 83.62 8.96 10.72 
Humidity 12.54 0.82 6.57 12.62 0.89 7.03 12.12 0.81 6.72 
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APPENDIX C FIGURES 
 
 
Figure C.1:  A.fumigatus with benomyl ED50  and ED90 after 24 hrs incubation 
 
 
Figure C.2: PCA score plot of C.albicans 48 hrs incubation at 37°C in NB. (Key: Ca: 
C.albicans: 10(2), 10(4) and 10(6): 10
2
, 10
4
 and 10
6
 cells ml
-1
) 
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Figure C.3: PCA score plot of K.pneumonaie after 24 hrs incubation at 37°C in NB. 
One outlier was removed. (Key: Kp: K.pneumoniae: 10(2), 10(4) and 10(6): 10
2
, 10
4
 
and 10
6
 cells ml
-1
). 
 
 
Figure C.4: Growth rates of A.fumigatus at 37°C with different concentrations of 
benomyl on MEA over a period of 9 days. 
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Figure C.5: Growth rates of C.albicans at 25°C with different concentrations of 
fluconazole in NB over a period of 6 days. 
 
Figure C.6: PCA plot after 48 hrs incubation on MEA at 37°C of A.fumigatus (Af) with 
ED50/ED90 concentrations (ED50/ED90) of tebuconazole (T) and benomyl (B). Red 
dotted line: outlier.  
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Figure C.7: PCA plot of C.albicans after 48 hrs incubation at 25°C in NB. (Key: 
Ca+ED50/90-F: C.albicans+ED50/90 of fluconazole). 
Ward`s method
Euclidean distances
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Linkage Distance
Control-2
Control-3
Control-4
Control-1
Ca+ED50-T-3
Ca+ED50-T-2
Ca+ED50-T-1
Blank-4
Blank-3
Blank-2
Ca+ED90-T-3
Ca+ED90-T-2
Ca+ED90-T-1
Ca+ED50-T-4
Ca+ED90-T-4
Blank-1
 
Figure C.8: Dendrogram of C.albicans after 48 hrs incubation at 25° C in NB. (Key: 
Blank: NB without inoculum; Control: C.albicans without anti-fungal; Ca+ED50/90-T: 
C.albicans+ED50/90 of tebuconazole). 
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Figure C.9: Bar chart of some compounds found in distinctive amounts between blank 
medium and five VAP microorganisms by using SIFT-MS system after 24 hrs 
incubation at 37°C on NA. No replicates were analysed. 
 
 
Figure C.10: Histogram for the resulting distribution for the in vitro model in saline 
solution+0.2% glucose-0.2% peptone at 37°C after 24 hrs incubation using PLS-DA 
method. (Key: SS: saline solution; LV: latent variable; MC: mean-centred scale). 
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APPENDIX D PUBLICATIONS, ORAL PRESENTATIONS 
AND POSTERS 
D.1 Publications 
1. Planas, N., Kendall, C., Magan, N. (2009). Early Discrimination Of Microorganisms 
Involved In Ventilator Associated Pneumonia Using Qualitative Volatile Fingerprints.  
International Symposium on Olfaction and Electronic nose, Brescia 2009, Italy. 
Proceedings. 
2. Camardo Leggieri, M., Planas Pont, N., Battilani, P., Magan, N. (2011). Detection 
and discrimination between ochratoxin producer and non-producer strains of 
Penicillium nordicum on a ham-based medium using an electronic nose. Mycotoxin 
Research 27, 29-35. 
3. Humphreys, L., Orme, R., Moore, P., Charaklias, N., Sahgal, N., Planas Pont, N.,  
Magan, N., Stone, N., Kendall, C.C. (2011). Electronic nose analysis of bronchoalveolar 
lavage fluid. European Journal of Clinical Investigation 41, 52-58. 
4. Planas Pont, N., Kendall, C., Magan, N. Analysis of volatile fingerprints for 
monitoring anti-fungal efficacy against the primary and opportunistic pathogen 
Aspergillus fumigatus. Being submitted to Mycophatologia.  
5. Planas Pont, N., Kendall, C., Magan, N. Use of a similar and medically relevant lung 
fluid medium for discrimination between microorganisms involved in VAP and for 
building up a model for unknown samples. In preparation. 
Student’s contribution to papers 1, 4 and 5: to plan the experiments, prepare the samples 
and do the e-nose analyses, perform the statistical analyses and prepare a paper draft. 
Student’s contribution to paper 2: I assisted the first author to analyse the samples by 
the e-nose and obtain the results with statistical methods. 
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Student’s contribution to paper 3: I analysed with the e-nose the latest clinical samples 
and I assisted the first author in providing any needed information related to the e-nose 
procedure.  
D.2 Oral presentations 
1. Electronic Nose for early detection and discrimination of microorganisms involved in 
Ventilator-Associated Pneumonia (VAP). Presented at the Postgraduate Students 
Conference, September 2010, Cranfield Health, Cranfield University, UK. 
D.3 Posters 
 
1. Planas, N., Sahgal, N., Kendal, C., Barr, H. and Magan, N. In vitro discrimination 
of microorganisms involved in ventilated associated pneumonia using the Electronic 
nose.  Multistrand Conference, May 2008, Cranfield University, UK. 
2. Kendall, C., Humphreys, ML., Charaklias, N., Orme, R., Moore, P., Sahgal,  
Planas, N, Magan, N., Ston, N. IPEM annual Scientific meeting, September 2008, 
Bath University, UK. 
3. Planas, N., Sahgal, N., Kendal, C., Barr, H. and Magan, N. Early discrimination of 
microorganisms involved in Ventilator Associated Pneumonia (VAP) using 
qualitative volatile fingerprints. International Symposium on Olfaction and 
Electronic nose, April 2009, Brescia University, Italy. 
4. Planas, N., Sahgal, N., Kendal, C., Barr, H. and Magan, N. Screening of drugs and 
discrimination of microorganisms involved in Ventilator Associated Pneumonia 
(VAP) using volatile fingerprints. Postgraduate Students Conference, September 
2009, Cranfield Health, Cranfield University, UK. 
5. Planas, N., Sahgal, N., Kendal, C. and Magan, N. Volatiles fingerprints: use of a 
hybrid sensor array electronic nose to screen anti-fungal efficacy against 
A.fumigatus and C.albicans. 20
th
 Anniversary World Congress on Biosensors, May 
2010, Glasgow, UK. 
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Analysis of volatile fingerprints for monitoring anti-fungal efficacy against the 
primary and opportunistic pathogen Aspergillus fumigatus 
Neus Planas Pont
a
, Catherine A. Kendall
b
, Naresh Magan
a,* 
 
a
Applied Mycology Group, Cranfield Health, Cranfield University, Bedfordshire MK43 
0AL, UK 
b
Gloucestershire Hospitals NHS Foundation Trust, Great Western Road, 
Gloucestershire, GL1 3NN, UK. 
 
Corresponding author: Prof. N. Magan, Applied Mycology Group, Cranfield Health, 
Cranfield University. Tel.: +44 1234 758308; Fax: +44 1234 758380; E.mail: 
n.magan@cranfield.ac.uk. 
 
Key words: Hybrid sensor array, volatile fingerprints, anti-fungals, lung infections, 
volatile compounds. 
 
Abstract 
The aims of this study were to use of qualitative volatile fingerprints obtained using a 
hybrid sensor array system (12 metal oxide semiconductor sensors, 10 metal oxide 
semiconductor field effect transistor sensors) to screen anti-fungals for controlling the 
important lung infecting fungus, Aspergillus fumigatus, especially in immune-
compromised patients. SIFT-MS was also used to try and identify key volatiles 
produced by A.fumigatus.  Initial studies were carried out to identify the ED50 and ED90 
(effective dose) for inhibiting growth of A.fumigatus using three anti-fungal 
compounds, benomyl, tebuconazole and fluconazole. Subsequent studies involved 
inoculation of malt extract agar plates with spores of A.fumigatus (25, 37
o
C) over 
periods of 24-72 h to examine the head space volatile fingerprints generated from the 
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sample treatments using the hybrid sensor array system to compare controls and 
ED50/ED90 concentrations. The sensor responses for divergence for treatments were 
used to build a model. This showed discrimination between treatments after 48 h 
incubation when benomyl and tebuconazole were used against A.fumigatus at 37°C, and 
after 72 h at 25
o
C using Principal Components Analysis and Cluster Analysis. Studies 
using SIFT-MS showed that methyl pentadiene, ethanol, isoprene and methanol were 
key biomarker volatiles produced by A.fumigatus in the presence of anti-fungal 
compounds. This may also be a good approach for the development of rapid screening 
of anti-microbial compounds and potentially useful for the monitoring the possible build 
up of resistance to specific drug types. Volatile fingerprints produced by patient samples 
could also be used to evaluate whether lung infections are caused by bacteria or specific 
fungi to facilitate early diagnosis and enable the right drug treatment to be prescribed. 
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Neus Planas, Natasha Sahgal, Catherine Kendall*, Hugh Barr* and Naresh Magan
Applied Mycology Group, Cranfield Health, Cranfield, Bedford MK430AL and *Gloucestershire Royal 
Hospital, Great Western Road, Gloucester, Gloucestershire, GL1 3NN
•There has been interest in using breath analyses as a rapid diagnostic measurement of 
ventilator associated pneumonia (VAP). 
•VAP is caused by a range of individual or mixtures of micro-organisms. 
•We have thus initiated a research project to examine the potential for using volatile 
fingerprints as biomarkers of specific microbial infections to facilitate more effective 
treatment.
CULTURES: Three different bacteria (Enterobacter cloacae, 
Klebsiella pneumoniae and Staphylococcus sp) and two fungi 
(Aspergillus fumigatus and Candida albicans) were cultured in 
conical flasks and analysed in the Enose.
Results
In vitro discrimination of microorganisms involved in 
ventilated associated pneumonia using the Electronic nose
n.planaspont.s06@cranfield.ac.uk
© Cranfield University 2008
Headspace analysis
Every 24hrs   
(96 hrs)
E-nose-AS Nordic 3320
Fig 1: PCA Scores plot after 72 hours 
discriminating between five species with the 
same concentration  ( 104 CFU/ml)
Fig 2: PCA Loadings plot indicating the 
contribution of sensors in separating 
samples along PC1 and PC2
Specific vials for E-nose
Fig 3: Calibration curve for C.albicans after 
48hrs growth against absorbance at 640nm 
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Fig 4: PCA Scores plot after 24 hours showing 
the relative discrimination between three 
concentrations of A. fumigatus. (1% Nutrient 
Broth medium)
Conclusions
•Using PCA analyses it was possible to obtain good differentiation between the species after 72 hrs.
•The lowest concentration (102) is difficult to discriminate either from the blank (24hrs) or from 104 (72hrs).
•Further studies are necessary in order to optimise a medium for rapid discrimination between different species 
causing VAP.
•Work is now in progress to identify the sensitivity of detection of each species and to examine the effect of 
different drug treatments in vitro on the species responsible for VAP.
Fig 6: PCA Scores plot after 72 hours showing the 
relative discrimination between three concentrations 
of K. pneumoniae (1% Nutrient Broth medium)
Fig 5: Hierarchical Cluster Analysis of data from Fig 4 
showing the cluster of 106 CFUs distinctly separated 
from the others.
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4. Conclusions
5. References
• E-nose analysis provides a rapid and accurate method for
the detection of micro-organisms in BAL fluid.
• Potential to identify infecting organism.
• Effect of antibiotics is under further investigation.
• Potential for point-of-care diagnosis facilitating earlier
initiation of targeted antibiotic therapy, thereby improving
patient outcome, reducing hospital stay and resistance to
broad spectrum antibiotics.
 
Hypothesis: E-nose technology can detect micro-
organisms in BAL fluid, enabling targeted antibiotics to
be administered earlier, improving patient outcome.
• Patients ventilated > 72 hours.
• Clinical pneumonia infection score (CPIS) recorded
(modified from [3]).
•Blind bronchoalveolar lavage (BAL) with 20ml 0.9% NaCl.
Sniffing disease [1,2]
Microbiology E-nose
Multivariate Analysis
Principal Component (PC) fed Linear 
Discriminant Analysis (LDA)
BAL
48
hours
3. Results
• Microbiological growth identified in 40% (21/52) samples
collected from 27 patients.
• E-nose correctly classified 81% (42/52) of samples in a
growth versus no growth model.
Samples with no microbiological growth
•39% (12/31) samples with no microbiological growth were
classified as infected by the E-nose.
• No correlation between CPIS and microbiological growth.
• CPIS correlates with E-nose prediction in 68% (21/31)
samples with no microbiological growth.
• Could the microbiological culture have failed due to
antibiotic use? (~90% of patients on antibiotics).
• Testing E-nose response of lab cultures to antibiotic
therapy.
• Need more rigorous gold standard to test E-nose against.
63% (33/52)
samples correctly
classified in a 4
group clinical
model
Micro-organisms
grown from BAL
samples were
individually
cultured for a 4
group lab model
E-nose analysis
correctly identified
83% (81/98) of
samples
Figure (b) 4 group lab model
X-ray
Diagnosis of ventilator associated pneumonia (VAP) is 
a significant problem on ITU
Bronchoalveolar 
Lavage (BAL)
CPIS
Gram +ve Gram –ve Candida No growth
 Gloucestershire Hospitals
NHS Foundation Trust
Figure (a) 4 group clinical model
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